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Abstract 
While evidence-based medicine (EBM) is a widely accepted feature of contemporary 
medicine, the applicability of evidence to clinical practice is often questioned. The 
proprietary system UpToDate has emerged as one of the most heavily used point-of-care 
evidence resources. While some existing research evaluates UpToDate’s utility and features, 
no critical analysis of its content exists. This thesis is a multiple, mixed methods case study 
examining how evidence, authors, and the patient-physician relationship are situated in 
UpToDate. A descriptive analysis of the type and features of the cited evidence, as well as an 
overarching textual analysis of the clinician and patient information entries was completed 
for seven cases (conditions), chosen to represent different levels of certainty (with respect to 
diagnosis and/or treatment), medicalization, and contestation (with respect to the ‘legitimacy’ 
of a condition). Cross-case analyses were also conducted.  Data analysis was informed by the 
field of Science and Technology Studies, which recognizes the study and development of 
science and technology as social and interactive processes. Findings indicate that, in the 
absence of explicit and transparent guidelines, authors who contribute to UpToDate adhere 
loosely to the general principles of EBM. The content of entries suggests that UpToDate acts 
not only as an evidence provider but as a ‘mentor’ and ‘curbside consultant’ to users, 
functioning as a technological surrogate for in-person interactions. UpToDate is an attempt to 
bridge a real gap between evidence and practice, however, this study brings to light signs of a 
‘hidden curriculum’ embedded in this clinical tool. While on the surface UpToDate is 
designed to support ‘scientific’ practice by incorporating clinical judgment, expertise, and 
advice about tailoring care for patients with research evidence, it may also perpetuate 
physician-centred, rather than patient-centred, care, and focus on the “art” rather than 
“science” of medicine, seemingly contradicting EBM’s core purposes.  
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Chapter 1: Introduction and Literature Review 
Introduction  
 The breadth and depth of medical evidence has expanded greatly in the last half-
century. To address the information overload reported by physicians and healthcare 
practitioners (Bennett, Casebeer, Kristofco & Collins, 2005; Cook, Sorensen, Wilkinson & 
Berger, 2013), information resources and tools that distill and summarize clinical evidence 
have been developed. These tools are rapidly becoming the go-to information sources for 
clinicians who are integrating evidence into their clinical decision-making. UpToDate is 
reported to be the most popular summary resource currently used by doctors (Cooper & 
Elnicki, 2011; Duran-Nelson, Gladding, Beattie & Nixon, 2013; Ensan, Faghankhani, 
Javanbakht, Ahmadi & Baradaran, 2011; Hoogendam, Stalenhoef, Robbe & Overbeke, 2008; 
Leff & Harper, 2006; Peterson, Rowat, Kreiter & Mandel, 2004; Schilling, Steiner, Lundahl 
& Anderson, 2005). By using tools such as UpToDate, physicians who may previously have 
struggled to find applicable and usable answers by consulting original research publications 
(Chambliss & Conley, 1996; Gorman, Ash & Wykoff, 1994; Hoogendam et al., 2008; Thiele, 
Poiro, Scalzo & Nemergut, 2010) are now able to find more concise and seemingly certain 
answers to their clinical questions (Campbell & Ash, 2006; Ensan et al., 2011; Hoogendam et 
al., 2008).  
The content of UpToDate is developed by experts in the field of clinical medicine with 
the goal of articulating their recommendations to fellow clinicians. While clinical science is 
often presented as objective and precise, the actual practice of medicine relies heavily on 
judgment and reasoning (Turpin & Higgs, 2009). Likewise, the creation of content for 
UpToDate and the related decisions regarding the inclusion and exclusion of certain 
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information resources into summary resources derive from thoroughly social and interactive 
processes. Using a Science and Technologies Studies (STS) lens, in which technologies and 
social practices are understood to be deeply connected, this study is an attempt to discover 
what information is lost and what information is privileged during the distillation of 
traditional health information sources, such as clinical studies and systematic reviews, into 
point of care resources, specifically, UpToDate. While the evolution and distillation 
processes which occur when the results and conclusions of original studies are summarized 
into systematic reviews have been well explored, the process through which clinical research 
is distilled into highly synthesized summary levels of evidence for clinical practice is not 
well understood. The study reported here is an attempt to begin to address this gap (Figure 1 
represents the area of research interest). Further, while summary resources, like UpToDate, 
have been evaluated repeatedly in terms of their timeliness, breadth, depth of coverage and 
the level(s) of evidence included; a critical analysis of the distillation and summarization 
processes has yet to be undertaken.  This study is one of the first systematic critical analyses 
of the most popular resource used in clinical practice and represents an attempt to understand 
the value and meaning of UpToDate within medical practice. As such, this study will be of 
interest to medical librarians, clinicians, health educators and product developers, as well as 
STS scholars. 
 
 
 
 
 
Figure 1: The Continuum of Evidence Summarization: Area of Research Interest 
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Literature Review 
Evidence-Based Medicine 
  Prior to the evidence-based medicine movement, clinicians relied heavily on “the art of 
medicine” for medical decision-making. This comprised a knowledge base combining a 
clinician’s experience and the collective experiences of the profession learned primarily 
through apprenticeship and modeling (Daly, 2005). The art of medicine was the dominant 
approach to medical care until the 1970s, when its validity began to be questioned. The art of 
medicine was considered, in part, to blame for the field of medicine being fraught with 
inconsistencies, overspending, and unproven and patriarchal health care practices.  The 
movement towards evidence-based medicine was, in part, an effort to downplay the ‘artistic’ 
practice of medicine to a model of consistent clinical care based in science.  
The ways in which evidence-based medicine is enacted in practice have evolved from 
its roots more than four decades ago. Archie Cochrane’s 1972 text, Effectiveness and 
Efficiency: Random Reflections on Health Services, laid the foundation for evidence-based 
medicine. In this text, Cochrane’s goals were connected to his commitment to social justice 
and his belief that limited health resources should be used to provide equitable access to 
those treatments shown to be most effective through high quality research studies 
(specifically, the randomized controlled trial, or RCT). Cochrane’s early text provided the 
seeds of what has now evolved into the Cochrane Collaboration and, more broadly, evidence-
based medicine. Building on his early writings, in 1979 Cochrane called for the medical 
profession to create an organized collection of summarized RCTs (Cochrane, 1979). A 
decade later, Cochrane made the first reference to a systematic review of RCTs in obstetric 
care, referring to the review as “a real milestone in the history of randomized trials and in the 
evaluation of care” (Cochrane, 1989, p. 3). He urged health practitioners to continue this 
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practice in support of what was later termed evidence-based medicine. Five years following 
Cochrane’s death in 1993, the Cochrane Collaboration, a not-for-profit volunteer 
organization committed to the systematic organization of medical research, was established 
and over time many of his ideas came to fruition.  
Following soon after the development of the Cochrane Collaboration, in 1995, Frank 
Davidoff and his colleagues launched the journal Evidence-based Medicine and provided the 
following description: 
Evidence-based medicine is rooted in five linked ideas: firstly, clinical decisions 
should be based on the best available scientific evidence; secondly, the clinical 
problem, rather than habits or protocols, should determine the evidence to be 
sought; thirdly, identifying the best evidence means using epidemiological and 
biostatistical ways of thinking; fourthly, conclusions derived from identifying and 
critically appraising evidence are useful only if put into action in managing 
patients or making health care decisions; and, finally, performance should be 
constantly evaluated. (Davidoff, Haynes, Sackett & Smith, 1995, pp. 1085-1086) 
 
Davidoff et al. provided the first and most comprehensive definition of evidence-based 
medicine (Cohen, Stavri & Hersch, 2004). One year later,  Canadian physician David Sackett 
and his colleagues (1996) formalized and defined the term Evidence-based Medicine (EBM) 
as “the conscientious, explicit and judicious use of current best evidence in making decisions 
about the care of individual patients” (p. 71). It is this definition that is commonly used and 
operationalized. EBM is intended to bring a scientific foundation to clinical work and to 
assist physicians to apply results from the vast amount of medical research to clinical 
practice. As a result of the EBM movement, publishers, clinicians and authors have 
developed new types of information tools and resources, including systematic reviews and 
the very popular electronic point of care information tools, including UpToDate1. 
  
                                                 
1 Other summary resources available include DynaMed and FIRSTConsult 
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STS Perspective: EBM as a Technology of Medicine 
Science and Technology Studies (STS) is a diverse and innovative field of 
scholarship in which numerous fields of study, including sociology, history, philosophy, 
anthropology, technology, medicine and information science, intersect. STS provides a 
unique and much needed perspective on information technologies. Outside STS, technologies 
are often conceived of as relatively straightforward and practical applications of science; 
however, scholars of STS challenge this assumption and examine science and technology as 
social activities. STS scholars assert that while scientists and engineers use the material 
world in their work, their work is not merely translated into knowledge and objects by a 
mechanical process, but rather through thoroughly social and interactive processes 
(Sismondo, 2010). A necessity of scientific development is the sharing of research results 
within and between scientific communities. Research can be challenged, defended, 
supported, or built upon—but all scientific sharing and exchange is social and interactive.  
Similarly, the process of distilling the body of clinical research into a usable and summarized 
format is not a mechanical or neutral process but rather a process driven by social 
interactions and personal judgment. Clinical experts make choices during the summarization 
process about what information to include and what information to discard. These choices are 
made not only at the resource level (what clinical studies to include or reject) but also at the 
content level (what information that was reported in the clinical research to privilege enough 
to include in these short summaries). The type of information that is included or excluded is 
significant because summary resources are developed as a means to convince or at least 
explain to physicians the best approach to clinical care. 
STS provides an important and helpful lens to study the development, design and use 
of information technologies.  Information and STS scholars, Bowker and Star (2000), 
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explored the ways in which information is formally and informally categorized and 
classified. Their observations about the informal and invisible categorizations of information 
that exist in communities of practice are helpful to understand the development and creation 
of summarized resources. Systems that are used to organize knowledge and information 
shape what we know and how we understand our environment. Bowker and Star suggest that 
communities of practice (or groups of individuals who conduct activities together and share 
items, processes and routines associated with these activities) often share ‘naturalized’ 
systems of categories of information. Naturalization occurs when individuals and 
communities forget about how a system or object is created and lose sight of the situated 
nature of such a system.  Members of communities often forget that the meanings of such 
systems or objects embedded in their activities are local in nature. The more entrenched 
individuals become in a community, the more likely they are to forget that their own 
categories may seem odd or out of place to those outside the community. Bowker and Star 
use the example of the anachronistic “cut and paste” metaphor used for using a mouse, 
selecting text, and digitally moving the text from one space to another. A basic medical 
example is physicians’ routine use of the word negative to mean ‘normal.’ For example, 
“your blood test came back negative for mono”. Conversely, ‘positive’ is used to imply an 
abnormal result, which signifies bad news. Bowker and Star suggest that infrastructural 
technologies “become a form of collective forgetting, or naturalization, of the contingent, 
messy work that they replace” (p. 299). As these systems become increasingly embedded 
into communities, they also become more invisible and more potent.  The exploration of such 
classifications is important because they may have significant political and ethical 
dimensions and consequences. In this study, evidence selected by the community of 
physicians who create and develop the summarized information for UpToDate was 
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examined.  The types of research and evidence selected as references for UpToDate content, 
as well as what content is selected for inclusion in the UpToDate entries, were investigated. 
In addition to gaining an understanding of the information included in the evidence 
summaries, some of the features of the evidence not included in the entry were identified. As 
Bowker and Star point out, there is value in understanding what and who are left out or 
remain invisible within a community’s information categories.  
When problems of knowledge and practice arise in healthcare, technological solutions 
are often advocated (May, Rapley, Moreira, Finch & Heaven, 2006). Technologies such as 
the electronic health record, patient blood pressure monitoring devices, diabetic insulin and 
blood glucose meters are technological solutions for problems encountered in health care and 
these technologies have been investigated by STS scholars. Similarly, the tools that deliver 
health evidence to professionals, as well as the evidence itself, are technologies that also 
warrant attention using an STS lens.   
May (2007) has examined information innovations in clinical care.  He suggests that 
while autonomy and control over knowledge is a hallmark of professionalism, the current 
information landscape in medical practice poses two challenges to physicians’ autonomy and 
control over their knowledge. First, because medical knowledge is continually expanding, the 
body of medical knowledge is impossible to master and within this massive corpus of 
knowledge are variations and contradictions that bring about uncertainties and 
inconsistencies in practice (Haynes, 2001). Second, physicians are faced with health policies 
and practices, such as patient centered care2, that increasingly rest on the assumption that 
patients are active consumers of health information and capable of developing their own 
                                                 
2 The IOM (Institute of Medicine) defines patient-centered care as: "Providing care that is respectful 
of and responsive to individual patient preferences, needs, and values, and ensuring that patient values 
guide all clinical decisions".   
              8 
 
expertise, assessing and choosing treatment options, and managing personal illness 
trajectories (May, 2007). It is in the context of these two attributes of the health information 
landscape that evidence-based medicine and its related tools are proliferating, including 
summary sources such as UpToDate.  
Circuit of Culture. Scholars of Science and Technology Studies have an interest in 
how technologies acquire cultural meaning, shape our environments, and enact the cultures in 
which they are created. One model which is helpful in understanding the cultural meaning 
and value of an object is Hall’s Circuit of Culture.  The Circuit of Culture framework is made 
up of five coexisting processes: Representation; Production; Consumption; Identity; and 
Regulation, which are all connected and interconnected (du Gay, Hall, Janes, Mackay & 
Negus, 1997). The resulting Circuit provides a means to understand the cultural text or 
artefact through examination of “how it is represented, what social identities are associated 
with it, how it is produced and created, and what mechanisms regulate its distribution and 
use” (du Gay et al., p. 3). Originally used to understand the cultural meaning of the 
Walkman, the Circuit of Culture provides a framework to garner a greater understanding of 
the shared meaning of textual objects and technologies, like UpToDate, within contemporary 
medical and information environments (Hall, 1997). 
Resistance to and Acceptance of EBM 
Evidence-based medicine garners both significant support, and critique. The 
professional and scholarly body of literature addressing evidence-based medicine is replete 
with voices from both positions. Both sides are passionate, as evidenced by the zealous 
language used: those who celebrate EBM often describe it using terms of religion and 
salvation, while those who are critical sometimes rely on radical political and authoritative 
language to support their claims.   
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Resistance to EBM. Published literature highlighting the shortcomings and 
limitations of EBM emerged quickly after Davidoff and colleagues first defined it in 1995 
(Feinstein & Horowitz, 1997; Horowitz, 1996; Maynard, 1997; Naylor, 1995). The number 
of scholars who express criticism and concern over the adoption of EBM has continued to 
grow in the last two decades (Freshwater & Rolfe, 2004; Goldenberg 2006, 2010; Green, 
2000; Holmes, Murray, Perron & Rail, 2006; Staller, 2006).   
In a 2004 review, Cohen et al. identified five themes found in EBM critiques : 1) 
EBM is based on empiricism, misunderstands or misrepresents the philosophy of science, 
and is a poor philosophic basis for medicine; 2) the definition of evidence in EBM is too 
narrow and excludes important information; 3) the usability and application of evidence to 
individual patients is limited; 4) EBM threatens the autonomy of the patient and physicians’ 
relationship; and 5) there is no evidence that EBM is effective, and therefore, EBM itself is 
not evidence-based (re-ordered from Cohen et al.). These themes, described by Cohen et al. a 
decade ago, continue to be explored in current publications. Of particular interest in current 
research are the first four themes: 
EBM is based on empiricism, a poor philosophic basis for medicine. One of the 
foundational concepts of EBM is that studies that ‘count’ as evidence should adhere to the 
guidelines of positivistic quantitative research and provide an evidence base that minimizes 
bias and attempts to generate an objective observer. However, EBM conflates the aim to 
reduce bias and ensure objectivity with the notion that these qualities are actually achieved in 
empirical research (Cohen, Stavri & Hersh, 2004). As a result of having the focus on 
observation rather than understanding as the basis of medical knowledge, EBM is criticized 
for disconnecting medicine from its scientific roots. Medical practitioners also condemn 
EBM for drawing their focus away from understanding physiological processes and the 
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mechanisms of disease towards evaluating the statistical purity of studies (Charlton & Miles, 
1998). The objectivity, evaluation, and bias inherent in observation gives rise to the criticism 
that the epistemological approach of empiricism on which EBM is based is inappropriate for 
medicine and draws attention away from more scientific and holistic understandings.  
The definition of evidence in EBM is too narrow and excludes important 
information. The notion of ‘best’ evidence is a key concept in all definitions of evidence-
based medicine. EBM ranks and grades evidence with the goal of excluding poor evidence 
and including only the best evidence. EBM has identified and defined the best study design 
for the array of clinical questions including diagnosis (cross sectional study), prognosis 
(cohort study), aetiology (cohort study); however, the preeminent example of this 
classification of research quality is the randomized controlled trial (RCT) as the best 
evidence for the evaluation of interventions. The evidence defined as best is given 
precedence – in a literal hierarchy - over all other types of evidence such as ethnographic 
studies, qualitative research, or clinical experience/case study/anecdote.  
The criticism of the RCT is longstanding. In 1991, Alvan Feinstein accused clinical 
epidemiologists of being obsessed with RCTs, assuming that the methodology possesses a 
superior form of truth, rather than recognizing it merely as an effective method for assessing 
whether treatment A is better than treatment B (Daly, 2005, p.104).  The restriction on the 
types of results considered to be ‘evidence’ within specific types of research designs, namely 
the RCT, has given rise to multiple critiques. First, the RCT can only answer a limited 
number of types of questions. Research topics, such as quality of life and personal wellness 
in relation to treatment protocols, require more subjective evaluation (qualitative methods or 
natural observation) and cannot be effectively investigated by the methods that EBM deems 
‘best’ (or even acceptable). Second, when epidemiological and statistical methods are applied 
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to clinical trial results, the individual patient results are averaged out, which can lead to the 
exclusion or disregard of important clinical details found within the data (Cohen et al., 2004). 
Lastly, the narrow definition of evidence deemphasizes other types of clinically relevant 
knowledge, including the patient and/or professionals’ qualitative understanding, knowledge 
and experiences with respect to medical interventions and related psychosocial factors.  
 Critics of EBM suggest that the notion of best evidence, a fundamental element of all 
definitions of evidence-based medicine, has the potential to eliminate, or at least discount, 
other potentially important forms of knowledge. In other words, the selection of specific 
evidence for EBM does not capture the ‘whole story’ of what occurs in clinical practice. 
The usability and application of evidence to individual patients is limited. The 
ability to effectively apply the results of the best evidence to specific patients has been called 
into question. EBM requires clinicians to begin by utilizing “knowledge derived from large 
trials, or from systematic reviews and meta-analysis—and translating this knowledge about 
collectivities into an individual plan for a specific patient” (May et al., 2006, p. 1026). 
However, the application of the results of clinical trials to clinical practice is not 
straightforward because, unavoidably, the patients who comprise the subject base of a study 
do not precisely reflect the population seen by physicians in their clinics (Daly, 2005).  RCTs 
enroll a restricted population: often those expected to be responsive to the treatment or 
intervention being evaluated (Feinstein & Horowitz, 1997; Greenhalgh, Howick & Maskrey, 
2014).  Tonelli (1998) asserts: “to the extent that relevant differences between individuals 
cannot be made explicit and quantified, an epistemologic gap between research and practice 
must remain” (p. 1238). The heterogeneity of the population as well as the complexity of the 
human body are substantial hurdles in the application of evidence to the individual patient. 
Further, when applying research that evaluates treatment options, it is the average 
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that is considered for each individual patient; however, “average” may not suffice in many 
situations (Greenhalgh, Howick & Maskrey, 2014). Clinicians themselves do not consider the 
application of a recommendation based on an average derived from the results in a select 
population sample acceptable to answer the questions presented by the unique and complex 
predicaments of their patient population (Greenhalgh, 2002). Greenhalgh and Weiringa 
(2011) argue that “knowledge obstinately refuses to be driven unproblematically into 
practice” (p. 501) because clinical practice is much more than a series of clinical questions 
answerable by clinical trials. In spite of these concerns, The Users’ Guide to Medical 
Literature: Essentials of Evidence-Based Clinical Practice encourages clinicians to consider 
the question: “is there some compelling reasons why the results do not apply to the patient?” 
(emphasis added, Guyatt, Rennie, Meade & Cook, 2008, p. 103) and continues its guidance 
to physicians by suggesting that clinicians “usually will not find a compelling reason, and 
most often you can generalize the results to your patient with confidence” (Guyatt et al., 
2008, p. 103).  While questions of whether or not there is a compelling reason to not apply 
the evidence, this approach turns a blind eye to what STS scholars Zuiderent-Jerak and 
Jensen refer to as the “radical indeterminacy of the actor” (2007, p. 232). In their discussion 
of ‘intervention’ in STS studies, they remind us that interventions, like medical treatments, 
are themselves risky, complex and partly uncontrollable process(es), given that patients 
themselves are largely unpredictable.  
EBM threatens the autonomy of the doctor and the patient. Critics also suggest that 
the autonomy of both the doctor and the patient is jeopardized by EBM in multiple ways 
(Cohen et al., 2004; Holmes et al., 2006; May, 2007), and therefore the relationship between 
the two can be compromised.  Since its inception, EBM proponents have fought the notion 
that it is merely ‘cookbook medicine’, and that it restricts patients’ and doctors’ choices in 
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care (Tonelli, 1998). Those who conceived of EBM are adamant that it is not about 
restrictions, however as Cohen et al. point out “the originators of EBM have no control over 
how EBM is used or deployed” (p. 41). EBM’s focus on statistics has been condemned for 
inflicting “the weight of numbers down on [clinical decisions],” perhaps restricting or 
influencing the choices that are made (Cohen et al., 2004, p. 40). The weight of numbers is 
not only a consequence of physicians’ review of evidence in the literature, but also as a result 
of organization-imposed standards. EBM critics suggest that evidence-based medicine has 
provided the groundwork for enforcing guidelines intended to control clinical practice and, in 
some instances, to contain costs.   
The development and creation of Clinical Practice Guidelines (CPGs) has been an 
area of interest to STS scholars, in particular their role in monitoring, regulating, and 
standardizing medical practice. May (2007) argues that, increasingly, medicine and the 
clinical interaction are becoming an “intensively governed terrain” (p. 29). Guidelines, 
protocols, standards and algorithms can be seen as a series of directives that prescribe what 
should be done in each clinical instance (Sepers & ter Meulen, 2005). Some suggest that, by 
prescribing the interventions that physicians are to use, there is an intrusion of the interests of 
corporate entities, both public and private, into the clinical encounter. Increasingly, the 
clinical encounter is undergoing surveillance, regulation and governance, with the goal of 
standardizing medical care. This type of management and control also makes way for 
performance-based medicine to be implemented whereby physicians can be rewarded for 
observing guidelines set by the organization(s) for whom they work or by whom they are 
paid (and, presumably, penalized when they do not) (Lewis and Orland, 2004). STS scholars 
frame the regulation and standardization that are a result of information systems and 
technologies as “technogovernance” (May, 2006, p. 1022). 
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In the last decade, critiques of EBM have become increasingly political, with a focus 
on the systemic effects of standardization. Canadian nursing scholar David Holmes and his 
colleagues describe the power that EBM imposes on doctors and patients in the clinical 
encounter as “a good example of microfascism at play in the contemporary scientific arena” 
(Holmes et al., 2006, p. 180). In a later article, they argue that EBM adopts 
corporate models of efficiency and accountability, right down to a corporate lexicon; 
EBM relies reductively on quantitative evidence in which RCTs are fetishised; EBM 
denigrates other forms of knowledge, including clinician experience and patient 
testimony; finally, EBM evacuates the social and ethical responsibilities that ought to 
distinguish health care professions, such as nursing (Murray et al., 2008, p. 27). 
 
Although Holmes frames the limitations of evidence-based medicine in an extreme fashion, 
even EBM’s more moderate critics cite similar concerns.  
Acceptance of EBM.  EBM’s proponents argue that it addresses overspending, 
inconsistencies, and unproven and patriarchal health care practices. By enacting EBM’s 
tenets, physicians no longer need to rely on intuition and experience to provide clinical care. 
The resources (studies, reviews, summary resources) and tools (critical appraisal techniques) 
that have evolved from the EBM movement represent attempts to give physicians new ways 
of providing the best clinical care supported by the best possible evidence. Daly (2005) 
explains: 
Instead of having to face the dishearteningly subjective task of basing their decisions 
on intuitions we could not explain (Sackett et al. 1999, p. ix), clinicians had available 
to them a science that generated objective knowledge of effective interventions based, 
where possible, on the results of unbiased experiments (p. 1). 
 
By directly applying the knowledge gained from the best available evidence, such as 
the “unbiased experiments” that Daly (2005) mentions, EBM is heralded for promoting 
consistency in treatments, contributing to the establishment of national standards of patient 
care, ensuring optimal patient outcomes, and measuring performance in medical practice 
(Lewis & Orland, 2004). EBM supporters argue that positive outcomes for patients include 
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the: “[prevention of] numerous avoidable deaths and injuries while improving the quality of 
life for millions of individuals” (Roberts & Yeager, 2004, p. iv).  Such was the enthusiasm 
for EBM that Feinstein and Horwitz (1997) wrote that EBM had acquired the “sanctity often 
accorded to motherhood, home, and the flag” (p. 529).  Indeed, The New York Times hailed 
the “revolution” of EBM as one of the most influential ideas of the year (Hitt, 2001) and, in 
2006, Borry and Schotsmans descried EBM as a moral imperative. 
EBM and Medical Education 
The conversation regarding the applicability and appropriateness of evidence-based 
medicine is clearly polarized; nevertheless, EBM has survived much of the criticism that has 
been levelled at it and is now well integrated into undergraduate and graduate medical 
curricula worldwide, as well as part of continuing medical education programs for practicing 
physicians (Guyatt, Cook & Haynes, 2004; Green, 2000). In 1992, the Evidence-based 
Medicine Working Group defined evidence-based practice in terms of four basic 
competencies: (1) the recognition of a patient problem and construction of a structured 
clinical question; (2) the ability to efficiently and effectively search the medical literature to 
retrieve the best available evidence to answer the clinical question; (3) the ability to critically 
appraise the evidence; and (4) the ability to integrate the evidence with all aspects of 
individual patient decision making to determine the best clinical care for the patient.  In order 
to train effective evidence-based practitioners, EBM proponents advocate focused 
educational interventions targeting each of these specific skills (Ghali et al., 2000). Currently, 
research efforts in EBM education focus on building evidence to demonstrate the 
effectiveness of teaching EBM in undergraduate and graduate medical curricula (Dorsch, 
Aiyer, Meyer, 2004; Green, 2000; Hatalla & Guyatt, 2002; Vidyarthi, Kamei, Chan, Goh & 
Ngee, 2015; West, Jaeger & McDonald, 2011). EBM teachings appear to have a positive 
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impact on students’ knowledge and perceived value of evidence-based medicine. However, 
systematic reviews suggest that EBM education does not result in a change in behaviours and 
outcomes in clinical practice (Coomarasamy & Khan, 2004; Norman & Shannon, 1998; 
Young, Rohwer, Volmink, Clarke, 2014). 
Clinical relevance and biological focus. The direct connection of EBM to clinical 
practice is appealing for many, especially medical students who are eager to embark on their 
medical careers and identify themselves as physicians. Evidence-based practice places 
student learning out of the classroom and into the clinic. As Rosenberg and Donald (1995) 
explain, “[a]n immediate attraction of evidence-based medicine is that it integrates medical 
education with clinical practice” (p. 1125). Through the lens of evidence-based medicine, the 
socialization of new professionals into the practice of medicine focuses on the biological and 
technological aspects of health and illness. EBM’s technological focus on clinical care allows 
medicine to downplay other issues.  For instance, Daly (2005) suggests that incorporating 
EBM into the medical school allows the messy and complicated issues of community health 
and the related social and political issues to be relegated “to the sidelines” (p. 126).  
Uncertainty in medical knowledge. The relationship between evidence-based 
medicine and uncertainty in medical knowledge-- whether it addresses or alleviates 
uncertainty-- is another antecedent to the preoccupation with EBM in medical education. The 
transformation of medicine into a practice based on concrete, scientific, evidence can be 
attractive to stressed physicians and medical students (Armstrong, 2002; Daly, 2005). Not 
only has the basic element of EBM, the clinical trial, been “institutionalized as the ultimate 
arbiter for resolution of uncertainty about therapeutics” (Djulbegovic, 2001, p. 390), but the 
packaging and summarization of evidence in clinical tools, such as UpToDate, has 
contributed to a sense of attainable certainty in clinical practice.  Timmerman and Angell’s 
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(2001) research on medical residents suggests that synthesized and summarized information 
not only distills information into an easily accessible format but also guides “the budding 
physician through the clinical encounter… [offering] a definitive answer to the problem of 
clinical uncertainty” (pp. 343-344). According to Timmerman and Angell, even if these tools 
do not provide the answer, they provide comfort to practitioners.   
Six decades ago, medical sociologist Renee Fox (1957) argued that the practice of 
medicine is inherently uncertain due to gaps and disparities in the knowledge base. While the 
volume of medical information and research has exploded in the intervening years, 
uncertainties in medical knowledge continue (Fox, 2012; Haynes, 2001; May, 2006). 
Multiple ambiguities—unknowns, biases, errors, and differences in personal views—weaken 
connections between a patient’s actual condition from the selection of a diagnostic test or 
treatment. Medical information scientist Szolovits (1995) captures multiple points of 
uncertainty in medicine through various levels of the process of clinical care: 
Patients cannot describe exactly what has happened to them or how they feel, 
doctors and nurses cannot tell exactly what they observe, laboratories report 
results only with some degree of error, physiologists do not understand 
precisely how the human body works, medical researchers cannot precisely 
characterize how diseases alter normal functioning of the body, 
pharmacologists do not fully understand the mechanisms accounting for the 
effectiveness of drugs, and no one can precisely determine one’s prognosis  
(p. 111). 
 
Although uncertainty is woven throughout the medical encounter, doctors and 
patients regularly make decisions about diagnosis, treatment and prognosis.  Prior to the 
EBM movement, to handle this uncertainty clinicians relied on a knowledge base made up of 
their own experience, along with the collective experiences of the profession learned through 
the apprenticeship and modeling of clinicians, teachers and mentors (Daly, 2005). The 
movement towards EBM in the 1980s was, in part, an effort to move away from this ‘art’ 
towards clinical care that is based in ‘hard science’. However, while the goal of clinical 
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research and the evidence derived from it is to reduce uncertainty, uncertainty is inherent to 
EBM. Uncertainty exists in EBM by way of unknowns, biases, errors, non-responders, and 
even communication challenges. These attributes weaken the connections between an actual 
patient’s reality and the EBM knowledge base. Szolovotis (1995) suggests that the 
uncertainty in medicine is so “tacit and so obvious that it is beneath mention” (p. 113). The 
application of research and evidence to clinical practice is a way to temper or mitigate 
uncertainty in the clinical encounter and provides clinicians with a “secure foundation for 
their clinical task” (Daly, 2005, p.1).   
The desire for a ‘secure foundation’ and its potential to alleviate uncertainty may, in 
some measure, account for the uptake and proliferation of EBM as a pillar of medical 
education and practice (Good, 1998). The role of summarized evidence in clinical practice 
appears to be clear: Physicians seek and use this type of information to confirm their 
speculation or raise their level of certainty about their decisions (Gorman & Helfand, 1995). 
Information Needs and Information Behaviour of Physicians 
Reviews by Elayyan (1988), Verhoeven, Boerma, and Meyboom-de Jong (1995), and 
Haug (1997) capture the research findings concerning the information needs and preferences 
of physicians up to the 21st century. Numerous themes run through these three reviews. Print 
textbooks and journals in printed format were important resources to meet physicians’ 
information needs, with academic and scholarly journals being the most important sources 
for the latest developments in medical care (Elayyan, 1988; Haug, 1997; Verhoeven et al, 
1995), and, in comparison with practicing physicians, medical students, residents and 
inexperienced physicians were more likely to make use of medical textbooks and medical 
libraries (Elayyan, 1988; Verhoeven et al., 1995). Physicians gained access to the medical 
literature primarily by browsing journals, apparently because they had little knowledge about 
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and experience with print indexes and abstracts (Elayyan, 1988).  
At the time of these reviews, online databases were in their infancy.  Interestingly, at 
a time when physicians were largely limited to the medical research available through print 
resources, they were already reporting information overload (Elayyan, 1988).  Consultations 
with colleagues were found to be equally, if not more important information sources than the 
printed medical literature (Elayyan, 1988; Haug, 1997; Verhoeven et al, 1995). Accessibility 
and time were found to be critical factors in the choice of information physicians used in 
clinical practice (Verhoeven et al., 1995). 
In an effort to build a model of information-seeking for professionals, Leckie, 
Pettigrew, and Sylvain (1996) examined and synthesized what was known about information 
seeking practices of three distinct professional groups:  engineers, health care workers, and 
lawyers.  They found that several information-seeking and information-related practices 
crossed professional divisions and that these practices are more similar across diverse 
professions than had been previously thought. Leckie and her colleagues identified five 
themes and patterns that traversed the different professions:  (1) Despite training in a 
particular area of expertise, professionals assume multiple, complex, and diverse work roles; 
(2) these roles have a constellation of tasks associated with them; (3) these tasks are likely to 
prompt information seeking; (4) intervening factors, including the awareness of information 
and sources of information, may facilitate or inhibit information access and use; and (5) it 
often takes more than one attempt to find appropriate information. These themes informed 
Leckie’s General Model of the Information Seeking of Professionals.  Six components 
comprise the model, including work roles; associated tasks; characteristics of information 
needs; factors affecting information seeking, such as awareness of sources; sources of 
information; and outcomes. In summary, the roles and related tasks that are a part of the 
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professionals’ daily work trigger information needs and initiate an information seeking 
process. The information-seeking outcome is affected by multiple variables and throughout 
the model feedback loops capture the iterative and non-linear nature of the process. 
Of particular relevance to this research is the way in which the five themes are 
manifest in information-seeking behaviours of health care professionals. Studies of the 
information behaviours of physicians, nurses, and dentists were included in Leckie et al.’s 
synthesis. Patient care is the most often cited trigger for information needs; however, health 
care professionals’ information needs are also prompted by related tasks associated with 
distinct work roles including practice management, administration, teaching, research, 
current awareness, and continuing education. Health care professionals seek information 
from multiple sources—formal and informal sources, interpersonal sources, and “print” 
sources (much of the research reviewed was conducted before the Internet revolution). The 
preference for and choice of certain resources is very much influenced by ease of access, past 
experience, availability of time and the perceived quality.  
 Since Leckie et al.’s model was published in 1996, research and reviews examining 
the information needs and behaviours of physicians have continued to support the model. 
Patient care remains the primary role, which leads to an information need and to information 
seeking (Bryant, 2004; Clarke et al., 2013; Gonzalez-Gonzalez et al., 2007), and 
interpersonal sources of information and knowledge continue to play an important role in 
answering the clinical questions of physicians (Andrews, Pearce, Ireson & Love, 2005; 
Clarke et al., 2013; Gonzalez-Gonzalez et al., 2007). While these patterns continue to be 
supported, one cannot turn a blind eye to the impact of digital technology on the information 
landscape of physicians. Less than two decades ago, printed books and journals were critical 
information sources for physicians (Dawes & Sampson, 2003; Elayyan, 1988; Haug, 1997). 
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However, since the advent and proliferation of digital and Internet-based resources, print 
resources have dropped dramatically in popularity (Bryant, 2004; Clarke et al., 2013). 
Physicians not only have access to research studies and articles in digital format, but also 
new types of evidence resources, that is, new and summarized evidence resources.  
Evolving Medical Evidence for Clinical Practice  
In order to address the reported shortcomings of more traditional forms of evidence, 
such as the research article, in answering physicians’ clinical questions (Bennett, et al. 2005; 
Gorman & Helfand, 1995; Rosenberg & Donald, 1995), producers and publishers of 
evidence resources have attempted to build new tools to capture evidence in a way that meets 
the needs of physicians. These new resources are described by EBM scholars, such as 
Haynes (2001), as increasingly ‘evolved’.  An exploration of what is currently understood 
about this evolution of medical evidence to meet physicians’ needs is significant to the 
research undertaken in this thesis. 
The likelihood that physicians will search for information is greatly influenced by 
their beliefs about whether an answer exists for their clinical problem. According to Gorman 
and Helfand (1995), often doctors do not believe that they will successfully answer their 
clinical questions through the published literature (Gorman & Helfand, 1995). Doctors’ 
conviction that they will be unsuccessful is attributed to their belief that studies are “invalid 
and irrelevant” (Rosenberg & Donald, 1995, p. 1122). Twenty years ago, Gorman, Ash, and 
Wykoff (1994) studied the effectiveness of the medical journal literature to answer primary 
care physicians’ questions. The design of the study employed librarians to locate articles that 
provided “answers” to clinical questions arising from physicians’ clinical practice. Clinicians 
were then asked to provide feedback regarding the relevance and usefulness of the 
information retrieved. Clinicians felt that the information provided a “clear answer” to their 
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questions in less than half of the instances (44%). At the time of Rosenberg and Donald’s 
study, the primary information resource was published journal articles. Since then, 
synthesized and summarized information sources have proliferated.  Moja and Banzi (2011) 
posit that “publishers’ mission is changing: publishing trials and reviews in general or 
specialist formats is perceived as too static and remote from practice” and suggest that 
“[p]ublishers should find a balance between information consumed at the point of care—
necessarily distilled, unnecessarily simplistic—and fidelity to a cumulative and extended 
approach to information” (p. 10). The physician-identified barriers of too much information, 
too few searching skills, and too few answers in the medical research and primary literature 
have led scholars and publishers to develop resources in which information is pre-packaged 
in a synthesized and summarized format. The use of these resources has been strongly 
supported by EBM advocates (see, for example, Guyatt et al., 2008). 
The various levels of health information synthesis and summarization have been 
described by numerous authors, many of whom conceptualize these classes of information as 
a hierarchical evidence pyramid (for example: Grandage, Slawson, Shaughnessy, 2002; 
Pandis, 2011; Haynes, 2001). Of these hierarchical schematics, the 6S Model—originally 
created as a 4S model in 2005 (Haynes, 2001) and then later evolving into the 5S and 6S 
models (Haynes, 2006; DiCenso, Bayley, Haynes, 2009)—is currently the most widely used 
(Brown-Epstein, 2012) (see Figure 2). Initially, the four levels of organization of evidence in 
the 4S model were studies (original research articles), syntheses (systematic reviews), 
synopses (succinct summaries of articles), and systems. Here,  ‘systems’ were defined as 
computerized decision support systems that were integrated into electronic health records, as 
well as advanced electronic decision support tools, such as UpToDate and Clinical Evidence. 
One year later, products such as UpToDate, Clinical Evidence and DynaMed were classified 
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in the fifth “S”–Summaries. The sixth and final “S” created a distinction between synopses of 
studies and synopses of syntheses (DiCenso, Bayley & Haynes, 2009).  
 
Figure 2: Levels of Organization of Evidence as suggested by Haynes and colleagues 
From: National Collaborating Centre for Methods and Tools:  
http://www.nccmt.ca/eiph/search-eng.html  
 
Haynes (2001) suggests that “[p]roviders and consumers of evidence-based health 
care can help themselves to the best current evidence by recognising the most evolved 
information services in the topic areas of concern to them” (emphasis added). Practitioners 
are directed to “begin the search for evidence to guide clinical decisions at the highest 
possible level of the 5S pyramid of evidence” (Haynes, 2007, p. 7). If you do not find the 
answer in one level then drop to the next level, but when one of the resources addresses the 
query, “you don’t need to look any further” (Haynes, 2007, p. 7). According to Haynes 
(2001), it is only when “every other S fails (ie, no system, [summaries,] synopses, or 
syntheses)” that it is appropriate to look for original studies (p. 37). Embedded in such 
guidance is the assumption that all the evidence physicians need for clinical decision-making 
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can be found in a single summary resource; or, indeed, that this evidence even exists. 
In the 6S model, the concepts of quality and synthesis appear to be conflated in a 
problematic way. Haynes’ (2006) use of the term ‘evolved’ implies more advanced 
knowledge, yet synthesis and summarization refers to a distillation process in which some 
information has been removed. The National Collaborating Centre for Methods and Tool’s 
(NCCMT) tutorial explicitly states, “starting a search at the top (or the highest possible layer 
of the 6S pyramid model) yields the highest quality and most synthesized research evidence 
first” (NCCMT, 2011, emphasis added). Even though the summarization and distillation 
process is not well understood at the top of the evidence pyramid, the most summarized and 
distilled information is clearly presented in this teaching tool to be of the highest quality and 
the most “evolved” information available to clinicians. 
 Currently, the resources that occupy the top “S” of the pyramid, systems, are not well 
developed nor are they readily available. Systems are sources of evidence that are integrated 
into electronic health records, delivering to doctors and health care professionals relevant 
evidence as called upon via the electronic health record.  Although it is anticipated that these 
resources will greatly improve the integration of evidence into the clinical encounter in the 
future (Bates et al., 2003), summaries are the highest level of organization of evidence 
currently in widespread use.  Haynes (2006) argues that “a current summary trumps an 
individual synopsis, synthesis, or study or a collection of these” (p. 6), suggesting that 
summary sources provide all the information/evidence necessary for clinical understanding 
and decision-making.  
Research demonstrates that clinicians have readily adopted the recommended 
guidance of integrating only the highest level of evidence into clinical practice. A study of 
residents at the University of Minnesota Medical School revealed that the most popular 
              25 
 
resource accessed for information at point of care is the summary resource UpToDate, with 
85% of residents using it daily (Duran-Nelson, Gladding, Beattie & Nixon, 2013). In 
contrast, only 13.3% of residents accessed PubMed/MEDLINE (the main access point for 
research studies) daily. Moreover, Wikipedia and the Google search engine were used with 
greater frequency than PubMed/MEDLINE. While both speed and trust in information 
quality were important factors in choosing a resource, speed appeared to be the users’ more 
important consideration (Duran-Nelson et al., 2013); these results that align with Leckie’s 
1996 model of professionals’ information seeking.  
A more in-depth analysis of the 6S’s three main levels of organization - Studies, 
Synthesis and Summaries - as well as the recommended structure for clinical questions that 
provide the basis for these resources, is needed to understand the evolution of evidence for 
clinical practice. 
Clinical questions.  The Centre for Evidence-based Medicine at the University of 
Oxford declares that “one of the fundamental skills required for practising EBM is the asking 
of well-built clinical questions” (Centre for Evidence Based Medicine, 2017). Evidence-
based medicine recommends a standard framework for clinical questions, the PICO 
framework, which includes four elements: Patient or Problems, Intervention, Comparison 
and Outcome. This framework was first proposed in a journal editorial by Richardson, 
Wilson, Nishikawa, and Hayward (1995) for therapy-type clinical questions, but later 
expanded to questions of aetiology. Proponents of EBM suggest that the PICO framework 
helps clinicians with the queries by clearly articulating the essential components of their 
question and assisting the clinician to identify concepts. While PICO is widely advocated and 
taught to medical students and clinicians, research indicates that the format may not reflect 
real-world clinical questions. For example, Huang et al. found that actual primary care 
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questions rarely contain all four elements (Huang, Lin & Demner-Fushman, 2006). 
Nevertheless, the PICO format is often used as a structure for research study and systematic 
review design, and provides a helpful structure for examining UpToDate. 
Studies. Clinically-focused primary biomedical research can be organized in two 
main categories: clinical studies and preclinical research. Preclinical studies provide a strong 
knowledge base in order to ensure safety and efficacy prior to human clinical studies, for 
example via animal studies, model-testing, etc. Clinical studies comprise the observational 
medical research on human subjects that generate safety and efficacy data for health 
interventions (therapies, diagnostics, devices, prognostics).  Practice is informed by these 
clinical studies and clinicians are directed to them to answer the questions that arise in their 
practice. While the most commonly discussed clinical questions relate to therapies and other 
treatment-oriented interventions, other types of clinical questions include those relating to 
diagnosis, prognosis, and aetiology (particularly risk factors). For clinical questions that 
address therapy, the RCT is considered to be the best study design to reduce bias and 
increase validity. Randomization, in this sense, is the allocation of patients into treatment 
groups so as to increase the likelihood of creating groups that are comparable on pre-
identified baseline factors, both known or unknown, which may affect the study outcomes.  
As noted earlier, clinicians question the application of research studies at the point of 
care and claim that the usefulness of primary research is quite limited in practice (McKibbon, 
Lokker, Keepanasseril, Wilczynski, Haynes, 2013). Specific limitations of clinical studies 
cited in the literature include the speed at which single clinical trials are contradicted or 
challenged; the inefficiency of clinician search skills (Bennett, Casebeer, Kristofco & 
Collins, 2005) and subsequent time it takes for clinicians to find credible and applicable 
research studies (Chambliss & Conley, 1996; González-González, et al., 2007; Gorman et al., 
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1994; Rudolph et al., 2002); and clinicians’ overall attitude that there is too much 
information available and they are unlikely to find an answer regardless of their search 
efforts (Bennett et al., 2005).  In general, clinicians have not embraced clinical studies as an 
efficient and effective source of evidence for their point of care needs.  
Synthesis. Systematic reviews comprise the synthesis level of the 5/6S schema. The 
Institute of Medicine (IOM) defined systematic review in 2011 as "a scientific investigation 
that focuses on a specific question and uses explicit, prespecified scientific methods to 
identify, select, assess, and summarize the findings of similar but separate studies.” 
Systematic reviews are structured and rigorous reviews of literature pertaining to a focused 
clinical question aimed to identify, select, appraise and synthesize all available high quality 
evidence relevant to that question. Systematic reviews were a key element in Cochrane’s 
vision of evidence-based medicine and are considered to be a foundation for the development 
of evidence-based clinical practice guidelines (Cook & Greengold, 1997).  The Cochrane 
Collaboration, and its more than 5,000 reviews is considered a leader of evidence-based 
medicine3.  
The development of systematic reviews, specifically the decision to include or 
exclude studies in systematic reviews, has generated a great deal of attention and debate in 
the literature. Developers of systematic reviews recognize that the conclusions of a 
systematic review can only be trusted and implemented if the studies included are of the 
                                                 
3 In 2000, the Campbell Collaboration was formed to focus on the effect of social 
interactions, encouraging the creation of systematic reviews on non-biomedical (and often 
more complex) topics. The Campbell Collaboration contains just over 100 reviews in its 
collection compared to the Cochrane Collaboration’s more than 5,000 reviews. Synthesis of 
qualitative research differs from synthesis of quantitative research, as the end product is a 
meta-synthesis, where findings from across the research are integrated to generate new 
interpretations, formulate understandings, and produce new generalizations. 
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highest quality, but how quality is defined and assessed is contentious (Juni, Altman & 
Egger, 2001). One approach is to exclude trials that fail to meet a pre-defined standard of 
quality, although this practice has the potential to exclude studies that might contribute valid 
information. For clinical questions related to therapies, most systematic reviews exclude all 
studies that are not RCTs or related comparative designs employing randomization.  
The use and application of systematic reviews is not without critics.  For instance, 
Greenhalgh (2012) writes: “The problem is that the Cochrane machinery is built on the 
assumption that by summarizing the findings around tightly focused questions we will build 
a meaningful knowledge base” (p. 371). Systematic reviews best address ‘tightly focused 
questions’ such as the efficacy of treatment A on condition X, however many health 
challenges are complex and multifaceted. In addition to the narrowness and inapplicability of 
the questions that are addressed through systematics reviews, the vast number of systematic 
reviews (over 5000 in the Cochrane Library alone) has also been called into question. The 
large and diverse body of systematic reviews may be overwhelming in much the same way 
that the huge array of primary studies once overwhelmed (Hyde, Stanworth, Brunskill & 
Murphy, 2005).   As such, systematic reviews have been dismissed as a point of care 
resource, and instead are suggested to “feed” point of care resources, including Summaries 
(Banzi et al., 2010). 
Summaries. Summary resources are intended to provide health care professionals an 
outline of the evidence suitable for the point of care. Summary resources are suggested to be 
appropriate when physicians need the “clinical bottom line” (Windish, 2013, p. 96). 
Summaries are intended to incorporate the highest quality and most synthesized sources of 
research evidence. Two categories of resources are included in the summary level of the 5/6 
S schemes: evidence-based summary resources (like UpToDate and DynaMed) and clinical 
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practice guidelines (CPGs). One of the defining qualities of summary resources is their goal 
to “[convey] a clear and concise message about what to do within the context of a provider-
patient dyad” (Moja & Banzi, 2011, p. 6). The summary resource explicitly lays out a 
recommendation for clinical care. 
CPGs provide clinicians with clear recommendation about how to provide care for 
patients with specific conditions. Evidence-based CPGs are “statements that include 
recommendations intended to optimize patient care that are informed by a systematic review 
of evidence and an assessment of the benefits and harms of alternative care options” 
(Institute of Medicine, 2011). Such guidelines “seek to bring recommendations that generally 
prescribe where, when and how care professionals should act, aimed at reaching more 
uniformity and transparency in health care delivery” (van Loon, Zuiderent-Jerak & Bal, 
2013, p. 2). Empirical research on the use of guidelines in everyday clinical practice raises 
questions about their applicability and usability (Kendall, Sunderland, Muenchberger, & 
Armstrong, 2009; Rashidian, Eccles & Russel, 2008).  Identified shortcomings of guidelines 
include a narrow focus on one specific and static condition, restricted options for treatment, 
and a lack of recognition of the diversity of roles that health care practitioners hold (Van 
Loon, Zuiderent-Jerak & Bal, 2014; Kendall, Sunderland, Muechenberger & Armdytoh. 
2009).  
The most popular of the summary resource tools, related in many ways to CPGs, is 
UpToDate. UpToDate is described as “an evidence-based, physician-authored clinical 
decision support resource which clinicians trust to make the right point-of-care decisions” 
(UpToDate, “About Us,” 2017). It is this resource that forms the base for the current research 
study. 
Summarised resources are now the ‘go-to’ resource for clinical questions (Alper, 
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White & Ge, 2005; Edson et al., 2010). In a multi-institution study (Edson et al., 2010) 
UpToDate was identified as the most effective resource for knowledge acquisition by 94.6% 
of residents and cited as the first choice for answering clinical questions by 88.9% of 
residents. In addition to noting the dramatic preference of clinicians for tools such as 
UpToDate, their effect on clinical practice is noteworthy. Alper, White, and Ge (2005) found 
that by making use of the summary resource DynaMed, primary care clinicians answered 
more questions and changed clinical decisions more often without increasing overall search 
time.   
UpToDate: Overview and Previous Research 
UpToDate is an online resource that provides physicians with evidence to support 
their clinical decision-making. UpToDate is also the name of the parent company of the 
resource, a brand of the Health Division of Wolters Kluwer Publishing. In 1992, UpToDate 
was launched by nephrologist Dr. Burton Rose, with the aim of “creating the information that 
doctors needed” (UpToDate, “The UpToDate Story,” 2012). After a potential publisher 
claimed that no money was to be made by the Internet, Dr. Rose and his colleague Dr. Joseph 
Rush developed UpToDate in Rose’s basement with the initial content being a print 
nephrology textbook authored by Rose. UpToDate now provides articles related to more than 
24 specialties, authored by over 6,500 physicians, editors and peer reviewers (UpToDate, 
“About Us,” 2017). More than 10,500 topics are included in UpToDate, covering a wide 
variety of medical conditions, therapies, and issues. All entries include Summary and 
Recommendations, and References as consistent subtopics. Beyond these core subtopics, 
there is a varied level of specificity relating to individual topics that, ultimately, does not 
facilitate a consistent structure across all entries/articles.  Possible subtopics included in 
UpToDate entries are: Physiology and Anatomy; Treatment; Evaluation; Management; and 
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Prognosis. An additional feature of UpToDate available for some topics is the classification 
of the level of recommendation based on the Grading of Recommendations, Assessment, 
Development, and Evaluation (GRADE) system. GRADE is a system of rating the quality of 
evidence and strength of recommendations in synthesis and summary resources (Guyatt, et 
al., 2011).  GRADE uses an explicit and transparent process and criteria to evaluate the 
evidence including study design, risk of bias, inconsistency, indirectness, and magnitude of 
effect. The inclusion of this classification of recommendation is not included in all UpToDate 
articles (Farrell, 2008). 
The translation of current evidence into clear recommendations for clinicians is a 
unique feature of UpToDate, which relies upon physician expertise to determine what 
evidence should be applied to individual patients and provide clear recommendations to their 
colleagues (UpToDate, “Creating Content,” 2017). The necessity for the expertise offered by 
UpToDate’s physician-authors is captured in UpToDate’s philosophy that “(e)vidence alone 
is never sufficient to make a clinical decision — expertise is required to move from evidence 
to recommendations”. UpToDate describes the work of the physician-authors as “a 
systematic process for identifying, reviewing and synthesizing the medical literature as it 
applies to a clinical question” (UpToDate, “Creating Content”, emphasis added). The details 
of the ‘systematic process’ referred to by UpToDate are not readily available.  However, a 
short description on the UpToDate website reads: 
UpToDate follows a hierarchy of evidence consistent with most evidence-based 
resources. At the top of the hierarchy are meta-analyses of randomized trials of high 
methodological quality, followed by randomized trials with methodological 
limitations, observational studies and unsystematic clinical observations. Inferences 
are stronger when the evidence is summarized in systematic reviews of the literature 
that present all relevant data. 
Each topic has an author who is an expert in the area discussed, and at least two 
separate physician reviewers. This group works together to perform a comprehensive 
review of the literature and carefully select studies for presentation based on the 
quality of the study, the hierarchy of evidence discussed above, and clinical 
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relevance. When current, high-quality systematic reviews are available, UpToDate 
topics and recommendations rely heavily on these reviews. When such reviews are 
unavailable, UpToDate summarizes the key studies bearing on the clinical issues at 
hand.  (UpToDate, “Editorial Policy,” 2017) 
 
The UpToDate site states that the authors select the evidence for the topic based on the 
widely accepted hierarchy of evidence, with no additional details. This brief description can 
be contrasted against the processes followed and made public by the Cochrane Collaboration. 
The details of the meticulous Cochrane process are described in a 670-page handbook, 
Cochrane Handbook for Systematic Reviews, and is made publicly available through the 
Cochrane website (Cochrane Collaboration, Cochrane Handbook, 2015).  While the 
systematic process claimed by UpToDate is not clear, UpToDate positions itself as a leader 
in using the best available evidence: “While other clinical information resources may use — 
or claim to use — the best available evidence, UpToDate excels in determining how that 
evidence is applied to the individual patient.”  
UpToDate provides a list of 466 journals that are hand-searched by a community of 
physician-authors that is responsible for selecting the evidence to be included, and using this 
evidence to inform the creation of each UpToDate entry. In the study described in this thesis, 
these journals are referred to as UpToDate’s core journals. In addition to the hand-searched 
journals, UpToDate provides a list of resources from which evidence is derived including 
electronic searching of key databases, practice guidelines, published reports of clinical trials 
by governmental agencies, conference and meeting proceedings, and “the clinical experience 
and observations of our authors, editors, and peer reviewers” (UpToDate. “Editorial Policy”, 
2017). These resources are the base of evidence from which the content of UpToDate is 
derived. 
Over 1,300,000 physicians in more than 187 countries use UpToDate to find medical 
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information for clinical decision-making; access is online, and more recently on mobile 
devices, primarily through personal and institutional subscriptions (UpToDate, “About Us”, 
2017).  As well as being one of the most popular medical resources, UpToDate is also one of 
the most well-researched point-of-care summary resources. More than 25 empirical studies 
have been undertaken by information scientists, clinicians, and librarians to examine the 
structure and use of UpToDate. These studies reveal that UpToDate is consistently one of, if 
not the most consulted evidence-based resource for clinical practice (Chisolm & Finnel, 
2012; Cook, Enders, Linderbaum, Zwart & Lloyd, 2014; Marshall et al., 2013, Nasir, 
Nicholson, Vandermeer, Kumar& Robinson, 2014; Shariff et al., 2011) and is rated very 
positively by physicians for ease of use, layout, and quality of content (Campbell & Ash, 
2006; Duran-Nelson, Gladding, Beattie & Nixon, 2013; Ensan et al., 2011; Marshall et al., 
2013; Phua & Lim, 2008). Doctors consult UpToDate to obtain information about treatments, 
to find drug information, to identify appropriate diagnostic tests, to reduce delay in treatment, 
and to seek reassurance about clinical decisions (Addison, Witcombe & Glover, 2012; 
Chisholm & Finnell, 2012).   
More than one-third of the identified studies of UpToDate focus on how medical 
students, clerks and residents adopt, use and learn from UpToDate (Duran-Nelson, Gladding, 
Beattie & Nixon, 2013; Egle, Smeenge, Kassem & Mittal, 2015; Hoogendam, Stalenhoef, 
Robbe, Overbeke, 2008; Kim, Willett, Murphy, O’Rourke, Sharma & Shea, 2008; Leff & 
Harper, 2006; O’Carroll, Westby, Dooley & Gordon, 2015; Phua & Lim, 2008).  Medical 
students have been found to be more likely to adopt UpToDate than practicing clinicians 
(Peterson, Rowat, Krieter, and Mandel, 2004; Marshall et al., 2013) and students identified 
UpToDate as the most effective and most popular resource for knowledge acquisition (Edson 
et al., 2010; Lai et al., 2006; Leff & Harper, 2006). Students tend to use UpToDate primarily 
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for patient care and preparation for physician rounds, and much less for exam preparation 
(Cooper & Elnicki; Edson et al.; Peterson et al.). However in two studies it is reported that 
UpToDate was an effective learning tool for exam preparation (McDonald et al, 2007; Reed 
et al., 2012).  
Many studies have compared the efficacy and efficiency of UpToDate with other 
evidence resources.  Table 1 outlines evidence resources across the 6S pyramid and the 
studies that compare these resources to UpToDate. 
Organization of 
Evidence (6S) 
Resources 
Study reporting 
comparison to UpToDate. 
Systems Currently in development  
Summaries UpToDate, DynaMed, ACP PIER 
(now ACP Smart Medicine), 
Essential Evidence Plus, BMJ 
Point-of-Care, Cline-Guide, 
Nursing Reference Centre, 
Micromedex, PEPID Best 
Practice, BMJ Clinical Evidence, 
Bandolier, MedScape Reference, 
Diseasedex, InfoRetriever, 
FirstConsult, ClinicalKey 
Clinical Practice Guidelines 
(accessed via National Guidelines 
Clearinghouse),  
Ahmadi et al. (2011); 
Campbell & Ash (2006); 
Chan & Stieda (2011); Egle 
et al. (2015); Farrell (2008); 
Fenton & Badgett (2007); 
Hayes (2012); Hoogendam 
et al. (2008); Jeffrey et al. 
(2012); Ketchum et al. 
(2011); Kronenfield et al. 
(2013); Nasir et al., (2014); 
O’Carroll et al., 2015; 
Prorok et al. (2012); Shurtz 
& Foster (2011); Turvey et 
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al., 2013 
Synopsis of 
Synthesis 
Cochrane Summaries, Evidence 
Based Abstract Journals (e.g.,: 
ACP Journal Club, Evidence-
Based Medicine, Cancer Care 
Reviews) 
 
Synthesis Cochrane Collaboration / Library   
Synopsis of 
Studies 
Evidence Based Abstract Journals 
(e.g.,: ACP Journal Club, 
Evidence-Based Medicine, Cancer 
Treatment Reviews) 
 
Studies Journal articles indexed in 
PubMed, OVID Medline, 
PsychInfo, AMED 
Ensan et al. (2011); 
Hoogendam et al. (2008); 
Schulling et al. (2005); 
Thiele et al.  (2010) 
Other  Google, Google Scholar, 
Wikipedia 
Duran-Nelson et al. (2013); 
Hasty, et al. (2014); Thiele 
et al. (2010) 
Table 1: Resources across the 6S Levels of Organization of Evidence and related studies 
Because UpToDate is not the only summary resource designed for clinicians, several 
studies have set out to compare it with other competing products (Ahmadi et al., 2011; 
Campbell & Ash, 2006; Chan & Stieda, 2011; Farrell, 2008; Thiele, Poiro, Scalzo & 
Nemergut, 2010; Hoogendam et al., 2008; Ketchum, Saleh & Jeong, 2011; Shurtz & Foster, 
2011; Turvey, Hussain, Banfield & Bhandari, 2013). Multiple studies in which student and 
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physician ability to answer clinical questions using UpToDate (a summary resource) is 
compared with use of PubMed (a database providing access to studies and synthesis, and to a 
lesser extent clinical practice guidelines, synopsis of studies, and synopsis of synthesis) 
(Ensan et al., 2011; Hoogendam et al., 2008; Schilling et al., 2005; Thiele et al., 2010) 
suggest that, by using UpToDate, study participants were able to locate more relevant 
answers to clinical questions, and to find answers to clinical questions in a shorter time. In 
addition to PubMed, UpToDate has also been evaluated against a variety of combinations of 
products including: ACP's PIER, DISEASEDEX, FIRSTConsult, InfoRetriever,  BMJ 
Clinical Evidence, Bandolier, Google, OVID, Essential Evidence Plus, BMJ Point-of-Care, 
Clin-eguide, AskMayoExpert, ClinicalKey, Nursing Reference, and the National Guidelines 
Clearinghouse (Ahmadi et al., 2011; Campbell & Ash, 2006; Chan & Stieda, 2011; Farrell, 
2008; Fenton & Badgett, 2007; Kronenfeld, Bay & Coombs, 2013; Theile et al., 2010; 
Turvey et al., 2013). In studies evaluating a resource’s usefulness for answering physicians’ 
clinical questions, UpToDate consistently rated at the top (Ahmadi et al., 2011; Campbell & 
Ash, 2006; Thiele et al., 2010). Physicians were also able to answer clinical questions more 
quickly using UpToDate in comparison with other products (Ahmadi et al., 2011; Thiele et 
al., 2010). Only Google was reported to be as quick as UpToDate, however physicians did 
not report a high level of trust and confidence in Google. In only one study, in which 
UpToDate and related products were evaluated by non-physicians (nurses, administrators, 
librarians) as well as physicians, was no difference between product preferences reported 
(Chan & Stieda, 2010).  
The breadth and depth of UpToDate’s content for two specialties, primary care and 
orthopaedic surgery, has been compared against similar products. While UpToDate had 
greater breadth of content related to primary care than National Guidelines Clearinghouse 
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(Fenton & Badgett, 2007), UpToDate had the most limited orthopaedic content compared 
with ACP Pier, DynaMed, FirstConsult, and Clinical Evidence (Turvey et al., 2013). While 
UpToDate claims to address twenty-one specialties, the depth of coverage across specialties 
appears to be inconsistent. 
The influence of UpToDate on clinical decisions and clinical practices has also been 
explored (see, for example, Addison et al., 2013; Bonis, Pickens, Rind & Foster, 2008; Isaac, 
Zheng & Jha, 2012; Phua & Lim, 2008; Phua, See, Khalisah, Low & Kim, 2012; Schilling et 
al., 2005). Physicians have repeatedly reported that consulting UpToDate affects their 
clinical decision-making: Phua and Lim found that 57.9% of physicians using UpToDate 
reported that the use of UpToDate led to a change in the way that they managed patients.  
UpToDate it touted  as the “ONLY decision support resource associated with improved 
outcomes” (UpToDate, “About Us,” 2017), and, indeed, two studies by Bonis et al. (2008) 
and Isaac et al. (2012) provide particularly startling results about the effects of using 
UpToDate on outcomes. It should be noted that UpToDate funded both of these studies and 
two of the authors of Bonis et al.’s study were employees of UpToDate. The authors 
compared the practices and outcomes of hospitals with and without access to UpToDate and 
report that hospitals using UpToDate consistently demonstrated reduced length of stay, lower 
risk-adjusted mortality rates, and higher quality performance 4. From this comparison, the 
authors extrapolate that UpToDate can save lives, going so far as to announce that UpToDate 
prevented 11,500 deaths in 424 US hospitals in a three-year period (Isaac, Zheng & Jha, 
2012).   
                                                 
4 To assess the quality of hospital performance the researchers used the US Hospital Quality 
Alliance process measures for four conditions (acute myocardial infarction, congestive heart 
failures, pneumonia, surgical infection prevention). The quality of performance is judged 
according to how well an entity provides care to its patients based on the evidence that 
particular processes are followed.  In other words, ‘quality’ here reflects process adherence. 
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While UpToDate has been the subject of numerous studies, its structure, 
development, and content have not been extensively or systematically studied. Three small 
studies examined its structure and content.  Jeffrey et al. (2012) compared the currency of 
DynaMed, UpToDate, ACP Pier, and Best Practice and found that, across 200 topics, the 
time elapsed since the last update varied substantially for the four platforms. The average 
time since the last update for each topic ranged from 170 days for DynaMed to 488 days for 
PIER and the topics in UpToDate averaged 427 days since the last update. When assessing 
the need for topics to be potentially updated, UpToDate lagged significantly behind 
DynaMed, with 104 topics in UpToDate needing potential updates in comparison with 47 
topics in DynaMed. Health sciences librarian Andrea Ketchum and her colleagues compared 
the number, levels, and currency of evidence used in five resources, including UpToDate 
(Ketchum et al., 2011). Again, UpToDate was found to be not as current as DynaMed. 
DynaMed also had significantly more references per topic and relative to the other 4 
resources, UpToDate had the lowest percentage of evidence from two of the top levels of 
evidence, systematic reviews and randomized controlled trials. Amber, Dhiman, and 
Goodman (2014) examined UpToDate’s treatment of six topics that have controversial or 
uncertain treatment. They examined the topics for evidence of potential conflict of interest 
(including financial) and report that authors and editors of UpToDate were allowed to 
maintain financial relationships with drug companies whose products are evaluated within 
these articles. Each of these three studies provides indications of the structure and content of 
UpToDate, as well as suggesting some of its potential shortcomings.  
Medicalization 
 As noted earlier, more than 10,500 topics are covered in UpToDate, and more topics 
are continuously being added. Interestingly, not all the topics covered by UpToDate would 
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be found in medical textbooks from 100 or 50 years ago.  Included in the vast number of 
UpToDate entries are ailments and illnesses that have been ‘medicalized’ over time. 
Medicalization is the process by which medical definitions and practices are applied to 
behaviours, psychological phenomena, and somatic experiences not previously within the 
conceptual or therapeutic scope of medicine. In the simplest terms, medicalization arises 
when previously non-medical problems are defined and treated as medical problems, usually 
in terms of illnesses or disorders. Medicalization has been a topic of interest to researchers in 
sociology, anthropology, medicine, history, and science and technology studies for more than 
four decades (Davis, 2010). In 1972, Zola’s definition of medicalization as “the involvement 
of medicine in the management of society” focused on medicalization as a means of medical 
control and regulation (p. 488). Originally, researchers interested in this field focused on the 
medicalization of deviant behaviours (for example, children’s misbehaviours and child 
abuse) and natural life processes (for example, childbirth and menopause).  However, the 
concept of medicalization has evolved and expanded. Medicalization is not only about 
medical control but also results from individuals’ eagerness to seek diagnosis, affecting not 
only the utilization of medical interventions but also the expansion of medical categories 
themselves (Conrad, 2005, 2007). 
Changing patterns of medicalization have been attributed to the “rise of corporate 
managed care and the corresponding decline of physicians’ professional power” (Barker, 
2008), p. 21). Researchers and critics note that the practice of medicalization can: increase 
unnecessary medical labelling, promote poor treatment decisions, and increase the marketing 
of unnecessary pharmaceutical treatments (Moynihan, Heath, & Henry, 2002; Conrad & 
Leiter, 2004). Moynihan et al. (2002) examine medicalization in relation to “widening the 
boundaries of treatable illness in order to expand markets for those who sell and deliver 
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treatments” (p. 886), characterizing it as a form of ‘disease mongering’.  They describe five 
(non-discrete) categories of medicalization: ordinary processes or ailments of life classified 
as medical problems; mild symptoms portrayed as portents of a serious disease; personal or 
social problems seen as medical ones; risks conceptualised as diseases; and disease 
prevalence estimates framed to maximise the size of a medical problem.  Medicalized 
conditions often are unique in the ways in which the patient is positioned, the certainty of the 
“evidence” available, and the roles in which experts and expertise enact; this makes them a 
useful site of investigation for the present study.   
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Chapter 2: Research Questions and Methods 
As evidenced in the published literature, UpToDate dominates as the resource tool of 
choice for physicians who are looking for answers to their clinical questions. A physician’s 
choice to use the information found in summary sources of information, such as UpToDate, 
is supported by the principles of evidence-based practice (Guyatt et al., 2008) and aligns with 
Haynes’s suggestion that “[providers and consumers of evidence-based health care can help 
themselves to the best current evidence by recognizing the most evolved information services 
in the topic area of concern to them” (2001, p. 37). The drive towards the use of summary 
resources is directly tied to the notion that these resources provide information that is more 
evolved and as such, of a higher quality. However, the discursive practice of referring to 
these resources as ‘evolved’ may be problematic as evolution infers a transformation from a 
simpler form to a more complex form. This is actually contrary to the process that evidence 
goes through during the summarization process. As the basis of evidence moves from the 
bottom of the 6S pyramid (studies) to the top (summaries and systems) information does not 
become more complex; in fact, it becomes less complex, and seemingly more certain. A key 
question posed in the present study is how a more simple (and certain) product ‘evolves’ 
from the complex (uncertain) inputs and how evolution corresponds with a process that 
actually distills and strips away detail.    
While summarized resources have been examined in several studies in terms of their 
editorial quality, uptake and application, breadth of coverage of medical conditions, and 
timeliness, the ‘evolution’ of primary evidence into summary resources has not yet been 
systematically investigated.  Important questions to be explored about the ‘evolutionary’ 
process include what evidence is selected for inclusion and how such evidence is positioned 
vis-a-vis clinical practice.   
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Summary resources, such as UpToDate, present the body of clinical research on a 
topic in a usable and understandable format suitable for clinical practice. Greenhalgh (2012) 
describes the evolution of clinical research to systematic reviews as the “technical process of 
stripping away all but the bare bones of a focused experimental question” and further 
contends that this stripping away “removes what practitioners and policymakers most need to 
engage with: the messy context in which people get ill, seek health care (or not), receive and 
take treatment (or not), and change their behaviour (or not)” (p. 371).  Greenhalgh describes 
a distillation—rather than evolution—process, i.e., a process that purifies and condenses in 
order to collect a refined product.  This process, by definition, requires the loss or removal of 
some of the initial substance. This research delves into the distillation process that moves 
(some) clinical research into the summary resource, UpToDate. The main research question 
addressed in this study is: What information is sacrificed and what information is privileged 
during the summarization process? Additional research sub-questions include how the 
complexities inherent in clinical practice are presented in summarized information sources 
and how the patient and patient-centered care is or is not presented in UpToDate. 
In the summarization process, potentially thousands of pages of information that 
make up the corpus of evidence on a topic must be distilled into a few paragraphs. Unlike 
chemical distillation, however, the selection, filtering, and condensing of information is not 
mechanical, consistent or pure, rather these are conscious human and social acts. The 
UpToDate website describes this summarization work undertaken by its authors:  
Drawing on their extensive experience, our physician authors and editors begin 
with a structured clinical question, placing the latest evidence about the topic in 
context with the larger body of available evidence. Next, they synthesize that 
evidence into recommendations clinicians can use to diagnose and treat their 
patients, even when the evidence is thin or no consensus exists. (UpToDate, 
“Physician Authors and Editors,” 2017) 
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A multiple case study analysis explored these processes. By examining seven cases5 and 
following up with a cross-case analysis, what information is privileged and excluded in 
UpToDate at various points in the distillation process was identified. The investigation 
included what types of evidence as well as what content from the evidence base was 
included.  
Content Analysis and Multiple Case Study Design  
Content analysis is a useful method for identifying both the conscious and 
unconscious messages within a text (i.e., what is stated explicitly and what is implied by the 
manner in which content is expressed) (Krippendorff, 2013). It is a flexible methodology that 
lends itself to both qualitative and quantitative analysis (Cavanagh, 1997). Its roots are found 
in the 1950s as a quantitative method used in the study of mass communications. Since then, 
researchers across many fields have adapted content analysis as a quantitative and qualitative 
approach to address a wide range of research questions and research strategies. It is used 
extensively in library science, information studies, and medical fields (Hseih & Shannon, 
2005; Krippendorff, 2010; Neuendorf, 2002; Weber, 1990; White & Marsh, 2006). 
Descriptive information was collected to understand the evidence base utilized by UpToDate 
and a qualitative content analytic approach was used to gain a more holistic understanding of 
the context and process of summarizing evidence for clinical practice.   
Qualitative content analysis "is the intellectual process of categorizing qualitative 
textual data into clusters of similar entities, or conceptual categories, to identify consistent 
patterns and relationships between variables or themes" (Julien, 2008, p. 121). Analytic 
                                                 
5 The multiple case study analysis is made up of seven cases. Because the grief and 
bereavement case is made up of two entries: one addressing normal grief and bereavement 
and one addressing complicated grief and bereavement, eight UpToDate topic entries are 
analysed to make up the seven cases.  
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constructs, or rules of inference, are used to find prominent patterns within the data and yield 
inferences from textual data. While there is quite an extensive body of literature evaluating 
and describing selected resources supporting evidence based medicine, an analysis of the 
context, process, and underlying meaning of how lower order “S”s (e.g., studies and 
syntheses) become higher order summaries has not been evaluated. The flexibility afforded 
by the content analysis methodology was important to this research because there was some 
uncertainty about what would emerge from the data.  An inductive approach was used in that, 
rather than looking for preconceived categories in the analysis, the categories were allowed 
to emerge from the data. Content analysis allows researchers to identify what is stated 
explicitly and what is implied by the manner in which content is expressed and, while it may 
not provide definitive answers to critical concerns, content analysis can provide ‘signposts” 
for further inquiry (Beach et al., 2009, p. 136).  
 In this study, the units of text that were subjected to analysis were the main clinician 
entries of UpToDate for eight conditions (making up the seven cases), the associated patient 
information where available, and the abstracts of the referenced evidence (evidence cited 
within the UpToDate entry). The data from these texts were analysed individually by topic 
and then analysed across the topics to understand the points of divergence and convergence 
across the topics (Figure 3). Descriptive information from these three data sources was also 
extracted, collected, and analysed. 
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Figure 3: Comparing Similar Phenomena Inferred From Different Texts  
(Adapted from Krippendorff, 2013, p. 94) 
 
In order to ensure that this research captured a holistic and comprehensive 
understanding of how UpToDate functions within health information practices and culture, 
following the descriptive and qualitative analysis, the results were considered in relation to 
Stuart Hall’s ‘Circuit of Culture’ framework (DuGay, Hall, Janes, Mackay & Negus, 1997). 
The Circuit of Culture framework presents five coexisting processes: Representation; 
Production; Consumption; Identity; and Regulation, which “taken together complete a sort of 
circuit...through which any analysis of a cultural text or artefact must pass if it is to be 
adequately studied" (DuGay, et al., p.3). Examining UpToDate using the framework of the 
Circuit of Culture provides insight into the position and meaning of UpToDate in medical 
and information environments, Figure 4 provides an overview of the model, including short 
definitions for the five elements.  
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Figure 4: Circuit of Culture Framework (Adapted from Du Gay et al., 1997) 
 The framework poses several questions in this study: How and why is UpToDate 
created? (Production); How does the language of evidence based medicine and the language 
used in UpToDate create meaning? (Representation); How is UpToDate consumed and 
deployed by user groups (librarians and physicians)? (Consumption); What identities are 
created and reinforced by UpToDate? How is UpToDate used to create and reinforce the 
identity of its creators and users? (Identity); and What regulations, norms, and values 
influence how UpToDate is created and used? (Regulation). 
Data Sources for Content Analysis 
The number of topics that comprise the corpus of evidence for clinical practice is 
vast. More than 10,500 entries across 24 specialties are included in the UpToDate database. 
For this multiple case study analysis, eight UpToDate entries, representing seven case 
studies, were selected for evaluation. Each entry, along with the corresponding patient 
information (where available) was analysed as a separate case, with the exception of the 
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Grief case which comprises two UpToDate entries: the 2015 entry on treating complicated 
grief and the 2015 entry on non-complicated grief. As outlined in the Diagnostic and 
Statistical Manual of Mental Disorders by the American Psychiatric Association, the 
diagnostic criteria and subsequent treatment of grief underwent a substantial shift in 2013 
(American Psychiatric Association, 2013; Zachar, First, Kendler, 2017). A comprehensive 
explanation of the changes and the decision to include two UpToDate entries for the Grief 
case are included in the results section for Grief and Bereavement. An UpToDate entry is 
defined in this study as a single UpToDate webpage addressing a discrete subject related to a 
single condition/illness for either professionals or patients. The main clinician entry is 
defined as the webpage content written for professionals accessible only by subscription to 
the resource. 
A multiple case study structure allows researchers to examine how the phenomenon 
of interest presents in different environments (Stake, 2006). Whereas in a single case study 
researchers seek to identify the common themes within the case, in a multiple case study 
researchers are also interested in the atypical (i.e., unique concepts that do not transcend 
across the cases, and/or distinctive concepts that are not common across all cases) (Stake, 
2006). Toward this end, entries selected for analysis represent varying levels of complexity 
and certainty. Per Stake (2005), each topic represents its own case study and the cross-case 
analysis forms the multiple case study.   
 A unique feature of this research is that, unlike interviews where the text is analysed 
as it is presented, and taken to be the entirety of the story or perspective, there is additional 
information that is critically important to understanding the meaning and material embedded 
in the text, i.e., the referenced evidence. The referenced evidence for this study includes the 
studies, systematic reviews or other sources of evidence cited within the UpToDate entries 
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examined. As such, in addition to the content of the entry, the referenced evidence is a unit of 
analysis for which descriptive data is collected.  
Entries for Analysis  
The selection of cases is a critical and often challenging step in designing case study 
research (Yin, 2009). In an attempt to reflect the realities of clinical practice, the topics 
chosen as the cases address varying levels of complexity and medicalization of 
conditions/illnesses, as well as of clarity, i.e., the level of certainty regarding interventions 
and outcomes.  For example, the treatment for the topic, Treatment of Children with Otitis 
Media, would be expected to convey information about an illness with a clearly defined 
organic medical cause, in which drug and non-drug interventions are evaluated in an attempt 
to relieve the symptoms and cure the inflammation of the inner ear in children. In contrast, at 
the other end of the spectrum, Complicated Grief and Bereavement in Adults is a more 
complex and multifaceted topic.  Unlike a physical ailment, grief and bereavement is an 
emotional, but also highly medicalized, response to the loss of a loved one, which does not 
have clear treatment. Seven cases were chosen for analysis. Each case contained one main 
entry, with the exception of Grief and Bereavement, which contained two interrelated entries 
(described below). The seven cases (eight entries) selected for this study were6:  
1. Acute otitis media in children (AOM): Acute Otitis Media (AOM) is the medical 
term for inflammation of the inner ear. Otitis Media is a common childhood illness 
with a known organic cause and pathophysiology. While 80% of occurrences of 
AOM dissipate without treatment, AOM is the most common diagnosis for which 
children receive antibiotics (Grijalva, Nuorti & Griffin, 2009). While complications 
of acute otitis media are rare, complications include perforation of the eardrum, 
                                                 
6 Copies of the UpToDate entries analysed are available upon request 
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infection of the mastoid space behind the ear, and, in very rare cases, bacterial 
meningitis. For this case, the title of the entry analysed is Acute Otitis Media in 
Children: Treatment. 
2. Androgenetic alopecia (AGA): Androgenetic Alopecia is the medical term for male 
pattern balding. While research demonstrates that hair loss can affect self-esteem in 
men (Cash, 2001), Moynihan highlights that ordinary processes or ailments, like 
balding, are often framed as medical problems. Androgenetic alopecia is commonly 
diagnosed and treated by physicians, and the treatment for baldness is a multi-billion 
dollar industry with many products in development (Ellis, Sinclair & Harrap, 2002). 
Treatment of Androgenetic Alopecia in Men is the entry analysed.  
3. Irritable bowel syndrome in adults (IBS): Irritable bowel syndrome (IBS) is a 
chronic functional gastrointestinal disorder and has no known organic cause. As such, 
IBS is a symptom-based diagnosis characterized by chronic abdominal pain and 
altered bowel habits.  While there are individuals with IBS who are incapacitated by 
their symptoms, for many, IBS is “a mild functional disorder- requiring little more 
than reassurance about is benign natural course” (Moynihan et al., 2002, p. 887). IBS 
has been identified as a condition that has been medicalized, i.e., the relatively mild 
symptoms of this common disorder may be portrayed as a sign of a serious disease 
(Moynihan et al., 2002).  The title of the entry in UpToDate analysed in this case is 
Treatment of Irritable Bowel Syndrome in Adults.  
4. Fibromyalgia in adults (FIB): This topic represents an illness or condition with a 
high level of uncertainty with respect to its cause and treatment. Because 
fibromyalgia involves unpredictable pain, has no known organic cause and the 
treatment options are not consistently effective, there is a high level of uncertainty 
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about it among both patients and professionals. Although, currently, there is a general 
acceptance of fibromyalgia as a legitimate medical condition, questions have been 
raised about its physiological authenticity, whether it is a single condition, and even 
whether it represents a “medicalization of misery” (Hadler, 2003, p. 1668). The entry 
analysed in for the FIB case is Initial Treatment of Fibromyalgia in Adults. 
5. Chronic fatigue syndrome (CFS): Chronic Fatigue Syndrome (CFS) is an illness 
characterized by persistent fatigue for at least 6 months, and is often accompanied by 
several other symptoms including headaches, muscle pain, insomnia, and 
concentration issues. There is no clear cause identified and no effective diagnostic 
test developed for CFS. As such, CFS is diagnosed through symptom identification. 
The lack of cause and diagnostic test has led to questions and challenges about the 
legitimacy of CFS by some health care professionals who argue that a diagnosis of 
CFS may be self-validating, self-reinforcing and potentially a self-fulfilling prophecy 
(Huibers & Wessely, 1996). In February 2015, the United States Institute of Medicine 
(IOM) published a report renaming Chronic Fatigue Syndrome as Systemic Exertion 
Intolerance Disease (SEID), as well as proposing a redefinition of the diagnostic 
criteria for CFS. While the content of the entry primarily uses the term Chronic 
Fatigue Syndrome, the title does reflect the redefinition. The entry analysed for the 
CFS case is Treatment of Chronic Fatigue Syndrome (Systemic Exertion Intolerance 
Disease).  
6. Grief and bereavement (NGB and CGB): Increased attention was recently drawn to 
the potential for the medicalization of personal and social problems as a result of 
changes to the psychiatric manual, the DSM-V (Diagnostic Statistical Manual of 
Mental Disorders, Version 5), regarding guidelines and criteria for depression. Prior 
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versions of the DSM advised physicians not to diagnose major depressive order after 
the death of a loved one, even if all other criteria were met. The removal of the 
“bereavement” exclusion was met with harsh criticism as it suggested that the 
depressive syndromes that result from bereavement do not differ from “ordinary” 
occurrences of depression. The treatment of personal or social problems as medical 
problems has been questioned extensively. The case for Grief and Bereavement 
included two UpToDate entries: Grief and Bereavement in Adults: Management and 
Complicated Grief in Adults: Treatment. 
7. Intimate partner violence: (IPV): Intimate partner violence (IPV) is a complex social 
and health issue.  The physician’s role in supporting a patient experiencing abuse are 
often initiated when IPV is detected or disclosed. Physicians and health care workers 
are increasingly encouraged to talk about, screen for, and provide options for 
intervention when intimate partner violence is disclosed (American College of 
Obstetricians and Gynecologists, 2012; Cronholm, Fogarty, Ambuel & Harrison, 
2011; Society for Obstetricians and Gynecologists of Canada, 2009). While 
preventing IPV and ensuring supports and resources are in place for IPV victims is 
recognized as a priority and a potential outcome of the medicalization of IPV, the 
issues underlying these actions and potential consequences of these actions are 
numerous and complex. As such, the role of health care workers in identifying and 
providing intervention options for IPV has been debated extensively (Cole, 2000; 
Wathen & MacMillan, 2012). The entry analysed for the IPV case is titled Intimate 
Partner Violence: Intervention and Patient Management. 
Because the most common types of questions encountered in the clinical setting 
address the treatment of illnesses and conditions (Crowley et al., 2003), all entries chosen for 
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the multiple case study address treatment options.  Individual analysis was followed by cross-
case analysis. The triangulation between the seven cases, comprised of eight topics, highlight 
themes that transcend the cases, as well as themes that are unique to specific cases, were of 
interest. 
It is important to note here that UpToDate is an internet-based evidence resource and 
researchers face a number of challenges in conducting a content analysis of internet-based 
resources (Weare & Lin, 2000). First, internet-based content consistently includes multiple 
hyperlinks to additional material. These hyperlinks may be considered similar to “see also” 
references in a print source; however, the immediacy of the hyperlinked content encourages 
the reader to shift from the initial content to the supplementary reading. Moreover, the 
dynamic nature of Internet resources adds additional challenges to analysis. Any content 
captured may be edited or completely rewritten in minutes. This makes any particular 
snapshot of the content somewhat arbitrary (Weare & Lin, 2000). While UpToDate updates 
are not continual, and in fact can be quite slow (Prorok et al., 2012; Jeffrey et al., 2012), in 
this study the web content was captured as a PDF to address the dynamic nature of the web-
based data and ensure that the content analysed could be consistent throughout the study (as a 
PDF, see Appendices A to G). Although UpToDate entries were updated over the course of 
the study, the PDF of the captured entry was used for analysis.  
Research Questions 
Multiple case study research begins with core questions, but sub-questions are likely 
to evolve over the course of data collection and analysis and, eventually, will help to inform 
the themes that evolve from the data. It should be noted that the core research questions in 
case study research: (a) are open-ended, evolving, and non-directional, (b) reinforce the 
purpose of the research, (c) and are often ‘what’ or ‘how’ questions, rather than ‘why’ 
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(Cresswell, 201; Agee, 2009).  
 The following six research questions initially made up the base of the analysis and 
met the criteria for research questions that are appropriate when using the case study method: 
a.) What types of information sources do clinical experts include/privilege when developing 
content for the summary source, UpToDate? b.) What information is overlooked or excluded 
by clinical experts when developing content for the summary source UpToDate? c.) How is 
evidence situated in the entries for UpToDate? d.) How is expertise situated in the entries for 
UpToDate? e.) How is the patient situated in the entries for UpToDate? f.) How are these 
processes understood in the five concepts of the Circuit of Culture? 
Throughout the course of the analysis minor alterations were made to the research 
questions. For example, it was not anticipated that expertise would be tied so directly to the 
authors. Specifically, the entries heavily used phrases such as ‘In our experience’ and ‘we 
suggest.’ The authors prominently presented and described expertise as their own so in turn, 
the fourth question evolved from ‘How is expertise situated in the entries for UpToDate?’ to 
‘How is author situated in the entries for UpToDate?’ In addition, the final question changed 
from ‘How is the patient situated in the entries for UpToDate?’ to ‘How is the patient-
physician relationship situated in the entries for UpToDate?’ This change largely evolved 
from the inability to disentangle the two entities from the relationship as described in the text.  
The final six research questions informing the analysis were: 
1. What types of information sources do clinical experts include/privilege when 
developing content for the summary source, UpToDate?  
2. What information is overlooked or excluded by clinical experts when developing 
content for the summary source UpToDate?  
3. How is evidence situated in the entries for UpToDate? 
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4. How is expertise situated in the entries for UpToDate?  
5. How is the patient-physician relationship situated in the entries for UpToDate? 
6. How are these processes understood in the context of the five concepts of the Circuit 
of Culture? 
 
Figure 5: Data Collection and Analysis Schematic 
Four levels of analysis, as presented in Figure 5, addressed the five research questions 
described above. The Level 1 and Level 3 analysis focused on the availability and inclusion 
of evidence in UpToDate while the Level 2 analysis focused what content is included in each 
UpToDate entry. Then, an overarching qualitative content analysis of the eight entries 
making up the seven cases was performed as a means to better understand how evidence, 
expertise and the patient is situated within the UpToDate entries. Finally, the process(es) was 
examined in the context of the five key elements of the Circuit of Culture. 
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Descriptive Data Extraction 
Level 1 analysis relies heavily on the extraction of descriptive data from the 
referenced evidence. A core objective in this study is to understand what types of evidence 
sources are selected for inclusion as referenced evidence and what information is selected for 
inclusion in the entry. As such, along with the overall text of the UpToDate entry, key data 
sources for analysis were the referenced evidence of the eight entries. Referenced evidence 
refers to those articles or sources that have been listed in the topic citation list as evidence 
and appear in the reference list in the UpToDate entry. Descriptive information about the 
referenced evidence was gathered from the bibliographic record and the abstract. The full 
article was consulted when necessary. Information about when each case was downloaded, 
last update, and number of sources included as referenced evidence is presented in Table 2. 
Entry Title Download 
Date 
Review 
current 
Last  
Updated 
# of 
References 
Acute otitis media in children Sept 2015 Aug 2015 Jan 31, 2014 82 
Androgenetic alopecia in men Nov 2015 Oct 2015 July 21, 2015 41 
Irritable bowel syndrome in adults Jan 2015 Dec 2014 Oct 2, 2014 84 
Fibromyalgia in adults Oct 2015 Oct 2015 Aug 28, 2015 91 
Chronic fatigue syndrome Nov 2015 Nov 2015 Jul 30, 2015 46 
Grief and bereavement Dec 2015 Nov 2015 Aug 6, 2015 20 
Complicated grief  Oct 2015 Nov 2015 Aug 6 2015 30 
Intimate partner violence Nov 2015 Oct 2015  Apr 28, 2015 24 
Table 2: Number of Sources Cited as Referenced Evidence 
 Descriptive data were mined from the evidence sources.  The data extraction form 
was created for this study and web-based, making data entry more portable and easier using 
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form tools including: checklists, radio buttons and open text. Further the web-based form 
allowed the data to be easily exported to multiple formats (PDF, Word, Excel, SPSS) (see 
Appendix H). Descriptive data were collected not only to describe the content and the 
referenced evidence that make up the UpToDate topic information, but also to identify 
relationships between the evidence and the entries in relation to five primary elements: 
1. Publication Source: The titles of publication sources for each article cited 
within the eight entries were recorded. The publication title for each 
referenced evidence was also compared to the list of 466 core journals 
identified by UpToDate for hand-searching. Hand-searching refers to 
manually searching through select journal titles from cover to cover for 
articles and citations relevant to a topic. Hand-searching aims to identify 
articles that may be missed due to limitations in indexing practices. Since the 
proliferation of digital publishing, hand-searching is now mostly done online 
but still requires the careful review of online tables of content and online 
article-by-article browsing.  
2. Date of publication: The month (if available) and year of publication of the 
references were recorded for each source cited across the eight entries.  
3. Location of Study, if applicable: For research studies, the country where the 
study took place was recorded. The country location(s) of data collection was 
recorded, not the home institution of the author. If data were collected in more 
than one country, it was recorded as multinational, also capturing the 
individual countries. 
4. Authorship, professional/academic background: To understand the relative 
proportions of professional backgrounds that contribute to the UpToDate 
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evidence base, the authors’ professional backgrounds were noted. Each cited 
reference was given a weighting of one, and the background of each author of 
the reference was assigned proportional weighting based on the number of 
authors contributing to the cited reference. For example, a paper with a single 
physician author would be assigned a value of 1.0 for physician background 
and a paper co-written by a basic scientist, a nurse and two physicians, would 
be assigned a value of .25 for the background for nurses and basic scientists 
and .5 in the physician background.  No difference of weighting was given for 
order of authors. 
5. Type of Evidence: In order to gain a better understanding of the type of 
evidence included in UpToDate, each cited reference was analysed for the 
level of evidence from Haynes’ 6S model,’ (e.g. Study; Synthesis); Type of 
Resource (e.g. Quantitative Research; Systematic Review); and Research 
Design, if applicable (e.g., RCT, Longitudinal). If the evidence/source cited 
was not recognized under the 6S Model, this was recorded with details about 
the type of resource (e.g. public health website). 
6. PICO Elements of Clinical Question: The PICO framework identifies the 
Patient/Problem, Intervention, Comparison, and Outcome of the clinical 
question answered by the study. All identifiable elements of the referenced 
evidence were recorded. It was anticipated that certain PICO elements of the 
clinical question will have more or less importance in the entry depending on 
the topic and the question addressed. Using the PICO framework helped to 
separate and identify the features of the clinical question, as well as assist in 
identifying relevant evidence not included in the entries. 
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 The conclusions of the study were also recorded. In incidences where all relevant 
information could not be captured by the abstract, the full-text of the referenced evidence 
was used.  
 Evidence Not Selected. A survey of the literature was conducted to better understand 
the corpus from which the referenced evidence was selected. In addition to understanding 
what is included as evidence, as Bowker and Star (2000) note, there is value in understanding 
what has not been selected or has been omitted from the entry.  The content of UpToDate is 
claimed to follow “a hierarchy of evidence consistent with most evidence-based resources” 
(UpToDate, “Editorial Policy,” 2017). Specifically,   
[w]hen current, high-quality systematic reviews are available, 
UpToDate topics and recommendations rely heavily on these reviews. 
When such reviews are unavailable, UpToDate summarizes the key 
studies bearing on the clinical issues at hand. (UpToDate, “Editorial 
Policy,” 2016) 
 
To gain an understanding of the body of available evidence from which authors select 
systematic reviews and clinical trials, a purposeful search was conducted in PubMed. 
Specifically, the PubMed portlet, which links clinical trials to the systematic reviews, which 
subsequently cite them, was used (see Figure 6).   
 
Figure 6: PubMed Portlet to Identify Citing Systematic Reviews 
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By using the portlet, systematic reviews that address clinical questions with similar elements 
of PICO (i.e.: Patient, Intervention, Comparison, Outcome) to referenced clinical trials in the 
entry could be identified. 
Additionally, the size and nature of the body of qualitative research available across 
the eight topics was of interest. While clinical trials, especially randomized controlled trials, 
are privileged in the EBM hierarchy, qualitative research studies are rarely included in these, 
and rarely recognized as components of evidence for practice. While qualitative research is 
often overlooked in evidence hierarchies, this type of research provides empirical accounts of 
the lived experience of health conditions from the patient perspective (Al-Busaidi, 2008). In 
health-care, qualitative research provides insight about how patients experience, navigate, 
and respond to health challenges through empirical accounts of such events (Dancet, et al, 
2011; Given, 2008). Because the current study was interested in the ways that the patient and 
patient-centred care is situated within evidence-based medicine and in turn, the ways that 
patients and their experiences are situated within UpToDate, an understanding of the 
availability of qualitative research was sought. Targeted literature searches were performed 
to identify qualitative research on the eight topics. Qualitative findings are presented in single 
qualitative studies and meta-analyses. Table 3 provides an overview of the search strategies 
used in PubMed to identify qualitative evidence. The searches were limited to those articles 
where the topic or condition is assigned as a major subject heading (denoted in PubMed as 
[Majr]) by PubMed in order to identify focused and highly relevant articles.  
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Case Medical Subject 
Heading assigned to 
condition 
Date 
Limiter 
Strategy for  
Qualitative Studies 
Strategy for  
Meta-Analysis 
AOM "Otitis Media"[Majr] 08/2015 AND "Qualitative 
Research"[Mesh] AND 
("therapy"[Subheading] 
OR "therapy"[All 
Fields] OR 
"treatment"[All Fields] 
OR 
"therapeutics"[MeSH 
Terms] OR 
"therapeutics"[All 
Fields])  
AND (("meta 
synthesis" OR 
"metasynthesis") 
OR ("Meta-
Analysis" 
[Publication Type] 
or "meta-analysis" 
and qualitative)) 
AGA "Alopecia"[Majr] 
AND "male"[MeSH 
Terms] 
10/2015 
IBS "Irritable Bowel 
Syndrome"[Majr] 
10/2015 
FIB "Fibromyalgia"[Majr] 11/2015 
CFS "fatigue syndrome, 
chronic"[Majr] 
11/2015 
N/CGB (("Grief"[Majr]) OR 
"Bereavement"[Majr]) 
11/2015 
IPV (("Domestic 
Violence"[Majr]) 
10/2015 
Table 3: Search Strategies to Identify Availability of Qualitative Evidence 
 The targeted searches for systematic reviews and qualitative research are not intended 
to be comprehensive, but rather to gain a general sense of the body of literature from which 
authors select evidence for inclusion in UpToDate. This is particularly of interest because 
UpToDate “follows a hierarchy of evidence consistent with most evidence-based resources” 
but lacks clear guidelines for the selection of evidence for UpToDate entries. Searches for 
systematic reviews help to gain an understanding of whether the searches for evidence in 
UpToDate follow the guidance of evidence based medicine that it is only when “every other 
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S fails (ie, no system, [summaries,] synopses, or syntheses)” that it is appropriate to look for 
original studies (Haynes, 2001, p. 37). Identifying the availability of qualitative research 
helps to gain an understanding of the prominence of the patients’ accounts of illness 
experiences in comparison to physician experiences in treating such conditions.  
Overarching Qualitative Analysis 
As noted earlier, the goal of this research was not only to identify and analyze what is 
explicitly cited and stated in UpToDate entries but also to understand what is implied by the 
manner in which content is expressed, and how, if at all, this relates to the core constructs in 
the Circuit of Culture. As such, a key component of the study is the overarching analysis of 
the texts that make up the seven cases. The qualitative content analysis was undertaken to 
identify themes and patterns in the ways in which the authors of the entries present the 
content they have selected for inclusion (Berg, 1995, 2007).  Because this type of analysis 
has not been previously done, inductive analysis was critical to allow data analysis and 
concept development to occur simultaneously. The inductive approach allowed themes to 
emerge from the data iteratively, rather than relying on pre-determined themes. Qualitative 
content analysis was used for each entries making up the seven cases in an attempt to make 
inferences about three particular phenomena of interest: certainty, expertise, and the position 
of the patient, then relate these to the Circuit of Culture.  
In order to facilitate valid and reliable inferences, a systematic and transparent 
procedure was followed and documented. To develop the codes and categories inductively, 
the constant comparative method outlined by Strauss and Corbin (1990) was used as a guide 
for analysis. Initially, the texts of the entries were read and coded with general descriptions 
of the content. This process focused on “breaking down, examining, comparing, 
conceptualizing and categorizing the data” (Strauss & Corbin, 1990, p. 61) At this open 
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coding stage, many descriptors, categories and a wide range of codes were recorded to 
describe the various elements of the data (Berg, 1995). Axial coding, where connections 
between the initial codes and categories are made and recorded, followed, where new higher 
order concepts emerged, evolved and were ultimately labelled (Strauss & Corbin, 1990, p. 
96).  Core themes emerged from axial coding and extensive documentation of what falls 
beneath the broader themes was recorded. Finally, once the core themes were identified, the 
data were analysed as a whole with the core themes and the Circuit of Culture constructs in 
mind. Key content or phrases that support and confirm the core themes were selected from 
the text and noted. Outlying divergent statements were also selected and recorded. Multiple 
readings of the entries with the core themes and subheadings were needed in order to ensure 
reliable coding. This overarching qualitative analysis was assisted by the use of the 
qualitative analysis software NVivo (v. 10). 
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Chapter 3: Results 
This multiple case study analysis included seven topics, where two of the cases, i.e., 
those related to bereavement, were combined in the cross-case analysis. These cases 
represented varying levels of contestation, complexity, and certainty. This section first 
analyses the cases individually, followed by the cross-case analysis. Data sources analysed 
for each case included: the related main professional entries for each topic, the referenced 
evidence of the main entries (descriptive analysis only), and the patient information in Basic 
and/or Beyond the Basics format, when available. Each case contained one main entry, with 
the exception of Grief and Bereavement, which contained two interrelated entries. A brief 
introduction to each topic leads each case, including an overview of issues that are discussed 
and debated about the topic. A descriptive analysis of the references cited in each of the cases 
is then presented, followed by the textual analysis. Across the seven cases, three broad 
higher-order categories emerged from the textual analysis that address the initial research 
questions about certainty, expertise, and the role of patient: Situating the Authors, Situating 
the Evidence, and Situating the Patient-Physician Relationship.  
The analysis of the patient information entries was conducted to evaluate how 
these align with the main UpToDate entry for professionals, specifically in relation to 
the representation of certainty and uncertainty of evidence and the framing of the 
patient-physician relationship, including decision-making responsibilities. The analysis 
of the patient information focused on the section addressing treatment in order to best 
align the patient and professional content for comparison. 
Table 4 provides an overview of the topics and data sources analysed, including the 
review date (re: currency) and word counts of the analyzed data. 
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 Topic Main Basics Beyond 
Case  
# 
 Word Count 
Review 
Current 
Word Count 
Review 
Current 
Word Count 
Review 
Current 
1 
AOM 
Acute Otitis Media  6176 words 
08/2015 
732 words 
10/2015 
1539 words 
10/2015 
2 
AGA 
Androgenetic Alopecia 3693 words 
10/2015 
N/A* 
1430 words 
12/2015 
3 
FIB 
Fibromyalgia 7489 words 
10/2015 
534 words 
12/2015 
3371 words 
12/2015 
4 
CFS 
Chronic Fatigue Syndrome 3847 word 
11/2015 
736 words 
12/2015 
1369 words 
12/2015 
5 
IBS 
Irritable Bowel Syndrome 5374 words 
11/2015 
460 words 
12/2015 
3202 words 
01/2016 
6 
GRF 
Normal Grief and Bereavement 2182 words 
11/2015 
N/A N/A 
Complicated Grief 2669 words 
11/2015 
N/A N/A 
7 
IPV 
Intimate Partner Violence 3679words 
10/2015 
N/A N/A 
*N/A: UpToDate does not provide patient information at this level (Basics or Beyond the 
Basics) 
Table 4: Overview of Topics and Entries Analysed 
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Case Study Analysis: Acute Otitis Media 
 
Acute Otitis Media (AOM) is a painful ear infection that causes the middle ear to 
become inflamed. AOM is a common illness in children. More than two-thirds of children 
will experience AOM before the age of three (Vergison, Dagan & Arguedas, 2010). AOM 
has a clear organic cause, and the cause and validity of the illness is not contested. However, 
while AOM is the diagnosis for which children are most frequently prescribed antibiotics, the 
necessity for and role of antibiotics in treating AOM is heavily debated. Because children can 
recover spontaneously without treatment, one option for care is observation with comfort 
measures, i.e., watchful waiting with analgesics. The other primary strategy for care is to 
treat AOM with antibiotics although there is “strong evidence that antibiotics provide 
minimal benefit” (Hansen, Howlett, Del Mar & Hoffmann, 2015). The caregiver’s 
understanding of and desire for treatment with antibiotics has been shown to be a key 
influence in the likelihood of antibiotics being prescribed (Cockburn & Pit, 1997; Hansen et 
al.; McNulty, Nichols, French, Joshi & Butler, 2013). The debate is further magnified when 
considering the current focus on reducing the use of antibiotics in order to prevent 
development of antibiotic resistant bacteria. In a 2015 editorial on antibiotics and AOM, Del 
Mar, Venekamp, and Sanders explain: “any recommendation that may increase the use of 
antibiotics in primary care will contribute to antibiotic resistance, which is now a serious 
threat to global public health” (p. 1574).  
To guide physicians in providing care for children with AOM, the American 
Academy of Pediatrics (AAP) and American Academy of Family Physicians (AAFP) 
developed a clinical practice guideline in 2004. The organizations updated the guideline in 
2013. The document provides recommendations to primary care clinicians for the 
management of children from six months through 12 years of age with uncomplicated AOM. 
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The guidelines present both observation and antibiotics as options for care of children with 
AOM over six months of age. The presentation of both options and the perceived lack of 
decisiveness and clear position by guidelines has been criticized (Nikolopoulos, 2014). The 
debate about the best approach to antibiotics in AOM pervades and is addressed in the 
UpToDate entry, Acute Otitis Media in Children: Treatment. 
Descriptive Analysis 
The AOM case contained 82 cited references ranging in date of publication from 
1980-2015. Fewer than one quarter (n=18, 22%) of the references were published between 
2010 and 2015. The vast majority (74%) of cited references were from UpToDate’s list of 
core journals. The journal most commonly cited in the AOM main entry was Pediatric 
Infectious Disease Journal, a key journal identified by UpToDate. 
This UpToDate entry contained evidence situated in three levels of the 6S hierarchy: 
Summary, Synthesis, and Study (Figure 7). Of the 82 references, there are also 15 (18%) 
cited that are not recognized as evidence in the 6S hierarchy: non-systematic/narrative 
reviews (n=8); public websites (n=2); editorials/commentaries (n=3), textbooks (n=1) and 
case reports (n=1). The majority of referenced evidence (59%) were studies; all 48 studies 
were quantitative, 21 of which were RCTs.  
  
Figure 7: Types of Evidence in the AOM Entry 
 
Cited 
References
82
Not in 6S
15 (18%)
Summary
5 (6%)
Synthesis
14 (17%)
Study
48 (59%)
Quantitative
48 (59%)
RCT
21 (26%)
Other Quant
27 (33%)
Qualitative
0 (0%)
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More than half of the cited studies were conducted in the United States (n=27, 
56.3%). Three studies were multinational, all with partnerships with locations in the United 
States (two studies collaborating with sites in Canada and one with a site in Chile). Fourteen 
studies took place in European countries: (United Kingdom (n=4); France (n=3); Israel 
(n=3); Finland (n=2); and Italy (n=1); Denmark (n=1)); and one study each took place in 
Canada, Australia, Costa Rica and Japan.  
The 82 cited references were written by a total of 376 authors. Based on the number 
of authors contributing to the paper, a proportional weighting was assigned for the 
background of each author. Across the 82 papers, the highest known proportional 
representation (.56) of the authors had a Medical Doctor (MD) background (see Figure 8).  
 
Figure 8: Relative Contributions by Author Background 
 
Textual Analysis 
Situating the Authors. The content of the AOM case is connected closely with the 
expertise of the authors. Most prominently, the authors share their expertise through their 
recommendations. The authors explicitly communicate their recommendations to the reader 
as their own position: “We recommend treatment to reduce ear pain in children with AOM 
whether or not they are treated with antibiotics” (AOM). Using the phrase ‘we recommend’ 
or ‘we suggest’ extensively, the authors make it overt that their guidance is developing out of 
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their own expertise and understanding. For example, they provide the following 
recommendation: 
For children with AOM and tympanic membrane perforation, we suggest oral 
rather than topical antibiotic therapy. We suggest amoxicillin 90 mg/kg per 
day orally divided in two doses (we suggest a maximum of 3 g/day) as the 
preferred first-line oral therapy. (AOM) 
 
The authors commonly provide specific details about the ways in which treatment options are 
enacted (e.g., the timing and allocation of medication dosages) by way of their own 
recommendations/suggestions. In addition to details about the execution of treatment 
regimens, the authors frequently connect their recommendations to specific patient features 
and circumstances. For example:  
We suggest that children <2 years, children with AOM and tympanic 
membrane perforation, and children with a history of recurrent AOM be 
treated for 10 days. We suggest that children ≥2 years without tympanic 
membrane perforation or a history of recurrent AOM be treated for five to 
seven days. (AOM)  
 
Follow-up for children whose symptoms have resolved depends upon the 
child's age and underlying medical problems, particularly language delay 
or learning problems. We suggest that: 
Children <2 years be seen 8 to 12 weeks after diagnosis (by which 
time middle ear effusion will have resolved in 80 to 90 percent); 
many such children will already have a routine healthcare visit 
scheduled within this time frame 
Children ≥2 years who have language or learning problems be seen 8 
to 12 weeks after diagnosis  
Children ≥2 years who are without language or learning 
problems be followed up at their next health maintenance visit, 
or sooner if there are concerns regarding persistent hearing loss 
(AOM) 
 
The specific details about treatment, which vary depending on the individual patient’s 
circumstances (e.g., age, medical history, presence of language and learning issues), are often 
provided by way of a recommendation by the authors.  
There are 22 incidences where the authors utilize the phrase ‘we suggest’ or ‘we 
recommend’ to promote their approach to AOM through their own expertise.  On selected 
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occasions, the authors followed up their recommendation with published evidence, which 
supports their recommended approach:  
We suggest oral ibuprofen or acetaminophen for pain control in children with 
AOM […] In a multicenter trial, 219 children (one to six years of age) with 
AOM were treated with antibiotics and randomly assigned to receive 
ibuprofen 10 mg/kg three times per day, acetaminophen 10 mg/kg three times 
per day, or placebo. (AOM) 
 
We do not suggest pre-flight treatment with antihistamines or decongestants. 
In a randomized trial, predeparture administration of pseudoephedrine did not 
decrease ear pain, but was associated with increased drowsiness. (AOM) 
 
The authors’ endorsements of particular treatment options are presented first and then 
reinforced by clinical trials.  
In addition to providing explicit recommendations, the authors also provide accounts 
of their own practices. The authors describe the approach to treatment that they take when 
treating children with AOM: 
We generally treat children <2 years, children with tympanic membrane 
perforation, and children with recurrent AOM for 10 days. We generally treat 
children ≥2 years without a history of recurrent AOM for five to seven days. 
(AOM) 
 
Through the accounts of their own routine practices (e.g., length of treatment based of patient 
characteristics), authors make implicit recommendations when treating patients and like the 
explicit recommendations, also often address the tailoring of treatment to individual patients. 
In this case there is a noteworthy instance where the authors’ steady presentation of 
their own recommendations by the phrase ‘we recommend’ or ‘we suggest’ was relinquished 
when the approach shifted from the prescription of antibiotics to observation. The authors 
provide guidance for four subgroups of children with AOM:  
We recommend that children <6 months with AOM be treated immediately 
with an appropriate antibiotic. 
We suggest that children six months to two years with AOM be treated 
immediately with an appropriate antibiotic;  
We suggest that children ≥2 years who appear toxic; have persistent otalgia 
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for more than 48 hours; have temperature ≥102.2°F (39°C) in the past 48 
hours; have bilateral AOM or otorrhea; or have uncertain access to follow-up 
be immediately treated with an appropriate antibiotic.  
For children ≥2 years who are normal hosts (eg, immune competent, without 
craniofacial abnormalities) and have unilateral AOM with mild symptoms and 
signs and no otorrhea, initial observation may be appropriate [emphasis 
added] if the caretakers understand the risks and benefits of such an approach. 
(AOM) 
 
In this quotation, the authors provide a clear recommendation for antibiotics for three 
subgroups of children with otitis media. However, in the fourth and final bullet, the authors 
shift from the pattern of providing a clear recommendation—using ‘we recommend’ or ‘we 
suggest’—to stating that the approach of delaying or forgoing antibiotic treatment “may be 
appropriate” (AOM). Following three clear recommendations which the authors appear to 
‘own’, the authors appear not to endorse or support their final suggestion.   
 Later in the case the authors provide additional details with respect to observation 
as a possible approach to treatment:  
We suggest initial observation as an alternative to antimicrobial therapy for 
children ≥2 years who are normal hosts (eg, immune competent, without 
craniofacial abnormalities), without otorrhea, and who have mild 
symptoms and signs of unilateral acute otitis media (AOM) (ie, nonsevere 
ear pain for <48 hours and temperature <39°C [102.2°F]). Clinicians who 
recommend initial observation should exercise rigor in diagnosing AOM 
similar to that in the research protocols that support the safety of this 
practice. (AOM) 
 
In this quotation, the authors do not endorse the treatment, but rather frame observation as an 
alternative treatment for this subgroup of children. The authors further separate themselves 
from the approach by referring to “clinicians who recommend initial observation” (AOM). 
The authors’ lack of full endorsement for observation as a treatment option for AOM is 
significant because of its alignment, or misalignment, with key clinical practice guidelines 
discussed in the Situating the Evidence section.  
Situating the Evidence. The summary level of evidence is described by Haynes 
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(2007) as an integration of “best available evidence from the lower layers (drawing on 
syntheses [i.e., systematic reviews] as much as possible) to provide a full range of evidence 
concerning management options for a given health problem” (Haynes, p. 6). Both UpToDate 
and clinical practice guidelines are located in the Summary level of evidence. As established 
in the Situating the Authors section, the authors of this entry do not appear to fully endorse 
observation as a treatment option for children over 6 months of age.  In contrast, the 2013 
iteration of the AOM Clinical Practice Guideline of the American Academy of Pediatrics 
(AAP) and American Academy of Family Physicians (AAFP) recommends that for children 
as young as six months with unilateral AOM, “physicians should either prescribe antibiotic 
therapy or offer observation with close follow-up based on joint decision-making with the 
parent(s)/caregiver” (Lieberthal et al., 2013). The authors of the case acknowledge that their 
perspective counters this Clinical Practice Guideline:  
The 2013 American Academy of Pediatrics (AAP) and American 
Academy of Family Physicians (AAFP) guideline recommends immediate 
treatment for children <6 months, children with severe signs or symptoms 
(defined by moderate or severe ear pain, ear pain for ≥48 hours, or 
temperature ≥39°C [102.2°F]) and bilateral AOM in children <24 months 
of age. The 2013 AAP/AAFP guideline recommends either immediate 
treatment or observation (with pain control) for children between 6 and 24 
months with unilateral nonsevere AOM and for children ≥24 months with 
unilateral or bilateral nonsevere AOM. However, given the additional 
analysis now available showing a high rate of treatment failure among 
children <24 months with unilateral nonsevere AOM, we suggest that such 
children be treated with antimicrobial therapy. (AOM, emphasis added)  
 
The authors, here, describe the recommendations that are provided by the AAP and AAFP, 
which include options for both immediate treatment and observation, then highlight evidence 
that contradicts observation as a treatment option. In turn, they propose the alternative 
suggestion, the prescription of antimicrobial therapy for children less than 2 years of age. The 
preference for antimicrobial therapy aligns with their recommendation stated earlier: “We 
suggest that children six months to two years with AOM be treated immediately with an 
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appropriate antibiotic” (AOM).  The authors also draw attention to other clinical practice 
guidelines that counter their recommendation: “Guidelines from other countries (e.g., the 
Dutch College of General Practitioners) recommend a no or delayed antibiotic strategy for 
most children with AOM” (AOM). Although the authors appear not to endorse initial 
observation as a treatment strategy, the authors repeatedly make clear that the guidelines 
affirm the option for observation. There is a willingness by the authors to position themselves 
counter to the published clinical practice guidelines.   
In addition to highlighting the conclusions of clinical practice guidelines from the 
Summary level of evidence, the authors summon evidence from the Study and Synthesis 
level of the 6S hierarchy to exemplify certainty within the AOM case:  
A 2001 meta-analysis concluded there is no evidence to support any particular 
antibiotic regimen versus another for treatment of AOM. (AOM) 
 
Individual randomized trials that used stringent diagnostic criteria and 
experienced otoscopists to make the diagnosis of AOM and appropriate 
antibiotic regimens to treat AOM indicate that children younger than two 
years benefit from antibiotic therapy. (AOM) 
 
The presence or absence of evidence is highlighted as a source of certainty in these examples. 
Throughout the case, there is wide variance in the amount of information that is provided 
about the referenced evidence from these levels, ranging from no details about the study to 
scant descriptions to extensive reports. In the quotations below, the variance in the extent of 
descriptions is demonstrated: 
In a randomized trial, predeparture administration of pseudoephedrine did not 
decrease ear pain, but was associated with increased drowsiness. (AOM) 
 
In a multicenter trial, 219 children (one to six years of age) with AOM were 
treated with antibiotics and randomly assigned to receive ibuprofen 10 mg/kg 
three times per day, acetaminophen 10 mg/kg three times per day, or placebo. 
On the second day of illness, fewer children who received ibuprofen or 
acetaminophen had pain (7 and 10 percent, respectively, versus 25 percent 
among placebo recipients); the reduction in pain was only statistically 
significant for ibuprofen. (AOM) 
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While the type of study design is included in both descriptions, it is only in the second 
quotation that details about the study’s patient population (i.e., age and number), intervention 
(i.e., ibuprofen with dosage), comparators (i.e., placebo) and outcome (i.e., pain relief) were 
provided. Details about all elements of the PICO clinical question were included in the 
second quotation, while the first quotation only highlighted the basic outcomes of the study.  
Descriptions of meta-analysis and systematic reviews also included varying levels of 
detail. Examination of the reporting of synthesis level of evidence provides a good example 
of the ways that the results and conclusions of a study or review influenced the level of 
description and detail by the authors. More detail about meta-analyses and systematic 
reviews that supported the prescription of antibiotics were provided than those that did not 
support antibiotic prescription. The single meta-analysis that demonstrated benefit of 
antibiotic care was described in a paragraph: 
In a 2006 meta-analysis of individual data from six randomized trials (1643 
children age six months to 12 years), children who were younger than two 
years who had bilateral AOM and children with otorrhea benefited most from 
antibiotic therapy. Among children younger than two years with bilateral 
AOM, 25 percent (95% CI 14-36 percent) fewer children treated with 
antibiotics than with symptomatic care continued to have pain and/or fever on 
days three to seven of illness. Among children with otorrhea, 36 percent (95% 
CI 19-53 percent) fewer children treated with antibiotics than with 
symptomatic care continued to have pain and/or fever on days three to seven 
of illness. (AOM) 
 
The description of the meta-analysis includes details about the four PICO elements (i.e., 
patient, intervention, comparators, and outcome) of the investigated clinical question, as well 
as statistical results.  In contrast, the description of five systematic reviews that do not 
support the use antibiotics is considerably shorter:  
Systematic reviews and meta-analyses suggest that many children with AOM 
do well, even without antibiotic therapy, and that the benefits of antibiotics are 
modest. (AOM) 
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The authors cite five systematic reviews in the sentence quoted above. While the authors note 
that the intervention assessed was antibiotics in children, extensive details about the PICO 
elements are not provided, with the exception of a brief indication that the outcomes of the 
study found that “the benefits of antibiotics are modest” (AOM). The authors also follow-up 
the statement with critique of the conclusions:  
However, many of the studies included in the meta-analyses had increased 
risk of bias (related to nonstringent diagnostic criteria, inclusion of children 
with mild disease, exclusion of patients <2 years of age, use of an 
inappropriate antibiotic or inappropriate dose, etc), making the results difficult 
to interpret. (AOM) 
 
The authors highlight in this excerpt some of the shortcomings of the research, including bias 
within the study selection. The authors favour details about the systematic review supporting 
the use of antibiotics. The way in which these two systematic reviews containing conflicting 
findings are handled accentuate the authors’ ability to select what details about the evidence 
are brought to the fore.  
The inclusion of commentary on the available evidence is common throughout the 
AOM case. The authors repeatedly provide critiques of the body of evidence available for 
AOM: 
Randomized trials comparing immediate versus delayed antibiotics have 
used different outcome measures (eg, parental satisfaction, rate of filled 
prescriptions, etc) and types of follow-up (eg, telephone versus office 
examination). (AOM) 
 
In this example, the authors highlight that the research studies evaluating AOM treatments 
often do not measure the same outcomes. In addition to the inconsistent outcomes across 
research studies, the authors’ commentaries also highlight methodological shortcomings of 
specific research studies including a lack of placebo, atypical dosing regimes, and unreliable 
diagnostic criteria. The authors also comment on insufficiencies in the research base as a 
whole. In particular, they draw attention to multiple areas where evidence is lacking or is 
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inconsistent:   
Most clinical trials and standard pediatric practice provide a 10-day 
course of an oral antimicrobial agent for the treatment of AOM. 
However, some data suggest that a shorter course (ie, seven days) may be 
adequate. Unfortunately, many of the studies comparing short- and 
long-term antibiotic therapy have significant limitations that preclude 
definitive conclusions. (AOM) 
 
These therapies have been proposed, but there are no placebo-controlled trials 
that directly address their effectiveness. (AOM) 
 
The authors are transparent about gaps or inconsistencies in the current literature on AOM, 
giving rise to some uncertainty. In two instances within this entry, the authors fill in the lack 
of evidence in the research literature with their own recommendation:  
Interventions to equalize middle ear and atmospheric pressure have not 
been well studied in controlled trials. We suggest that children be awake 
during descent and chewing gum or food (or sucking on a pacifier or 
bottle if they are too young to chew gum or food) to open the Eustachian 
tube and facilitate equalization of middle ear pressure. (AOM) 
 
There are no randomized trials to guide treatment of recurrent AOM in 
children. […] 
When recurrence occurs within 30 days of completion of antimicrobial 
treatment for the previous episode, we suggest [list of antibiotics]. (AOM) 
 
The authors provide suggestions for care in the absence of evidence. This practice of 
authors ‘filling in’ where there is a lack of evidence aligns with the description of the 
work of authors and editors from UpToDate (UpToDate, “Physician Authors and 
Editors,” 2016).  
Situating the Patient-Physician Relationship. The clinical practice guideline from 
the AAP/AAFP, which is referenced in the entry, states that the decision on which of the two 
approaches, observation or antibiotics, is adopted for a patient occurs “after joint decision-
making with the parent(s)/caregiver” (Lieberthal et al., 2013, p. e965). In contrast, in the 
main UpToDate entry the clinician, rather than the patient, is positioned at the center of that 
choice: 
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When treating such children, practitioners should weigh the potential 
symptomatic benefit against the reported adverse events and potential for 
prolongation of middle ear effusion. (AOM) 
 
In the quotation above, the practitioners are the decision-makers who assess multiple factors 
in order to make a choice. Physicians’ need to consider specific patient characteristics is 
highlighted by the authors: “The choice of strategy depends upon the age of the child and the 
laterality and severity of illness” (AOM). Here, it is clear that the decision should take into 
consideration traits and characteristics of the patient; however, the responsibility for 
decision-making appears to rest with the physician. The focus on the physician in the 
decision-making process, and the subsequent absence of the patient/caregiver, runs counter to 
the AAP/AAFP guidelines that emphasize joint-decision making between the clinician and 
parent/caregiver (Lieberthal et al., 2013). Even when the factors are largely related to patient 
preference or patient context, overt acknowledgement and identification of the patient is 
absent in the text: 
When the decision is made to treat acute otitis media (AOM) with 
antimicrobial agents, the selection among available drugs is based upon: 
Clinical and microbiologic efficacy; Acceptability (taste, texture) of the oral 
preparation; Absence of side effects and toxicity; Convenience of the dosing 
schedule; Cost. (AOM) 
 
The decision-making for treatment is presented as the responsibility of physicians in 
consideration of the patient circumstances and preferences. The patient experience was 
treated much like patient preferences in that it was disconnected from the patient. The focus 
is not on patient experience, but rather the resolution of symptoms. 
There are three instances in the AOM case where the caretakers of children with 
AOM are specifically mentioned. All three are in relation to the caretakers’ need to 
understand the risks and benefits of observation:  
When the initial observation strategy is chosen, caretakers must understand 
the risks and benefits, and appropriate follow-up must be ensured so that 
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antibiotic therapy can be initiated if symptoms worsen or persist after 48 to 72 
hours. (AOM) 
 
As demonstrated in the excerpt above, the authors only refer to caretakers when emphasizing 
the need for caretakers to comprehend the risks and benefits of not initiating antibiotics 
immediately. The caretaker’s need for awareness of risks and benefits was only discussed in 
relation to observation therapy but not the alternative, antibiotic therapy. The effect of 
antibiotic resistance on the patient or the public is minimaly addressed in the entry: 
“Although the child is at higher risk for a nonsusceptible pathogen, we suggest high dose 
amoxicillin-clavulanate as initial therapy, even if the child received amoxicillin-clavulanate 
for the previous episode” (AOM). Antibiotic resistance is primarily discussed in relation to 
the resistance and domination of certain bacteria to particular antibiotics, but not in relation 
to the impact or responsibility of the patient:  
Macrolide or lincosamide antibiotics can be used to treat AOM in children 
who have had an immediate type 1 hypersensitivity reaction (anaphylaxis, 
angioedema, bronchospasm, or urticaria) to amoxicillin or other beta-lactam 
antimicrobial agents. However, macrolide or lincosamide resistance is 
common (approximately 25 to 35 percent) among isolates of S. pneumoniae, 
and macrolides and lincosamides generally are not effective for eradication of 
H. influenza. (AOM) 
 
Trimethoprim-sulfamethoxazole, macrolides (eg, erythromycin-sulfisoxazole, 
azithromycin, clarithromycin), and lincosamides (eg, clindamycin) are not 
recommended for AOM that fails to respond to treatment with high-dose 
amoxicillin. Pneumococcal surveillance studies indicate that resistance to 
these agents is substantial). (AOM) 
 
Antibiotics resistance is addressed through underscoring the antimicrobial activities of 
different antibiotics: physicians’ and patients’ responsibility to prevent antibiotics resistance 
is not addressed. The authors advise physicians to caution patients about the risks of 
observation; however, the side effects or risks of antibiotics are not included as key 
components of the physicians’ education for AOM caregivers.  
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Patient Information. UpToDate provides patient information in two forms, The 
Basics and Beyond the Basics. The two patient entries were analysed to evaluate how the 
patient information entries align with the main professional UpToDate entry in relation to the 
representation of certainty and uncertainty of evidence and the framing of patient-physician 
relationship, including decision-making responsibilities. The analysis of the patient 
information is focused on the sections addressing treatment of acute otitis media in order to 
best align the patient and professional content for comparison. 
As discussed, two strategies for care are available when treating AOM in children. 
Both treatment approaches are presented in patient information entries. In The Basics, the 
two treatments options for AOM are outlined as such: 
Doctors can treat ear infections with antibiotics. These medicines kill the 
bacteria that cause some ear infections. But doctors do not always prescribe 
these medicines right away. That’s because many ear infections are caused by 
viruses — not bacteria — and antibiotics do not kill viruses. Plus, many 
children get over ear infections without antibiotics. (AOM Basics) 
 
In this excerpt from The Basics patient information, the rationale behind each choice is 
described. The cause of AOM and the effects of antibiotics primarily dictate this choice. This 
explanation of choice is followed by an explanation of what children commonly are and are 
not prescribed antibiotics. 
Doctors usually prescribe antibiotics to treat ear infections in infants younger 
than 2 years old. For children older than 2, doctors sometimes hold off on 
antibiotics. Your child’s doctor might suggest watching your child’s 
symptoms for 1 or 2 days before trying antibiotics if: Your child is healthy in 
general; The pain and fever are not severe. (AOM Basics) 
 
The recommendations outlined here align with author recommendations to prescribe 
antibiotics for children under the age of two. In contrast, the 2013 clinical practice guideline 
of the AAP/AAFP “recommends either immediate treatment or observation (with pain 
control) for children between 6 and 24 months with unilateral nonsevere AOM” (AOM). The 
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patient information, while presenting both options for care, the specifics of the two treatment 
options align closer with the authors’ recommendations than with the AAP/AAFP guidelines.  
The Basics version of the patient information does align closely with the AAP/AAFP 
in terms of a shared decision-making process between health care professional and caretaker:    
You and your doctor should discuss whether or not to give your child 
antibiotics. This will depend on your child’s age, health problems, and how 
many ear infections he or she has had in the past. (AOM Basics) 
 
The physician and the caregiver are presented as shared decision-makers. This emphasis on 
joint decision-making is only present in the basic information. In contrast, decision-making 
in the Beyond the Basics patient information is not presented as a shared process. The choice 
is based on choosing the best treatment for the patient: “The ‘best’ treatment depends on the 
child's age, history of previous infections, degree of illness, and any underlying medical 
problems” (AOM Beyond). These four factors that dictate the best treatment are followed by 
short explanations about who is most likely to receive observation or antibiotics based on 
these four factors. For example, the following explanation about how age influences the 
likelihood of antibiotic prescription:  
Antibiotics are usually given to infants who are younger than 24 months or 
who have high fever or infection in both ears. Children who are older than 24 
months and have mild symptoms may be treated with an antibiotic or 
observed to see if they improve without antibiotics. (AOM Beyond) 
 
The appropriateness of antibiotics for children who are younger and or who have more 
significant symptoms is highlighted (aligning with the authors’ recommendations, not the 
AAP/AAFP guidelines). A similar description of who is best suited for observation (i.e., 
those who are older, healthy and have less severe symptoms) is also included in the entry. In 
the Beyond the Basics entry, the notion that there is a “best” treatment based on medical 
status and history places a great deal of decision-making responsibility with the physician 
because of the implied need for the physician’s expertise to identify the most suitable 
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treatment.  
Additional roles of the caregiver highlighted in both entries include ensuring 
symptom identification, pain control, and proper follow-up. The importance of monitoring 
and follow-up is emphasized when observation is adopted as the treatment approach. 
In substantial contrast to the UpToDate entry, the risks of antibiotics are put forth in 
the Beyond the Basics patient information: 
Antibiotics can have side effects such as diarrhea and rash, and overusing 
antibiotics can lead to more difficult to treat (resistant) bacteria. Resistance 
means that a particular antibiotic no longer works or that higher doses are 
needed next time. (AOM Beyond) 
 
These side effects are not emphasized in the main entry for professionals.  
The patient information does not reflect the same preference for antibiotics that the 
authors of the main entry inferred. The patient information resources present both 
observation and antimicrobial therapy as options for treatment. However, antibiotics for 
children between 6 months and 2 years of age are favoured over the AAP/AAFP guidelines 
for the choice between antibiotics or observation. Further, the patient information provides 
insight into some of the potential side effects and outcomes of antibiotic prescribing. There is 
also variance within the two patient information sources concerning with whom the 
responsibility for decision-making sits. Specifically, The Basics accentuate the need for 
shared decision-making between patient and physician. In contrast, the presentation of a 
“best” treatment in Beyond the Basics implies that physician expertise is needed to identify 
the best option. There are substantial inconsistencies across the main professional entry, The 
Basics patient information, and the Beyond the Basics patient information.   
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Case Analysis: Androgenetic Alopecia 
Androgenetic alopecia (AGA) is a common form of hair loss and is often referred to 
as male pattern balding. In AGA, hair is lost in a well-defined pattern beginning above both 
temples and over time, the hairline recedes to form a characteristic ‘M’ shape. While 
androgenetic alopecia can affect both men and women, the analyzed UpToDate main entry, 
Treatment of Androgenetic Alopecia in Men, only addresses the condition in men. A separate 
entry for AGA in women is included in UpToDate. AGA affects 30% of Caucasian men by 
the age of 30 and the incidence of AGA increases with age with up to 80% of men affected 
by the age of 70 (Ellis, Sinclair & Harrap, 2002; Yip, Rufaut & Sinclair, 2011). While 
alopecia in men is a common process that accompanies aging, the societal imperatives 
regarding maintenance of the appearance of vigour and vitality has led to a demand for 
intervention to treat this common process. Although balding is a normal process of aging, 
androgenetic alopecia is a condition often diagnosed and treated by physicians (Ellis, Sinclair 
& Harrap, 2002; Moynihan, 2002).  
Descriptive Analysis 
The AGA case contained 41 cited references ranging in publication date from 1987 to 
2015. Twelve of the 41 references (29%) were published between 2010 and 2015. The 
majority (63%, n=26) of cited references were from UpToDate’s list of core journals. The 
most commonly cited journal in the AGA main entry was the Journal of the American 
Academy of Dermatology, a core UpToDate journal. 
The UpToDate entry for AGA contained three types of evidence from the 6S 
hierarchy: Summary, Synthesis, and Study (see Figure 9). Twenty-two per cent (n=9) of the 
cited references were not recognized as evidence in the 6S hierarchy. These nine references 
were made up of seven non-systematic reviews, a case report/brief, and a drug information 
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brief. Only one summary and one synthesis (systematic review) were cited in the entry.  
  
Figure 9: Types of Evidence in AGA Main Entry 
 
Approximately three quarters of the cited references (n=30) were studies, all of which 
were quantitative, with 24 RCTs and most conducted in the US (n=20, 67%). Two 
multinational studies were cited, both in partnerships with locations in United States. Three 
studies took place in European countries (Germany (n=2), Turkey (n=1)), and one each in 
Canada, Japan, Iran, and India. It is unknown where one study of the 30 studies was 
conducted. 
The 41 cited references were written by a total of 203 authors. Across the 82 papers, 
the highest known proportional representation (.51) of the authors had a Medical Doctor 
(MD) background.  
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Textual Analysis 
Situating the Authors. While the use of ‘we’ is supported by the Editorial Policy of 
UpToDate and is common throughout the previous case (AOM), in the AGA case, the 
authors did not overtly acknowledge themselves in the content. Instead, the authors presented 
the information without explicit recognition of themselves as a source of expertise.  
The authors only make one reference to themselves as authors and experts:  
For male patients with androgenetic alopecia who desire treatment, we 
suggest treatment with oral finasteride (1 mg/day) over topical minoxidil 
Treatment with minoxidil 5% solution or foam is an alternative first-line 
therapy that may be preferred by patients who prefer to avoid systemic 
therapy. The response to treatment with both agents is variable. No high 
quality randomized trials have directly compared their efficacies. (AGA) 
 
In this quotation, which appears in the Summary and Recommendation section, the authors 
provide guidance to the reader to use one treatment over another. By making use of the ‘we 
suggest’ statement, the authors make explicit that this recommendation comes from their own 
endorsement, aligning with UpToDate policy (UpToDate, “Editorial Policy,” 2016). 
Concurrently in the statement, the authors acknowledge that the evidence base to support 
their recommendation is not strong.   
There is content in the main entry for which the source of the knowledge is 
ambiguous; it may be emerging from the authors’ expertise, but there is no explicit 
acknowledgment as such. For example, the authors note that: “[m]en utilizing minoxidil for 
androgenetic alopecia should be advised of the following: [List of patient information 
needs]” (AGA). There is no reference to where this information originates and the use of the 
word ‘should’ frames this as guidance. The source of the expertise, experience, or evidence is 
not made explicit.  
Situating the Evidence. In the absence of situating themselves in the content, the 
authors present the evidence as the primary source of certainty for the effectiveness of 
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treatments for AGA. The body of evidence available to the authors is the basis for justifying 
treatment selections: 
In addition to improved hair counts, other factors, such as increases in hair 
thickness, pigmentation, and length may contribute to the perception of 
improved scalp coverage during therapy. This concept is supported by a 
randomized trial that followed men treated with finasteride for up to 192 
weeks and found that net improvements in hair weight were greater than 
improvements in hair count. (AGA) 
 
Here, the authors draw from a randomized trial for support. The authors also highlight the 
existence of a seemingly broad research base as a means to support the two first-line 
treatments: 
Topical minoxidil and oral finasteride are the therapeutic agents that have 
been most extensively studied for the treatment of androgenetic alopecia in 
men. Both drugs have demonstrated efficacy and high tolerability in 
placebo-controlled randomized trials, supporting their status as first-line 
agents. (AGA) 
 
The authors evaluate treatments based upon type and breadth of research available, often 
underscoring the volume of research available: “In comparison to finasteride, fewer studies 
have evaluated the efficacy and safety of dutasteride in male androgenetic alopecia” (AGA). 
They note the lack of a broad research base and bring attention to areas where the evidence is 
insufficient. In turn, they highlight the need for more research evaluating novel therapies, 
comparing between treatment options, appraising the effectives of combination therapies, and 
assessing treatment side effects.  
The highlighted lack of significant research and understanding about the risk for 
sexual dysfunction and male breast cancer as a result of a first-line AGA treatment is 
noteworthy. The authors state that little is known about sexual dysfunction as a side effect of 
finasteride and the need for more research:  
Additional studies are needed to validate these findings and evaluate the 
frequency with which persistent sexual dysfunction might occur. (AGA) 
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Nevertheless, finasteride is identified as a first-line therapy. 
The majority (73%) of the references cited in the AGA entry were quantitative 
studies, and more than half were RCTs. The details provided about the studies varied greatly. 
Few or no details were provided for some (e.g., “A randomized trial of 326 men found that 
the drug was efficacious for frontal scalp hair thinning” (AGA)) while others were detailed 
extensively:  
Data from an evaluator-blinded randomized trial of 99 men with midfrontal 
and/or vertex androgenetic alopecia that compared finasteride 1 mg/day with 
the 2% formulation of minoxidil are less straightforward. Although patients 
and evaluating clinicians were more likely to perceive increased hair growth 
at three months with minoxidil, at 12 months, finasteride was associated with 
significantly greater increases in hair counts, and the differences in patient and 
evaluator global assessments of clinical response were not statistically 
significant (62 versus 56 percent improved on blinded evaluator assessment) 
(AGA). 
 
In the largest randomized trial that compared the 5% and 2% solutions, 
393 men with androgenetic alopecia were randomly assigned to treatment 
with 5% or 2% topical minoxidil solution or placebo. After 48 weeks of 
therapy, 5% minoxidil was significantly better than the 2% solution or 
placebo in terms of change from baseline in nonvellus hair count (increase 
in count of 18.6, 12.7, and 3.9 per cm2, respectively), patient ratings of 
scalp coverage and treatment benefit, and investigator rating of scalp 
coverage. Treatment with 5% minoxidil was also associated with an 
earlier therapeutic response and an improvement in the patients' 
psychological perceptions of hair loss. However, patients treated with 5% 
compared with 2% minoxidil reported more pruritus and local irritation. 
(AGA) 
 
The sole systematic review was cited twice in the AGA main entry with a focus 
on study outcomes:  
A meta-analysis of placebo-controlled randomized trials identified 
moderate quality evidence in support of the use of finasteride for 
treatment of androgenetic alopecia in men. After 6 or 12 months of 
treatment, the mean percentage change in hair count was 9 percent higher 
among patients treated with finasteride compared with patients who were 
given placebo (95% CI 8-11 percent). This difference increased over 
time. After 48 months of therapy, the mean percentage change in hair 
count was 24 percent (95% CI 18-31 percent) higher in patients treated 
with finasteride. (AGA) 
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This systematic review is later cited when the side effects of sexual dysfunction are 
addressed in the AGA main case, stating: “A systematic review of nine trials with a total 
of 3570 patients found an overall absolute increase in sexual dysfunction of 1.5 percent” 
(AGA). Here, new information is provided about the review, including the number of 
studies and the number patients included. Both times the systematic review is cited, the 
authors highlight the type of evidence (i.e., systematic review) from which the 
knowledge emerges. In contrast, only one summary level resource was cited in the main 
entry of the AGA case and the authors made no indication of its level of evidence (i.e., 
summary) or type of resource (i.e., clinical practice guideline) when citing. The 
‘Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and 
in men’ was published in the Journal der Deutschen Dermatologischen Geselischaft. 
The main entry stated: “Hair shedding may occur at the initiation of treatment and is 
thought to occur as a result of the stimulation of telogen follicles to reenter the anagen 
phase” (AGA). While there is a parenthetical reference, there is no indication of the type 
of evidence from where the information emerges. There was also no acknowledgement 
of the type of resource that the information emerged from when information was cited 
from resources not recognized as evidence by the 6S hierarchy. 
Situating the Patient-Physician Relationship. The patient’s experience of hair loss 
is the key driver for people to seek treatment for the condition. The authors acknowledge in 
the beginning and at the end of the main entry that hair loss is a normal process that has 
evolved into a medical issue due to non-medical concerns: 
Although androgenetic alopecia is a benign and asymptomatic disorder, 
cosmetic concerns lead some patients to seek treatment. (AGA, repeated 
in summary) 
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AGA is a cosmetic, not medical, concern. While not explicitly denoted as an example of 
medicalization, the authors highlight that AGA poses no harm or risk to the patient. 
Beyond the recognition that it is “cosmetic concerns that lead some patients to seek 
treatment” (AGA), there is no explanation of how these cosmetic concerns affect the 
individual.  
References to the AGA patient focus on the potential for and experience of side 
effects when receiving treatment. Specifically, the side effects of the two first-line 
treatments are discussed. The side effects of and precautions for minoxidil are described 
in single paragraph highlighting that few patients experience side effects and the most 
common are skin reactions and irritations. In contrast, the side effects of and precautions 
for finasteride are covered more extensively. The authors advise that physicians be aware 
of rare side effects including gynecomastia, testicular pain, and depression that “are more 
likely to occur with the typical 5 mg dose used to treat benign prostatic hypertrophy” 
(AGA).  The authors also highlight uncertainty around the effect of treatment on the 
levels of prostate specific antigen, the risk of prostate lesions, and the risk for male breast 
cancer. While these and other precautions of finasteride are briefly acknowledged, more 
significant attention is paid to the effect of finasteride on sexual function. The 
information provided by the authors focus on the prevalence and persistence of the 
sexual side effects based on the published evidence: 
A systematic review of nine trials with a total of 3570 patients found an 
overall absolute increase in sexual dysfunction of 1.5 percent. The risk for 
sexual side effects increases with age. Sexual side effects related to 
finasteride usually resolve after discontinuation of the medication. 
However, persistent sexual dysfunction after the discontinuation of 
finasteride was reported in a survey-based study of 71 men who 
associated their symptoms of sexual dysfunction with the use of 
finasteride for hair loss. The mean age of the study participants was 26 
years and the mean duration of finasteride use was 28 months. Twenty 
percent of these men reported continued symptoms for greater than six 
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years after cessation of the medication. Moreover, a follow-up study of 54 
of the interviewed men found that 9 to 16 months after the initial survey, 
96 percent continued to report sexual side effects. Additional studies are 
needed to validate these findings and evaluate the frequency with which 
persistent sexual dysfunction might occur. Reductions in sperm count also 
may occur during treatment with finasteride. This effect reverses after 
drug discontinuation. (AGA) 
 
This excerpt cites one systematic review and eight studies that identify and evaluate side 
effects related to sexual function. The authors do not address the impact of these side 
effects on patient experience, the likelihood of patient discontinuation of treatment due to 
these side effects, or ways that physicians might address these side effects, based on 
published evidence or clinical observation.  Unlike other entries included in the multiple 
case study, the authors do not include their personal experiences, or their tacit 
knowledge, with patients as a source of knowledge.  
In the AGA case, there is little acknowledgement of the interaction between physician 
and patient during treatment. The role of the physician in patient education when treating is 
referred to once within the entry: “Men utilizing minoxidil for androgenetic alopecia should 
be advised of the following: [list].” Patient education for minoxidol in AGA treatment 
includes the need for: proper application, continuous treatment to maintain effect, and 
recognition of the possibility of side effects. This one instance of patient education is the only 
indication of interaction between the patient and physician.   
As stated in Situating the Evidence, the authors refer heavily to the results of 
studies as a key element for selecting treatments for patients; however, the authors do 
acknowledge the variability in patient preference that will influence the choice of 
treatments:  
Treatment with minoxidil 5% solution or foam is an alternative first-line 
therapy that may be preferred by patients who prefer to avoid systemic 
therapy. (AGA) 
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The subsequent development of minoxidil 5% foam offered an alternative 
vehicle for drug delivery that is preferred by some patients. (AGA) 
 
Preferences of patients are acknowledged as factors for consideration when deciding on a 
treatment plan; however, decision-making responsibility is not addressed explicitly 
within the entry. 
Patient Education. In stark contrast to the main entry written for professionals, the 
difficulties of experiencing hair loss are overtly and extensively addressed. The entry states 
early in the entry that for “many people, losing their hair is a frustrating experience” (AGA 
Beyond). The challenging nature of the condition is described in the patient information as: 
The psychosocial impact of hair loss can be severe for some people, especially 
women, since there is little understanding or acceptance of the condition. 
Women may have difficulty with issues of low self-esteem or feeling 
unattractive. (AGA Beyond) 
 
In this quotation, women are also suggested to have a more difficult time with hair loss and 
in turn may suffer from low self-esteem and feelings of being unattractive. While the main 
entry for AGA addressed only treatment in men, there was acknowledgement that men are 
pushed towards treatment because of cosmetic, not medical, concerns. The expansion of the 
patient information to include women provided interesting contrast to the ways the 
psychosocial effects of hair loss factors are framed. The cosmetic concerns are not outlined 
in any detail in the main entry, but “low self esteem and feeling unattractive” may also 
describe the cosmetic concerns of men.  
The entry contains additional guidance to help the patient navigate the psychological 
and social issues related to AGA: 
If you are having difficulty with the psychosocial impact of losing your hair, 
speak to a healthcare provider about your feelings. Providers can offer support 
and may recommend that a patient work with a therapist, clinical 
psychologist, or support group; individual and group therapy can help patients 
adjust and cope with hair loss, and may also provide tips on cosmetic 
coverings. (AGA Beyond). 
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While the need for psychosocial support is recognized in the patient information, there is no 
acknowledgement of the need for additional support in the professional entry.  
The two first-line treatments for men, minoxidil and finasteride, are discussed 
alongside a unique drug appropriate and safe only for women. Information about minoxidil 
includes how the treatment works, how to apply, what to expect (e. g. time to see effects; 
transience of effects after discontinuation).  The lack of consistent results for the treatment is 
also acknowledged in the patient information. 
Not all people benefit from minoxidil. The best results are seen when baldness 
has been present for less than five years, when it affects the crown (top) of the 
head, and when the area of hair loss is less than 10 centimeters in diameter. 
Studies have shown that 30 to 40 percent of men and women with crown hair 
loss experience cosmetically significant results with minoxidil. (AGA 
Beyond) 
 
The inconsistent results across patients are acknowledged and in turn the attributes that 
increase the likelihood of success are highlighted. The side effects and precautions of the 
treatment area also made clear:  
Minoxidil causes few side effects. Occasionally, the skin may become 
irritated. Body-wide side effects are possible if minoxidil is absorbed through 
cracks or cuts in the scalp. People with a history of heart disease, in particular, 
should watch for systemic side effects, such as an increased heart rate, 
swelling in the hands or feet, or weight gain. (AGA Beyond) 
 
The information provided about finasteride is much briefer. Finasteride is described as “a pill 
that decreases the production of one of the hormones associated with androgenetic alopecia, 
resulting in an increased amount of hair covering more of the scalp” (AGA Beyond). The 
possible effect of sexual dysfunction covered at length in the main professional entry is 
briefly acknowledged: 
Men can take finasteride by mouth at a dose of 1 milligram (mg) per day. 
Higher doses of finasteride (such as those used to treat some prostate 
conditions) can cause side effects including erectile dysfunction and decreased 
sex drive. However, such side effects are rarely seen with the 1 mg dose used 
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to treat hair loss. (AGA Beyond) 
 
Few details about the sexual side effects for finasteride are presented in the patient 
information. The patient information communicates that the side effects are rarely seen in 
patients treated with finasteride for hair loss. In comparison, the authors of the main 
professional entry call upon a systematic review, which included 3570 patients to provide a 
rate of prevalence for sexual side effects of 1.5%. When comparing the main professional 
and patient entries subtle differences in the presentation of the psychological effects of AGA 
and the potential side effects emerged. 
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Case Analysis: Irritable Bowel Syndrome 
Irritable Bowel Syndrome (IBS) affects the large intestine (colon) and is 
characterized by chronic abdominal pain, discomfort, bloating, and alteration of bowel 
habits. Diarrhea or constipation may predominate, or they may alternate. This variability has 
given rise to subtypes of irritable bowel syndrome: IBS-C (irritable bowel syndrome with 
constipation), IBS-D (irritable bowel syndrome with diarrhea), and IBS-M (mixed IBS with 
constipation and diarrhea). The cause of IBS is unknown and the diagnosis is symptom-
based. Because of the multiple factors that are considered to be elements of the root cause of 
IBS, including psychological influences, Wessely and Hotopf (1999) described IBS 
alongside Fibromyalgia and Chronic Fatigue Syndrome as occupying “that grey area between 
medicine and psychiatry” (p. 430). Moynihan et al. present the diagnosis of IBS as an 
example of medicalization because of its portrayal of mild problems as serious illnesses that 
need to be treated aggressively with medications. However treatment of IBS is complicated 
by the variability in symptoms, the uncertainty in the cause, and its psychological elements.  
Descriptive Analysis 
The IBS case cited 89 references ranging in date of publication from 1984-2015. 
Fewer than half (n=35, 39%) of the references were published between 2010 and 2015. 
Fewer than one quarter of the cited references (22%) were from UpToDate’s list of core 
journals. American Journal of Gastroenterology, a core journal, was the most commonly 
cited, at 14 times.  
The UpToDate entry contained three types of evidence from the 6S hierarchy:  
Summary, Synthesis, and Study (see Figure 11). Eleven of the 89 references (12%) cited are 
not sources recognized as evidence within the 6S hierarchy. Of these, seven are non-
systematic/narrative reviews, two are drug profiles, one is a textbook and the other is the U.S. 
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Food and Drug Administration website.  Three clinical practice guidelines (Summary level of 
evidence) were cited in the entry. Seventeen per cent of references cited (n=15) were 
systematic reviews, which are situated in the Synthesis level of the 6S hierarchy. Sixty of the 
89 references (67%) of the references were quantitative studies (n=60), of which 50 were 
RCTs.  
  
Figure 11: Type of Resources Cited in the IBS Main Entry 
 
The United States (n=26, 43%) is the most frequent location of the cited individual 
studies. The remaining 34 studies took place across the globe: United Kingdom (n=7), 
Australia (n=5), China (n=4), Netherlands (n=3), Norway (n=2), Iran (n=2), France (n=1), 
India (n=1), Canada (n=1), Belgium (n=1), Italy (n=1), Lebanon (n=1), Spain (n=1), Sweden 
(n=1), Taiwan (n=1). There were two multinational studies spanning the United States and 
Canada, and multiple European countries. 
The 89 references making up the IBS case were written by 534 authors. The relative 
contribution from the array of professional backgrounds of the authors was determined. 
Across the 89 papers, the highest known proportional representation (.33) of the authors had 
a Medical Doctor (MD) background followed by Basic Scientists (.08). The backgrounds of 
the authors of the articles cited in the IBS entry included professional organizations (.02) and 
non-physician (MD) health professionals (.03) (i.e., nurses, pharmacists, public health 
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professionals). Proportionally across all 46 papers, .54 of the backgrounds of authors were 
unknown.  
 
 
 
Figure 12: Relative Contribution by Authors’ Background in the IBS main entry 
Textual Analysis  
Situating the Authors. The authors share their expertise and experience 
throughout the main entry of IBS, mainly through the provision of recommendations. The 
authors of the case share their expertise by way of clear recommendations for the care of 
patients. For example, the authors advise: “In patients with persistent abdominal pain 
despite antispasmodics, we recommend a trial of antidepressants” (IBS). In alignment 
with the guidance of the UpToDate Editorial Policy, author recommendations are clearly 
delineated by the phrases ‘we recommend’ or ‘we suggest.’ 
The authors focus many of their recommendations on providing specific details 
about treatment regimens.  For example, they suggest specific details about the treatment 
regime for the pharmacotherapy, loperamide: “In patients with IBS-diarrhea (IBS-D), we 
suggest loperamide 2 mg 45 minutes before a meal on regularly scheduled doses” (IBS). 
The authors provide details about the exact dosage and timing of the drugs as a 
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suggestion. The recommendations often provide guidance to the reader about how to 
implement potential treatments.   
Overwhelmingly, the authors of the IBS case provide recommendations for 
treatments aimed at patients who have not responded to other initial therapies. The 
following examples demonstrate the recommendations for care following an unsuccessful 
treatment trial: 
In patients with IBS with constipation (IBS-C) who have failed a trial of 
soluble fiber (eg, psyllium/ispaghula), we suggest polyethylene glycol 
(PEG). We treat patients with persistent constipation despite treatment 
with PEG with lubiprostone or linaclotide. (IBS) 
 
We also suggest an empiric trial of a lactose-free diet in patients who 
complain of persistent abdominal bloating despite exclusion of 
gas-producing foods. (IBS) 
 
While antibiotics should not be routinely recommended in all patients with 
IBS, in patients with moderate to severe IBS without constipation, 
particularly those with bloating, who have failed to respond to other 
therapies (eg, a diet low in fermentable oligo-, di-, and monosaccharides 
and polyols [FODMAPs], antispasmodics, and TCAs), we suggest a 
two-week trial of rifaximin. (IBS) 
 
Because of the variability in IBS symptoms, the variability in treatment response, and the 
overall lack of clarity around IBS, multiple treatments aimed at alleviating symptoms often 
are attempted for a single patient. The authors provide their recommendations as to how 
physicians may progress and navigate through the treatment options, almost by trial and 
error. The possibility of repeated failed treatments led the authors to suggest treatments that 
lack strong evidence:   
We suggest a two-week trial of a gluten-free diet in patients with 
diarrhea-predominant IBS (IBS-D) with significant abdominal bloating 
and flatulence whose symptoms have failed to improve with a low 
FODMAP diet and avoidance of gas-producing foods. However, there is 
limited evidence to support gluten avoidance in patients with IBS. (IBS) 
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The authors acknowledge that there is little evidence to support the suggestion to avoid 
gluten in patients with IBS however UpToDate supports the provision of 
recommendations when strong evidence is not available.  
In addition to providing recommendations about treatments by way of phrases such as 
‘we recommend’ or ‘we suggest’, the authors also provide details about what they do in their 
own practice. For example,  
We initially start with 17 g of powder dissolved in 8 ounces of water once 
daily and titrate up or down (to a maximum of 34 g daily) to effect. 
However, side effects of bloating and abdominal discomfort limit the use 
of PEG. (IBS) 
 
In patients with abdominal pain due to IBS, we use antispasmodics on an 
as- needed basis. (IBS) 
 
The authors’ choice to present accounts of what occurs within their own practices 
gives rise to an implied endorsement, comparable to the explicit recommendations 
and suggestions for the treatment regime. Moreover, statements of the authors’ own 
practices are similar to the recommendations because they also address treatment 
options in light of failed treatment:  
We treat patients with persistent constipation despite treatment with 
PEG with lubiprostone or linaclotide. (IBS) 
 
In patients with persistent diarrhea despite antidiarrheals, we use bile 
acid sequestrants (eg, cholestyramine, colestipol, colesevelam). 
However, their use is limited by associated gastrointestinal side 
effects including bloating, flatulence, abdominal discomfort, and 
constipation. (IBS) 
 
The authors provide accounts of specific follow-up treatments they have applied based on 
patients’ individual responses, more specifically lack of responses, to treatments.  
Situating the Evidence. At the beginning of the entry, the alignment of the 
authors’ approach and CPG-based recommendations for treatment is made explicit: “Our 
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recommendations are largely consistent with the American College of Gastroenterology 
guidelines” (IBS).  
As noted above, multiple treatments have been studied in an attempt to alleviate 
symptoms, but none has been found to address the symptoms in all patients. Throughout 
the case, the authors present evidence to support the array of treatment options evaluated:  
The efficacy of linaclotide in the treatment of IBS-C has been 
demonstrated in two randomized controlled phase III trials. (IBS) 
 
A 2009 meta-analysis concluded that the overall treatment effects of 
SSRIs were similar to TCAs. (IBS) 
 
As demonstrated here, the type of study that has been called upon as evidence is used as 
an indicator of the strength of certainty. When the authors use recognized evidence 
resources, specifically systematic reviews or RCTs, the type of resource is often 
highlighted.  
In addition, the authors provide varying levels of detail about the 60 studies and 
15 systematic reviews cited in the case. Some research was cited with no description of 
the study details. For example, the following statement was followed by a parenthetical 
reference to a systematic review assessing the efficacy of probiotics in IBS: “Although 
[probiotics] have been associated with an improvement in symptoms, the magnitude of 
benefit and the most effective species and strain are uncertain” (IBS). This statement 
does not indicate that this information was derived from a systematic review or that 19 
RCTs were included. In contrast, the following is the most comprehensive description of 
a systematic review in the IBS main entry:   
A 2011 meta-analysis that included eight placebo-controlled trials of 
antidepressants in adults with IBS concluded that antidepressants were 
significantly more effective as compared with placebo in improving pain 
(54 versus 37 percent) and global symptoms (59 versus 39 percent). The 
number need to treat to benefit one patient was four. (IBS) 
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In this description, the study type (i.e., systematic review/meta-analysis) and number of 
studies included in the review were included, along with descriptions of the patients (i.e., 
adults with IBS), interventions (i.e., antidepressants), comparison (i.e., placebo), and 
outcomes (i.e., pain, global symptoms and number needed to treat).  The descriptions of 
the synthesis level of evidence were much briefer than study descriptions in the IBS 
main entry. The most extensive description of a study was related to a trial for the 
pharmaceutical linaclotide. The long paragraph provides multiple details about the 
patient (number of subjects), intervention (dosage), and comparison (placebo) alongside 
extensive details about the outcome of the study. Outcomes included both the positive 
effects of the drug, as well as the adverse side effects. Thus, the authors are selective 
when calling upon evidence. 
In addition to describing the research that provides evidence for treatment 
options, the authors also provide their own appraisal of the quality of research that is 
available:  
However, the randomized trials included in the meta-analysis had a 
relatively short- term follow-up and the improvement in abdominal 
bloating in patients with IBS without constipation was modest. (IBS) 
 
At times the authors suggest that readers should exercise prudence when considering the 
results of studies because of weaknesses in the research design:   
However, the results of this study should be interpreted with caution due 
to methodological limitations and small sample size. (IBS) 
 
The commentary on the research available goes beyond critiques of specific studies but 
also highlights the limitations of the wider research base: 
Randomized trials evaluating specific pharmacologic agents have 
demonstrated their superiority as compared with placebo. However, there 
have been few controlled trials evaluating specific strategies for how these 
drugs should be used in conjunction with other types of treatment (eg, 
fiber therapy), how long they should be used, or whether they should be 
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given continuously or as needed. (IBS) 
 
In this example, the authors’ commentary highlights a lack of high-quality controlled 
trials evaluating how non-pharmacological and pharmacological treatments can be used 
together.   
The authors often establish the relationship between their expertise and the 
chosen evidence in a consistent arrangement. They commonly present treatments by 
leading with their own recommendation or suggestion for treatment (as either an explicit 
recommendation or as a description of their own treatment practices), and then follow up 
the recommendation with evidence that supports their recommendation. For instance,  
We suggest a diet low in fermentable oligo-, di-, and monosaccharides 
and polyols (FODMAPs) in patients with IBS with abdominal bloating or 
pain despite exclusion of gas-producing foods… Studies have 
demonstrated an improvement in IBS symptoms with FODMAP 
restriction. In one randomized trial, 25 patients with IBS were randomly 
challenged by graded dose introduction of fructose and fructans alone or 
in combination, or glucose for a maximum test period of two weeks. 
Patients receiving fructose and/or fructans were more likely to report 
inadequate symptom control as compared with patients receiving glucose 
(70 to 79 versus 14 percent). Symptoms were dose-dependent and 
mimicked the patients' baseline IBS symptoms. In another randomized, 
single-blind, crossover trial, 30 patients with IBS and 8 healthy controls 
were assigned to 21 days of a diet low in FODMAPs or a moderate 
FODMAP Australian diet followed by a 21-day washout period before 
crossing over to an alternate diet. Subjects with IBS, but not controls, had 
significantly lower overall gastrointestinal symptoms scores with an 
improvement in scores for abdominal pain, bloating, flatulence, and 
dissatisfaction with stool consistency while on a low FODMAP diet as 
compared with the moderate FODMAP diet and their diet at baseline. 
(IBS) 
 
This same format is used when there is uncertainty within the evidence in spite of the 
authors’ recommendation. A qualified recommendation to trial fibre in patients with IBS 
is followed by conflicting evidence:   
The role of fiber in patients with IBS is controversial, but given the 
absence of serious side effects and potential benefit, psyllium/ispaghula 
should be considered in patients with IBS whose predominant symptom 
              100 
 
is constipation. As some patients may experience increased bloating and 
gas, we suggest a starting dose of psyllium of one-half to one tablespoon 
daily. The dose should then be slowly titrated up based on response to 
treatment.  
A 2011 systematic review that included 12 studies found no beneficial 
effect  
for bulking agents over placebo in improving abdominal pain, global 
assessment or symptom scores. On subgroup analyses, there was no 
significant benefit with either soluble (eg, psyllium) or insoluble fiber 
(eg, methylcellulose. However, another meta- analysis that pooled data 
from the same trials and used a combined endpoint for abdominal pain 
and global IBS symptoms demonstrated that in six trials, psyllium was 
associated with a small improvement in symptoms as compared with 
placebo with a number needed to treat to prevent one patient with IBS 
remaining symptomatic of six (RR of persistent symptoms 0.76, 95% CI 
0.63-0.96). (IBS) 
 
While suggesting that fibre should be considered as treatment for IBS patients, the 
authors frame its use for the treatment of the constipation variant as controversial 
because of conflicting outcomes from two systematic reviews.  
Situating the Physician-Patient Relationship. The clinician-patient relationship is 
explicitly mentioned three times in the IBS case. For example: 
Establishment of a clinician-patient relationship and continuity of care are 
critical to the management of all patients with irritable bowel syndrome 
(IBS).  
 
In all three instances, the authors call for the “establishment of a clinician-patient 
relationship” (IBS) with little explanation of what that relationship entails. In one 
instance, it is clarified that there is need for a therapeutic clinician-patient relationship  
It is important to establish a therapeutic clinician-patient relationship to 
validate the patient's symptoms. Patients should also be counseled that 
although IBS does not increase their risk of malignancy, it is a chronic 
disease. (IBS) 
 
Few details about what constitutes therapeutic clinician-patient relationship are included, 
beyond ensuring that the clinician validates the syndrome as real. The quotation also 
implies that patient education and counseling are key components; the section continues, 
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“The clinician should establish realistic expectations with consistent limits and involve 
the patient in treatment decisions” (IBS). This is the only instance in the entry where the 
patient’s role in decision-making is specified. While the clinician-patient relationship is 
mentioned in the IBS case, descriptions and guidance provided by the authors about what 
it entails are scant.  
As seen in the above excerpts, the authors choose to use the term ‘clinician’, 
rather than ‘physician’. In one instance, they do acknowledge the need for care from 
someone other than a physician: “Low FODMAP dietary education should be provided 
by a trained dietician to avoid unnecessary dietary over-restriction and a nutritionally 
replete diet” (IBS). While the authors choose to use the broad term clinician, the majority 
of the care and treatment (e.g., pharmaceuticals) described in the case are delivered by 
physicians.  
As discussed in the preceding two sections, there is very wide variation in IBS 
symptoms and experiences, and in patient responses to treatment. As such, the need to tailor 
treatment for the individual patient is featured prominently throughout the case: “Since IBS 
generally presents as a complex of symptoms, treatment should be based on the predominant 
symptom and subtype” (IBS), as is the emphasis on the need to adjust or change treatment 
approaches:  
For the treatment of abdominal pain in IBS, antidepressants should be started 
at low doses. The initial dose should be adjusted based upon tolerance and 
response. Due to the delayed onset of action of antidepressants, three to four 
weeks of therapy should be attempted before increasing the dose. (IBS)  
 
In patients with abdominal pain due to IBS, we use antispasmodics on an as- 
needed basis. In patients with IBS with constipation, we initiate 
antispasmodics only if the abdominal pain persists despite treatment of 
constipation. In patients with persistent abdominal pain despite 
antispasmodics, we recommend a trial of antidepressants. (IBS) 
 
While there are recognized psychological factors associated with IBS, the 
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acknowledgement of these factors throughout the UpToDate entry is minimal. The authors 
only acknowledge these factors in relation to the need for transitory or supplementary 
treatments: 
The use of anxiolytic agents in patients with IBS should be limited to 
short-term (less than two weeks) reduction of acute situational anxiety that 
may be contributing to symptoms. (IBS)  
 
For patients with IBS in whom depression is a cofactor, serotonin 
reuptake inhibitors (SSRIs) can also be used. (IBS) 
 
Patients with unrelenting symptoms that are associated with psychiatric 
impairment may benefit from behavioral modification in conjunction with 
antidepressants (IBS) 
 
The psychological factors are not treated individually in relation to the patient experience 
but rather as a circumstance or conditions requiring additional treatment. 
Patient Information. Both levels of patient information acknowledge that 
treatments “help alleviate symptoms but do not cure the condition” (IBS Beyond), which 
closely reflects the content of the main entry. The lack of cure is repeatedly highlighted 
in the patient information:  
Although many drugs are available to treat the symptoms of irritable 
bowel syndrome, these drugs do not cure the condition. They are primarily 
used to relieve symptoms. (IBS Beyond) 
 
Most people with IBS have the condition for the rest of their life. Even so, 
most people find ways to improve their symptoms. (IBS Basics) 
 
In these quotations, the lack of cure is indicated, first, by the recognition that pharmaceuticals 
are used only as a means to alleviate symptoms, and second, by the assertion that IBS is a 
life-long condition. This absence of a known cure largely arises out of the fact that a clear 
cause of IBS has not yet been identified. As noted in the Beyond the Basics information, 
“there are a number of theories about how and why irritable bowel syndrome (IBS) 
develops” (IBS Beyond). The Beyond the Basics also presents an overview of six potential 
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causes for IBS.  
Because of the many unknowns associated with IBS, the treatment plan for IBS is not 
clearly outlined for physicians. The subsequent need for patients to trial multiple therapies 
throughout their treatment is conveyed to patients in the two patient information sources. The 
trial and error approach is described in the Beyond the Basics entry as: 
Treatments are often given to reduce the pain and other symptoms of 
irritable bowel syndrome, and it may be necessary to try more than one 
combination of treatments to find the one that is most helpful for you. 
Treatment is usually a long-term process; during this process, it is 
important to communicate with your healthcare provider about symptoms, 
concerns, and any stressors or home/work/family problems that develop. 
(IBS Beyond) 
 
The same message of perseverance through multiple treatments is articulated in Basics: “The 
key is to keep working with your doctor or nurse until the 2 of you find an approach that 
works” (IBS Basics). The need to try multiple treatments in sequence is also reflected in the 
main professional entry where the authors attempt to map out a strategy for physicians to 
navigate the treatment options based on treatment responsiveness. When discussing the trial 
and error approach the relationship between patient and physician is also accentuated. The 
Beyond the Basics entry also emphasizes that patients should communicate with the clinician 
about symptoms, concerns and life stressors affecting health. This presentation of treatment 
planning and decision-making as a joint process between patient and clinician is not as 
evident in the main professional entry.  
  The effects and overlap between stress and IBS is more upfront in the patient 
information. In The Basics, counselling is suggested “because stress and worry can make the 
condition worse” (IBS Basics). The Beyond the Basics entry presents the management of 
stressors as a collaborative process between clinician and patient. 
The best approach for reducing stress and anxiety depends upon your situation 
and the severity of your symptoms. Have an open discussion with your 
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clinician about the possible role that stress and anxiety could be having on 
your symptoms, and together decide upon the best course of action. (IBS 
Beyond) 
 
Once again, open communication and joint decision-making is emphasized in the Beyond the 
Basics information when addressing the stress and anxiety. This co-management of stress 
that is underscored in the Beyond the Basics is not reflected clearly in the main professional 
entry. 
The strain that can develop in the relationship between physicians and IBS patients 
due to the chronicity and uncertainty of the illness is underscored in the patient information: 
“The chronic nature of irritable bowel syndrome and the challenge of controlling its 
symptoms can be frustrating for both patients and healthcare providers” (IBS Beyond). 
Because of the changing and chronic nature of IBS and the need to try many treatments in 
order to alleviate rather than cure the disease, frustration can develop in both patients and 
physicians. 
Both The Basics and Beyond the Basics information provides an overview of habits 
and practices which patients can adopt to help with their symptoms, prior to pharmacological 
interventions or concurrently with pharmacological interventions. These lifestyle changes 
include dietary monitoring, dietary modifications, and incorporation of an exercise program. 
The Beyond the Basics patient information reflects the main professional entry in its 
advocacy for treating patients first with non-pharmacological lifestyle changes prior to 
introducing medications. The Beyond the Basics patient information communicates, 
“medications are reserved for people whose symptoms have not adequately responded to 
more conservative measures such as changes in diet and fiber supplements” (IBS Beyond). In 
contrast, The Basics entry does not indicate that there is an attempt to treat IBS with dietary 
and lifestyle changes prior to introducing medications; it introduces a list of possible 
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medications that may be used to treat IBS with: 
How is IBS treated? — Medicines can ease the symptoms of IBS. But no 
treatment can cure the condition. Counseling might also help with IBS, 
because stress and worry can make the condition worse. 
The medicines that can help with IBS symptoms include: [followed by the 
types of medications used in to treat IBS (eg. “Medicines called 
‘antispasmodics’”]. (IBS Basics). 
 
While the Basics entry of the patient information does provide a list of lifestyle changes that 
may alleviate symptoms, there is no indication that these should be trialled prior to the 
introduction of medications. Only in the Beyond the Basics format of the patient information 
is the preference to try non-pharmacological approaches prior to medications underlined.  
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Case Analysis: Fibromyalgia 
Introduction 
Patients diagnosed with fibromyalgia have severe and often-debilitating symptoms, 
including distinctive tenderness on palpitation as well as widespread pain, fatigue, sleep 
disturbances, cognitive challenges, and depressive symptoms—all of which are medically 
unexplained. There is considerable controversy about the legitimacy of diagnosis (Wolfe, 
2009).  The scepticism by physicians, sociologists, medical historians, even family members 
is grounded in the perception that the diagnosis of fibromyalgia has arisen from the 
medicalization of discomfort in modern society, the need for labelling and diagnosis in order 
to access health and wellness supports, and the substantial power of the pharmaceutical 
industry (Wolfe). In response to the scepticism about the diagnosis of Fibromyalgia, patient 
advocacy groups, pharmaceutical companies, physician-specialists, professional 
organizations have fought hard to have fibromyalgia recognized as a “real disease,” and have 
been able to advocate for the development of criteria for diagnosis by the American College 
of Rheumatology (ACR) and an International Classification of Disease (ICD) code by the 
World Health Organization. These changes enable patients to provide proof of condition to 
employers, colleagues and family, as well as a diagnosis that is recognized and compensated 
by insurance companies and government agencies.   
While organizations and associations increasingly recognize fibromyalgia as a real 
illness, researchers and clinicians continue to search for the cause of the symptoms of 
fibromyalgia. Proposed contributing factors include psychological, genetic, neurobiological, 
and environmental origins. Because of the unknown cause and the possibility of a 
psychological component to the condition, there are challenges in clearly defining the 
medical profession’s approach to patients diagnosed with fibromyalgia. As a result, the 
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controversy extends beyond the diagnosis to treatment. Critics suggest that treatment of 
fibromyalgia prolongs and preserves the diagnosis rather than ameliorates it. According to 
Hayden (2003),   
The treatment acts, dripping with empty promises of elucidation and unproved 
promises of palliation, are iatrogenic. I would further suggest that these 
circular treatment acts will exacerbate whatever mood or thought disorder is 
complicating the plight of these patients. (p. 1669) 
 
The treatment is viewed as a self-perpetuating cycle in which more (not fewer) complications 
develop.   
Descriptive Analysis 
The main entry for fibromyalgia written for professionals contained 91 cited 
references ranging in date of publication from 1986-2015. Fewer than half (n=37, 41%) of 
the references were published between 2010 and 2015. The majority (73%) of cited 
references were from UpToDate’s list of core journals. The most commonly cited journal 
was Arthritis and Rheumatology, cited 17 times. UpToDate identifies Arthritis and 
Rheumatology as a core journal. 
UpToDate’s main entry addressing the treatment of fibromyalgia contained four types 
of evidence within the 6S hierarchy: Summary, Synopsis of Synthesis, Synthesis, and Study 
(see Figure 13). Only seven references (8%) cited in the entry were sources that are not 
recognized as evidence in the 6S hierarchy: All seven of these references were non-
systematic/narrative reviews. The largest proportion of references was from the study level of 
evidence (n=60), all of which were quantitative. Thirty-two of the 60 studies cited in the FIB 
case were randomized controlled trials.  
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Figure 13: Types of Evidence in FIB Main Entry 
The greatest proportion of empirical studies in the FIB case were conducted in North 
America with 32 studies conducted in the United States (53.3%) and 11 (18.3%) in Canada. 
Seven studies (12%) were conducted in Spain. Other European locations for these studies the 
United Kingdom (n=2), Turkey (n=2), and Denmark (n=1). One study was conducted in 
South Korea and four were multinational.  
The 91 references included in the fibromyalgia entry were written by a total of 531 
authors. Across the 91 papers, the highest known proportional representation (.41) of the 
authors had a Medical Doctor (MD) background (see Figure 14). 
 
 
Figure 14: Contributions by Authors’ Backgrounds for FIB main entry 
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Situating the Authors. Within the context of the many unanswered 
questions about fibromyalgia, physicians and specialists persevere in their attempts 
to treat the symptoms of fibromyalgia. It is also within this context of uncertainty 
that the authors of UpToDate share their personal expertise about the treatment of 
fibromyalgia. The authors’ knowledge and experiences are consistently positioned as 
central to the content presented in the fibromyalgia main entry.  
Aligning with UpToDate’s policy, the authors of the FIB entry share their 
expertise by way of explicit recommendations for treatment. The authors’ 
recommendations often provide specific details about how to deliver treatment 
regimens. For example, the authors provide recommendations about dosage and 
timing for tricyclic medications: 
We suggest initiating therapy with a low dose of a tricyclic 
medication (eg, amitriptyline 10 mg) at night time, especially since 
these drugs are effective, widely available, and far less costly for 
most patients than some of the newer agents. (FIB) 
 
In addition to the specific information about dosage and timing, the authors also highlight the 
accessibility of the drug treatment, information that is not often provided in the published 
research. In their recommendations, the authors provide extra information about the exact 
patient for whom the treatment is best. The authors provide information that facilitates a 
tailoring of the treatment based on the preferences, needs, and context of the patient:  
In patients who do not respond to trials of low-dose tricyclics or who have 
intolerable side effects, we advise a trial of pregabalin, duloxetine, or 
milnacipran, depending upon the patient’s symptoms. (FIB) 
 
In patients unresponsive to or intolerant of amitriptyline and in 
patients with more severe sleep disturbance in addition to pain, we 
suggest the use of pregabalin. (FIB) 
 
The authors here provide suggestions of ways to tailor care for individuals based on the 
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patient’s symptoms and responsiveness.  
In addition to explicit recommendations, the authors further integrate their personal 
expertise into the UpToDate entry by providing accounts of what occurs in their own 
practice. For example, the authors share their approach to patient counselling to encourage 
exercise in fibromyalgia patients: 
We counsel patients regarding the importance of exercise for 
reconditioning and for functional capacity, and caution that a temporary 
increase in myalgias may occur upon initiating an exercise program. 
(FIB) 
 
As demonstrated in this quotation, these descriptions of treatment practices from their own 
experience serve as an endorsement for the approach, albeit not explicitly. The authors also 
provide accounts of what occurs in their own practices when there is a lack of evidence: 
We use gabapentin, for which evidence is more limited, as an alternative 
to pregabalin in patients for whom cost of the medication or regulatory 
requirements limit the use of pregabalin. We begin with a dose of 100 mg 
at bedtime before titrating the dose upwards as tolerated and as required. 
The recommended dose is 1200 to 2400 mg/day, based upon the study 
described below. As with pregabalin, some patients may respond to lower 
doses. (FIB) 
 
In this quotation, there is no explicit recommendation for the drug gabapentin; however, the 
authors’ communication of their own practices to prescribe the drug is an implicit 
recommendation of this approach in light of the limited evidence available. 
The details about the authors’ approaches to care are often directly tied to tailoring 
treatment for individuals. For example, they provide guidance on how to administer two 
pharmacological treatments in order to meet the needs of specific patients:  
Milnacipran is an alternative to duloxetine in patients with severe fatigue 
in addition to pain. We initiate therapy with 12.5 mg each morning, 
gradually titrating as tolerated to 50 mg twice daily. Some patients will 
require a higher dose; up to 100 mg twice daily may be needed … In those 
patients with more severe problems with sleep, we use pregabalin taken at 
bedtime. (FIB) 
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In patients unresponsive to or intolerant of amitriptyline and in patients 
with more severe sleep disturbance in addition to pain, we suggest the use 
of pregabalin. We begin with a dose of 25 to 50 mg at bedtime before 
adjusting the dose upwards as tolerated to the recommended dose of 300 
to 450 mg/day. Some patients may respond to lower doses, such as 100 to 
300 mg/day, and do not require further dose escalation. (FIB) 
 
Treatments are adjusted to address patients’ individual preferences, socioeconomic 
status, symptom presentation, drug reactions and tolerability, or treatment 
responsiveness.  
The authors broaden the experiences and expertise they bring into the 
fibromyalgia entry by sharing with the reader some of the acquired knowledge from 
their experiences in treating patients: 
In our experience, patients generally have a better response to treatment 
when they understand that they are not harboring some infectious agent 
over which they have no control. (FIB) 
 
In our experience, sustained responses are seen in most patients receiving 
duloxetine who initially benefit from treatment, when such patients are 
followed for more than one year on continued therapy. (FIB) 
 
The authors set apart information derived from their clinical experience by explicitly using 
the phrase ‘in our experience’.  
The authors of this entry take such acquired knowledge and experience one step 
further to compare their practice-acquired knowledge to the results and conclusions of 
the published research. Specifically, the authors reveal to the reader where the 
approaches and conclusions of research and their own practice diverge:  
Various doses of cyclobenzaprine have been used in placebo-controlled trials, 
including 10 mg in the morning and 20 mg at night, 10 mg three times daily, 
10 mg in the morning and 30 mg in the evening, and 10 to 40 mg daily as 
needed. We usually start with doses of 10 mg near bedtime and increase as 
tolerated to the larger doses. In patients who find an initial dose of 10 mg too 
sedating, we reduce the dose to 5 mg before bedtime. (FIB) 
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In this example, the authors provide an overview of dosages used in research and contrast 
them with the unique approach that they have developed within their own practice. In 
other incidences, the realities of applying the conclusions of clinical research to practice 
are highlighted. The following quotation succeeds a statement extolling the benefits of 
exercise in fibromyalgia patients citing six published articles: 
In practice, it has been difficult to start and maintain fibromyalgia patients 
in a structured cardiovascular exercise program, because patients 
generally perceive that their pain and fatigue worsen as they begin to 
exercise. (FIB) 
 
Here, the authors contrast the research showing the benefits of exercise against their own 
experience in practice where patients are hesitant to start and sustain an exercise program 
because they perceive that exercise worsens their condition. This experience, however, 
does not preclude the authors from recommending “an exercise program, including 
aerobic conditioning, stretching, and strengthening” (FIB) as one of three key 
components of the initial treatment for fibromyalgia. While many drugs administered on 
their own appear to benefit patients in clinical trials, in the authors’ clinical experience 
no great benefit arises from a single medication.   
Despite the clinical trial efficacy, in “real-world experience” the majority 
of fibromyalgia patients do not achieve great benefit from any single 
medication. (FIB) 
 
Here, the authors explicitly contrast the results of clinical trials and the realities of 
everyday life outside of the structured inquiry.  
Situating the Evidence. The authors’ recommendations and experiences are 
central to the content in the fibromyalgia main entry. In turn, evidence is used to support 
the authors’ recommendations and approaches. The authors often share their 
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recommendations and practices at the outset of each section and then follow-up with an 
acknowledgement of the research that supports their approach:  
In patients unresponsive to or intolerant of amitriptyline and in patients 
with more severe sleep disturbance in addition to pain, we suggest the use 
of pregabalin. We begin with a dose of 25 to 50 mg at bedtime before 
adjusting the dose upwards as tolerated to the recommended dose of 300 
to 450 mg/day. Some patients may respond to lower doses, such as 100 to 
300 mg/day, and do not require further dose escalation. 
The efficacy and safety of pregabalin has been evaluated in randomized 
trials and in systematic reviews and meta-analyses. In a 2010 
meta-analysis involving three randomized trials and a total of 1890 
patients, those allocated to receive pregabalin in any one of three doses 
(600, 450, and 300 mg daily) were significantly more likely to respond to 
treatment, defined as a ≥30 percent reduction in pain score, compared 
with patients receiving placebo (odds ratios 1.7, 95% CI 1.27-2.29, 1.92, 
95% CI 1.49-2.12, and 1.53, 95% CI 1.18-1.98, respectively). (FIB) 
 
Here, the authors offer their expertise as recommendations for the drug preglabin and 
accounts of their practices with dosages and tolerability, then follow up their expertise 
with studies that support the efficacy and safety of their approach.  
The authors select studies and systematic reviews which provides evidence for 
their approach:  
In patients unresponsive to or intolerant of amitriptyline and in patients 
who have severe fatigue or who require concomitant drug therapy for 
depression in addition to pain, we suggest treatment with duloxetine in 
place of amitriptyline. It is also available in many countries for the 
treatment of depression and of diabetic neuropathy. Duloxetine should be 
used in the morning at breakfast. The usual starting dose in patients with 
fibromyalgia is 20 to 30 mg/day, which is gradually increased to the 
recommended dose of 60 mg/day… The benefits of duloxetine in 
fibromyalgia have been shown in a 2014 systematic review that identified 
six randomized trials involving 2249 patients in which duloxetine was 
compared with placebo. On meta-analysis of the data, duloxetine (60 mg 
daily) was significantly more likely than placebo to reduce pain by at least 
50 percent at 12 weeks (RR 1.57, 95% CI 1.20-2.06) and at 28 weeks (RR 
1.58, 95% CI 1.10-2.27). The number needed to benefit at 12 weeks was 8 
(95% CI 4-21). The efficacy of duloxetine in patients with fibromyalgia 
was initially demonstrated in two multicenter trials of 12 weeks’ duration. 
As an example, in one trial, pain was reduced by at least 30 percent in a 
significantly greater proportion of patients receiving duloxetine (60 mg 
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once or twice daily) compared with those taking placebo (55 and 54 
versus 33 percent, respectively). (FIB) 
 
In this example the authors select a systematic review and two randomized controlled 
trials to demonstrate the effectiveness of duloxetine in treating fibromyalgia patients. 
They bring attention to two trials that initially demonstrated the drug’s effectiveness, and 
select one systematic review for which to provide details. The authors are transparent at 
times that they have selected the evidence based on what they have deemed the best 
approach to treatment.  
The level of detail about the evidence that the authors call upon for support varies 
greatly. There are evidence sources for which few or no details about the studies are 
provided. In other instances, extensive details are included:  
In randomized trials, [milnacipran] improved pain and global wellbeing 
more than placebo. As an example, in one trial, 1196 patients were 
randomly assigned to treatment with one of two doses of milnacipran or to 
placebo [50]. Primary outcomes were improvement in a composite of 
pain, patient-reported global status, and self-reported physical function 
after 15 weeks of treatment. A greater than 30 percent improvement in the 
composite measure was significantly more likely among those receiving 
milnacipran at either dose (100 mg/day or 200 mg/day) than among the 
placebo group (OR 1.79, 95% CI 1.14-2.8, and 1.75, 95% CI 1.11-2.75, 
respectively). Greater improvements in individual component scores (ie, 
pain, global status, and physical function) were also noted in the 
milnacipran-treated patients compared with the placebo group. As an 
example, patient-reported pain (on a 100 point scale) improved from 
baseline levels by a statistically greater degree in the patients receiving 
milnacipran than those receiving placebo (-15.7 and -17.4 versus -13). 
Adverse effects leading to discontinuation of study drug were more 
common in the milnacipran-treated subjects than in the placebo group (19 
to 24 percent versus 9.5 percent, respectively). Commonly reported 
adverse effects were nausea, headache, and constipation. (FIB) 
 
In this description of a single study, extensive details are included about the intervention 
(i.e., dosage), comparison (i.e., placebo) and the outcome (i.e., improvements, side 
effects), as well as the number of patients involved.  
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The effectiveness of treatments, especially drug treatments, is a focus in the 
presentation in evidence; however, the limitations of particular treatments are also 
highlighted within the FIB case:  
Although all of these agents, including amitriptyline, duloxetine, and 
milnacipran, are considered as first-line medications by experts on 
fibromyalgia, a 2012 meta-analysis of antidepressants used for 
fibromyalgia found that only a minority of patients experienced 
substantial improvement with these drugs and that adverse side effects 
were common. Moderate degrees of benefit were seen in pain and sleep, 
but effects on fatigue and quality of life were small. (FIB) 
 
Here, the authors acknowledge that there are limitations to the efficacy of drug 
treatments for fibromyalgia.   
Occasionally in the fibromyalgia case, the authors extend the description of the 
evidence beyond describing features of the study to include a commentary on the 
evidence, whether studies or synthesis. For example, they highlight that conclusions may 
be weak due to methodological shortcomings: “The strength of the conclusions was 
limited, to some degree, by the lower methodological quality of the amitriptyline trials” 
(FIB). In addition to calling attention to the limitations of particular evidence sources, the 
authors also point out where the corpus of literature on the treatment of fibromyalgia is 
lacking: 
Strength training and flexibility exercises have not been extensively 
studied; However, there is some evidence of benefit from strength 
training in some small trials that used several different types of resistance 
training programs. (FIB) 
 
The efficacy of these drugs compared with placebo has been demonstrated 
in randomized trials and meta-analyses, but there have been few direct 
comparisons of one with another, particularly with the older drugs. (FIB) 
 
At the end of the main professional entry, the authors’ overall approach is 
compared to Clinical Practice Guidelines created by panels of experts: 
              116 
 
Our approach is generally consistent with the recommendations of 
various expert panels and with the guidelines from professional 
organizations that have been proposed for treatment of adults with 
fibromyalgia. Most of these guidelines preceded the regulatory approval 
of pregabalin, duloxetine, and milnacipran for fibromyalgia treatment. 
(FIB) 
 
In this quotation, the clinical practice guidelines to which the authors refer are sponsored by 
the European League Against Rheumatism and the Canadian Pain Society with the Canadian 
Rheumatology Association, and two guidelines that were not sponsored by an organization 
but authored by experts in the field.  Both the Clinical Practice Guidelines and UpToDate 
entry are considered to be evidence within the Summary level of evidence within the 6S 
hierarchy.  
Situating the Patient-Physician Relationship. The main professional entry for 
fibromyalgia starts with the following description: “Fibromyalgia is a chronic pain disorder 
that is challenging to treat.” From the outset of the entry, the challenging nature of the 
fibromyalgia is acknowledged. The authors of the case are explicit that the goal of treatment 
is not cure but rather, symptom reduction:  
Treatment of fibromyalgia is directed at reducing the major symptoms of this 
disorder, including chronic widespread pain, fatigue, insomnia, and cognitive 
dysfunction. 
 
 They underscore that patients are going to continue to experience the symptoms of 
fibromyalgia when they are receiving treatment:  
Most patients with fibromyalgia continue to have chronic pain and 
fatigue, although most longitudinal long-term studies of outcome in 
fibromyalgia have been from tertiary referral centers. One study of 538 
patients followed at six referral centers found that pain, fatigue, sleep 
disturbances, anxiety, and depression were essentially unchanged over a 
follow-up period of approximately eight years. Similarly, in the author’s 
experience at a referral rheumatology center, there has been little change 
in the patients’ symptoms. (FIB) 
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The authors use both the evidence base and their personal experience to support the 
chronicity and perseverance of symptoms even with treatment and advise that “patients 
need to appreciate that their symptoms will wax and wane but that the pain and fatigue 
generally persist” (FIB).  
The authors also point out that ambiguity exists about what type of health care 
professional is responsible for treatment—the specialist or the primary care physician:  
The issue of who should be in charge of the treatment of patients with 
fibromyalgia has been controversial. Most specialty groups recommend 
that the initial management of patients with fibromyalgia can and should 
be carried out in the primary care setting. Ideally, treatment should 
include an integrated, multidisciplinary nonpharmacologic and 
pharmacologic approach, but there have been relatively few trials that 
have formally evaluated such a combined approach to therapy. (FIB) 
 
Physiotherapists, psychologists, psychiatrists are all acknowledged as be potential 
members of a multidisciplinary approach to care. The challenges that patients face in 
receiving a diagnosis of fibromyalgia complicate the ownership of professional 
responsibility for care and affects the patient experience.  
Most patients have had fibromyalgia for years before the diagnosis is 
finally made. They often have undergone multiple diagnostic evaluations 
and have consulted with many different specialists. Some patients may 
feel rejected by the medical profession, while others may fear that a 
life-threatening illness will eventually be found. (FIB) 
 
The authors acknowledge that, for many patients, their contact with health care 
professionals has not always been positive or affirming. While the fibromyalgia 
controversy is well documented, the authors allude to, but do not overtly acknowledge, 
that doctors and other health care professionals who have previously cared for patients 
may not accept the diagnosis of fibromyalgia as legitimate. The authors situate their 
position in this argument by emphasizing that patient education must include reassurance 
that the illness is real. In the main professional entry for this case they identify 
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reassurance and validation as key to the patient-physician relationship. However, they 
also emphasize that patients must understand the condition is not progressive or life-
threatening: 
Reassurance that fibromyalgia is a real illness – The patient must be 
reassured that fibromyalgia is a real illness and is not imagined or “in your 
head.” The benign nature of the disorder should also be emphasized. As 
an example, patients must be told that this is not a deforming or 
deteriorating condition and that it is neither a life-threatening nor a 
cosmetic problem. (FIB) 
 
This passage highlights the challenge of balancing the validity of the condition with its 
relatively benign nature.  Other elements of patient education include the role of stress 
and mood disorders, the role of sleep disorders and sleep hygiene, the role of exercise, 
the prognosis for fibromyalgia, and the lack of evidence of persistent infection. Patient 
education “should also include family members” (FIB). The authors emphasize that 
patient education should reassure patients that “the great majority of patients live normal 
and active lives.” In contrast, the prognosis section underscores that there is “little 
change in patients’ symptoms” for those receiving treatment and fibromyalgia patients 
report a high incidence of being work-disabled. Multiple tensions within the patient-
physician relationship are highlighted in this entry, particularly with respect to ensuring 
balance in messages to patients. 
Patients’ role in treatment includes their engagement in non-pharmacological 
approach to treatments, including adopting proper sleep routines, exercise programs, 
relaxation techniques, and cognitive behavior therapy. The authors indicate that some 
patients respond so well to non-pharmacological measures that they do not require 
medications. They emphasize the importance of the patient maintaining a positive 
outlook to improve prognosis. Because of the complexities involved with this condition, 
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the treatment trajectory for fibromyalgia appears to be primarily the responsibility of the 
primary care physician, not the patient.   
Patient Education. UpToDate provides patient information in two formats for 
fibromyalgia, The Basics and Beyond the Basics.  
The level of comprehensiveness and sophistication of the Beyond the Basics 
patient information for fibromyalgia is noteworthy. As well as being lengthy, the level of 
sophistication and knowledge required to understand the content appears to be much 
higher than other Beyond the Basics patient information entries. Indeed, the information 
provided appears not to be directed towards the patient, but rather at physicians who 
provide patient education. For example, the entry states:  “Balanced and accurate patient 
information is critical to allow fibromyalgia patients to take charge of their illness and to 
best manage this disorder” (FIB). In contrast, The Basics patient information is targeted 
at patients and has a comparable level of sophistication and complexity to the other 
similar entries.  
Patients often seek medical care to be find a cure for an illness, however for 
patients with fibromyalgia, there is no cure currently available. The patient information 
included in The Basics clearly communicates that while physicians are able to treat the 
symptoms of fibromyalgia, they cannot cure it.   
Some people seem to get over fibromyalgia. But in most people it cannot be 
cured. Even so, people can learn to deal with the condition and lead fairly 
normal lives. Fibromyalgia does not get worse over time, and it is not life-
threatening. (FIB Basics) 
 
In light of the lack of cure, patients are asked to “deal with the condition” (FIB Basics). This 
same requirement for patient acceptance of the condition and its symptoms are 
communicated in the Beyond the Basics: 
It is important to have realistic expectations concerning the ability to function 
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and manage the condition over the long term. Symptoms often wax and wane 
over time, yet some degree of muscle pain and fatigue generally persist. 
Nevertheless, most people with fibromyalgia improve, and most patients lead 
full, active lives. (FIB Beyond)  
 
(The same passage appears verbatim in the main entry for medical professionals).  
In these entries the authors communicate that the uncertainty surrounding the cause of 
fibromyalgia extends beyond treatment: “Despite ongoing research, the cause, diagnosis, and 
optimal treatment of fibromyalgia are not clear” (FIB Beyond). In order to treat fibromyalgia, 
a multi-professional team approach is advocated. The members of the team include: “A 
doctor; A physical therapist; Someone trained in mental health (such as a social worker or 
counselor)” (FIB Basics). The Beyond the Basics entry echoes this roster of health care 
professionals, but places the patient as a member of the team: “Optimal treatment of 
fibromyalgia should include the patient, clinician, physical therapist, mental health 
professional, and other healthcare professionals” (FIB Beyond). The call for a multi-
professional approach appears in the main professional entry but the patient is positioned as 
member of the health care team only in the Beyond the Basics entry. 
Both pharmacological and non-pharmacological treatments are addressed in the 
patient information sources. The Basics entry indicates that patients will work with their team 
to find the right treatment combination:  
 
There are medicines and strategies to help with the symptoms of fibromyalgia. 
But there is no one treatment that works for everyone. You and your 
healthcare team will need to work together to find the right mix of treatments 
for you. In general, treatment can include: Medicines to relieve pain, improve 
sleep, or improve mood; Physical therapy to learn exercises and stretches; 
Relaxation therapy; Working with a counsellor. (FIB Basics) 
 
A collaborative approach to finding a combination of medications and non-pharmacological 
treatments is stressed. Few specifics about medication options are provided in The Basics 
although it includes a request for patients to “Be open to medicines” that are often described 
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for depression or seizures because “they work on the brain areas that deal with pain” (FIB 
Basics). In addition to a willingness to consider medications, the authors also encourage 
patients to become more active even though their symptoms may be aggravated initially.   
In contrast, in Beyond the Basics the details provided about the medications used to 
treat fibromyalgia are extensive. For instance,   
As of 2011, three medications had been approved by the FDA for the 
treatment of fibromyalgia. These included pregabalin, an alpha-2-ligand 
inhibitor, as well as duloxetine and milnacipran, which are selective 
norepinephrine and serotonin reuptake inhibitors. However, older medications 
that are generic or have not been as extensively studied may also be effective. 
(FIB Beyond) 
 
Here, the level of detail and advanced language is striking. There are many instances in the 
description of medications in Beyond the Basics patient information in which extensive 
background knowledge of medical terminology, medications, and biochemistry would be 
necessary for patients to understand the content. For example, “Although cyclobenzaprine is 
considered to be a muscle relaxant, its chemical structure and mode of action are very similar 
to those of amitriptyline” (FIB Beyond). The descriptions of the medications are 
comprehensive and complex; however, there is little information provided about for which 
patients the medications are best suited and how these decisions are made. Unlike the patient 
information provided in The Basics, the need to tailor treatment to the patient and how such 
decisions are made are not addressed in Beyond the Basics.  
The Beyond the Basics patient information for fibromyalgia places exercise under the 
heading “Complementary and Alternative Treatments of Fibromyalgia.” As in The Basics the 
expectation for exercise to initially worsen symptoms is shared. Other complementary and 
alternative treatments include relaxation therapies, hypnosis, biofeedback, cognitive 
behaviour therapy, acupuncture, and Tai chi and yoga.   
As highlighted in the main professional entry, the importance of maintaining a good 
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attitude in light of the diagnosis of fibromyalgia and the related experiences is emphasized in 
both patient entries. The Basics entry addresses the patient by offering the following words of 
encouragement: “It is also really important that you try not to be too negative about your life. 
Your outlook has a big effect on how you feel pain. Do your best to be positive” (FIB 
Basics). Similarly, the Beyond the Basics section ties the positive attitude of patients to their 
prognosis stating: “One of the most important factors in a person's long-term prognosis is the 
person's ability to take charge, to avoid ‘catastrophizing,’ and to learn to cope well with 
symptoms while remaining as active as possible” (FIB Beyond). In both patient entries, one 
of the primary roles of patients is to try to maintain a positive outlook.   
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Case Analysis: Chronic Fatigue Syndrome 
Chronic Fatigue Syndrome (CFS) is an illness characterized by persistent fatigue for 
at least 6 months, and is often accompanied by several other symptoms including headaches, 
muscle pain, insomnia, and concentration issues. The condition is complex and not well 
understood. There is no clear cause identified and no effective diagnostic test developed for 
CFS. As such, it is diagnosed through symptom identification. Chronic fatigue syndrome, 
irritable bowel syndrome and fibromyalgia are closely linked and many individuals 
concurrently meet the symptomatic criteria for two or three of these conditions. The lack of 
cause and diagnostic test has led to questions about and challenges to the legitimacy of the 
diagnosis of CFS. Some health care professionals argue that a diagnosis of CFS may be self-
validating, self-reinforcing and potentially a self-fulfilling prophecy (Huibers & Wessely, 
1996). Treatment of CFS is aimed at symptom relief, not cure; however, attempts to find 
effective treatments, even for symptom relief, have not been successful.  
In February 2015, the United States Institute of Medicine (IOM) published a report 
renaming Chronic Fatigue Syndrome as Systematic Exertion Intolerance Disease (SEID), as 
well as proposing a redefinition of the diagnostic criteria for CFS. The change to SEID has 
been met with some hesitation among patients and health care professionals (Jason, 
Sunnquist, MacManimen & Furst, 2015). Nevertheless, the authors of the IOM report hope 
that one outcome of the name change will be a shift in the perception of the disease and an 
overall increase of the acceptance of the condition (Institute of Medicine, 2015). While the 
term disease in the name implies a pathological mechanism, the authors of authors of the 
IOM report acknowledge that no disease process has yet been identified.  
Descriptive Analysis 
The authors of the CFS entry cite 46 references ranging in date of publication from 
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1986-2015. Fewer than one quarter (n=10, 22%) of the references were published between 
2010 and 2015. Forty-one of 46 references (89%) are published in UpToDate’s core journals. 
The most common journals cited in the Chronic Fatigue Syndrome main entry was The 
Lancet (cited seven times) and American Journal of Medicine (cited seven times), which are 
both identified as core journals by UpToDate. 
The UpToDate entry for CFS contains three types of evidence recognized by the 6S 
hierarchy:  Synopsis of Synthesis, Synthesis, and Study (see Figure 15). Seven of the 46 
references (15%) cited fall outside of the 6S hierarchy. All seven of the references that are 
not types of evidence included in the 6S hierarchy are non-systematic/narrative reviews. 
Only two references in the CFS case are systematic reviews, which are situated in the 
Synthesis level of the 6S hierarchy. Thirty-three of the 46 references are quantitative studies. 
Approximately half (n=24, 52%) of all references cited in the CFS case are randomized 
controlled trials.  
 
Figure 15: Types of Evidence in CFS Main Entry 
  
The studies took place primarily in the United States and United Kingdom with 12 of 
33 (36%) from the US and 11 of 33 (33%) from the UK.  Three studies took place in the 
Netherlands and two in Belgium. There was one multinational study spanning the United 
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States and multiple European countries. One study each took place in Australia, Denmark, 
and Norway. It is unknown where one older study took place.  
The 46 references making up the CFS case were written by 259 authors. Across the 
46 papers, the highest known proportional representation (.32) of the authors had a Medical 
Doctor (MD) background followed by Basic Scientists (.25). Proportionally across all 46 
papers, .38 of the backgrounds of authors were unknown (Figure 16).  
 
 
 
Figure 16: Relative Contribution by Authors’ Background in the CFS main entry 
 
Textual Analysis 
Situating the Author. While the UpToDate Editorial Policy encourages the authors 
and editors of UpToDate to make explicit recommendations for treatment, the authors of the 
CFS entry did not center the content on their own recommendations for treatment. The 
authors make use of the phrase ‘we (do not) recommend’ in only one instance: 
In a small double-blind, placebo-controlled crossover study that included 14 
patients with CFS/SEID, modafinil, a selective wakefulness-promoting agent, 
had a mixed effect on cognition; had no effect on fatigue, quality of life, or 
mood; and had a negative effect on mental flexibility and motor speed. We do 
not recommend this agent. (CFS) 
 
In this quotation, the authors provide information on a small RCT assessing the effectiveness 
of the drug modafinil followed by their own opposition to the use of the drug. This is the 
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only use of the ‘we recommend’ phrase in the CFS case. Although the authors do not 
concentrate on explicit recommendations, they do provide two accounts of their own clinical 
practices. In one instance, the authors simply affirm that they urge patients to push 
themselves when engaging in physical activity: “We encourage the patient to gently push 
himself or herself” (CFS). In the other instance, the authors provide a more extensive 
description of their approach to treating CFS as a form of neurally- mediated hypotension: 
We do not routinely perform tilt table testing on our patients with SEID/CFS 
since it is expensive, moderately uncomfortable, and without proven utility. 
However, after carefully explaining to a patient that the efficacy is not 
established, we are willing to try atenolol alone or with fludrocortisone, if the 
patient wishes. We start with low doses which are increased slowly over 
several weeks. (CFS) 
 
The authors do not center the content on their explicit recommendations; however, by 
providing accounts of their own practices, there is an implied endorsement of the approach.  
In the CFS case, the authors used the term ‘we’ in one additional context, noting that 
“if the cause is organic, we do not yet know how to find it or treat it” (CFS). In this example, 
the use of ‘we’ places the authors within that community of clinicians and researchers. 
Similarly, the authors encourage clinicians to “… emphasize that we have considerable 
knowledge and experience with SEID/CFS” (CFS). The authors use ‘we’ not to describe 
themselves as authors, but rather to describe themselves as part of the collective of 
researchers and clinicians. 
Situating the Evidence. Throughout the case the authors make it clear that there have 
been many attempts to find an effective treatment for chronic fatigue syndrome but there is 
no cure and there has been little success in finding a treatment that will alleviate symptoms. 
In the introduction of the main entry for CFS, the authors point out  that the evidence has 
identified only two therapies that produce what they  describe as ‘meaningful benefit’.  
Many therapies have been tried in chronic fatigue syndrome (CFS), also called 
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systemic exertion intolerance disease (SEID), but only counseling therapies 
(eg, cognitive behavioral therapy) and graded exercise therapy appear to 
produce meaningful benefit. (CFS) 
 
They note further that “neither of these modalities are curative. There is no known 
specific medical therapy for CFS/SEID” (CFS). The variety of options for delivery of 
these two non-pharmaceutical treatments is shared by way of the evidence that supports 
the approach. For example, cognitive behaviour therapy can be provided individually or 
in a group.  
Another way to administer CBT is in a group setting. In a randomized 
trial, cognitive behavioral group therapy was more effective than 
enhanced usual care (defined as management by a primary care physician 
or medical specialist) at improving physical functioning, bodily pain, and 
vitality at 16 months among patients with a variety of somatic syndromes, 
including CFS/SEID; the patients who received cognitive behavioral 
group therapy participated in nine three and a half hour sessions over four 
months. CBT appears to be more useful than participation in a support 
group. In one three-arm trial, 278 patients were randomly assigned to 
CBT, a support group, or no active intervention with follow-up at 8 and 
14 months. The CBT group had significantly improved fatigue severity, 
strength, overall sense of improvement, and lower sickness profile scores 
compared with the other groups at both time points. (CFS) 
 
The efficacy of CBT through group therapy is demonstrated by two randomized trials 
with two different types of comparisons (i.e., usual care and non CBT support groups). 
The demonstration of the efficacy of CBT and graded exercise therapy relies heavily on 
individual studies, citing only one systematic review on these treatments. 
In the CFS entry, substantial attention is paid to the research examining the 
treatments that have been trialed but have not demonstrated efficacy or for which the 
efficacy remains uncertain. The lack of proven effective treatments is made transparent. 
Throughout the case, the authors make clear that many treatments have been trialed but 
there has been little success:  
A number of medications and special diets have been evaluated in patients 
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with CFS/SEID, but none has proved successful. Among the modalities 
that have been tried are serum globulin, arituximba, acyclovir, 
galantamine, fluoxetine, and other antidepressants, methylphenidate and 
modafinil (simulants), glucocorticoids, amantadine, doxycycline, 
magnesium, evening primrose oil, vitamin B12, Ampligen, essential fatty 
acids, bovine or porcine liver extract, dialyzable leukocyte extract 
cimetidine, ranitidine, interferons, exclusion diets, BioBran MGN-3 (a 
natural killer cell stimulant), and removal of dental fillings. (CFS) 
 
After this extensive list of trialed and ineffective treatments, the authors go on to describe 
the evidence that has not been able to yield results to support the use of certain therapies 
in the treatments of CFS. For example, the association of CFS with the Epstein Barr virus 
infection lead researchers to try an antiviral drug but showed no benefits: “A controlled 
trial of intravenous and oral acyclovir was based upon the possible association with 
Epstein-Barr virus infection. The outcome showed no benefit of treatment” (CFS). In 
some instances, the authors provided details about specific trials. For example, the 
authors describe an RCT that assessed the efficacy of galantamine, a drug has been used 
in Alzheimer patients, in treating fibromyalgia. 
In the largest and best-designed randomized, double-blind, controlled trial 
that has been performed for the treatment of CFS/SEID, 434 patients at 
multiple centers were randomly assigned to one of four doses of 
galantamine or placebo. At 16 weeks, there was no benefit from 
galantamine in the primary end point (improvement in the Clinical Global 
Impression Scale) or in any secondary end points. (CFS) 
 
The authors selected this study because it best demonstrated the effect of the drug on 
fibromyalgia, and in turn, they also provided details about the patients, intervention, and 
outcomes of the study were provided. The authors describe in varying level of detail the 
evidence that refutes the many possible treatments that have been trialed as potential 
therapies for CFS.  
Over half of the referenced evidence cited in the case were studies; however, the 
length of descriptions and amount of detail that the authors provided varied greatly across the 
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24 studies. The extensiveness of the details extended from only parenthetical reference to 
minimal details about one or two of the study’s PICO elements to extensive details about all 
four PICO elements of a study. A single trial for rituximab was described in the following 
paragraph: 
In a double-blind, placebo-controlled trial, 30 patients with CFS/SEID were 
randomly assigned to receive rituximab (500 mg/m2) or saline, given twice 
two weeks apart. There were no differences in the primary endpoint, defined 
as effects on the fatigue score at three months after the intervention. 
However, a major or moderate response, defined as lasting improvements in 
self-reported fatigue score during follow-up, was seen in 10 of 15 patients 
(67 percent) who received rituximab and in 2 of 15 patients (13 percent) who 
received placebo. The mean duration of response within a one-year follow-
up period among the 10 responders in the rituximab group was 25 weeks 
(range 8 to 44 weeks). There were no differences in B cell levels between 
patients in the rituximab group who achieved a response compared with 
those who did not achieve a response. (CFS) 
 
In these examples, the authors highlight the study design (i.e., randomized controlled 
trial) and provide details about all four PICO patients (i.e., 30 patients with CFS), 
intervention (500 mg/m2 rituximab), comparison (i.e., saline) and outcomes (i.e., fatigue, 
B cell levels) of the study in order to demonstrate the effectiveness or lack of 
effectiveness of the therapies tested in the trial. In contrast, a study evaluating patient 
beliefs and outcomes was described as: “In one study, belief in a viral cause of the illness 
was associated with prolonged functional impairment” (CFS).  
The authors’ descriptions of the evidence in the CFS main entry extend beyond 
the description of the patient, intervention, comparison and outcome to include 
commentary or analysis of the research study itself. For example, they point out when 
studies examining drug treatments were not designed as a randomized controlled trials: 
“Although these results appeared intriguing, these studies were not placebo controlled, 
blinded, or randomized” (CFS). The authors suggest caution in interpreting the results 
based on the study design.  
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In addition to providing analysis of individual studies, the authors also highlight 
overarching issues with the interpretation and application of the body of research 
examining treatment for CFS. For example,  
A major problem with evaluating the effect of therapy in CFS/SEID is that the 
symptoms fluctuate over time, may remit spontaneously, and are subject to 
substantial response rates to placebo. (CFS) 
 
The authors also draw attention to insufficiency of evidence to support treatments. The 
description of rituximab treatment provides a good example of how they caution readers 
about the need for additional study despite the presence of positive results from a single 
study.  
Though intriguing, these findings are too preliminary to support the use of 
rituximab, a drug that can cause immunosuppression and serious 
complications. This study needs to be repeated with a larger number of 
patients. (CFS) 
 
The repeat this caution with respect to the use of the drug rintatolimod.  
Rintatolimod is an investigational immune modulator and antiviral drug that 
has been approved for the treatment of CFS/SEID in Canada and Europe. It 
improved measures of exercise performance in two randomized trials; 
however, the clinical implications were unclear. Treatment with this drug 
should be considered experimental until more studies have been done. (CFS) 
 
Although rintatolimod is approved for the treatment of CFS in Canada and Europe the 
authors advise that it should be considered ‘experimental’ until more research is completed. 
The clinical implications are considered to be unclear despite approval of the drug for 
treatment of CFS in Canada and Europe. The lack of clear understanding of what is 
considered to be ‘sufficient’ research is underscored in the CFS case.  
The authors acknowledge that the body of CFS studies often yields conflicting 
conclusions. In addition to commenting on the uncertainty regarding the long-term prognosis 
for the condition, they also point out divergent results found with respect to specific 
treatments.  
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Intramuscular immunoglobulin injections appeared to be beneficial in one 
small controlled trial. However, this finding is in contrast to the more general 
experience. Controlled trials of intravenous immune globulin yielded 
conflicting and unimpressive results with a high incidence of adverse effects. 
(CFS) 
 
Interestingly, in this instance the authors note that the benefits shown in one study do not 
align with others results but provide few details about the specifics of the cited research, 
yet they include other examples in which they provide considerable detail about the 
conflicting results. For example,   
The results of studies evaluating glucocorticoids have also been 
inconsistent. A double-blind, randomized, placebo-controlled trial of 25 to 
35 mg/day of oral hydrocortisone for 12 weeks in 70 patients showed 
modest benefit at the expense of adrenal suppression. By comparison, in a 
randomized crossover trial, clinical improvement was observed in 
response to 5 to 10 mg/day of hydrocortisone among 32 patients with 
chronic fatigue but without a comorbid psychiatric disorder. No adrenal 
suppression was observed, but the duration of therapy was only one 
month. (CFS) 
 
Here, by providing the descriptions of two studies, the authors highlight the inconsistent 
conclusions in the evaluation of glucocorticoids. Differences in the patients (i.e., number, 
comorbidities), and interventions (i.e., dosage), and outcomes (i.e., adrenal suppression) are 
noted as a means to demonstrate inconsistency in the evidence base.  
Situating the Patient-Physician Relationship. While the authors acknowledge in 
one instance that there is an opportunity for interprofessional care: “Graded exercise therapy 
should be supervised by a physical therapist or exercise therapist” (CFS), the primary focus 
of the content is the provision of care from a physician. The relationship between the patient 
and physician is acknowledged in the case as an important element of treatment. Under the 
heading ‘Treatment,’ the authors include three subheadings: the two treatments judged to be 
effective (i.e., Cognitive Behaviour Therapy and Graded Exercise Therapy), and ‘Supportive 
Approach’.  The authors advise physicians to “establish rapport with the patient to be able to 
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provide support and reassurance” (CFS). They describe six specific elements that comprise a 
supportive approach. For example, one bullet describes the physician’s role in validating the 
patient’s experience and diagnosis:  
Explain to the patient that the severity is variable but can be completely 
incapacitating and that the symptoms are real. CFS/SEID is a real illness, and 
the symptoms are not due to malingering. Because of the lack of laboratory 
abnormalities, most patients struggle with the validity of their disease (as do 
many of their clinicians) and may experience feelings of guilt. The patient 
must believe that you understand that they have a real disease or you will not 
be able to help them. (CFS) 
 
Physicians’ confirmation of CFS as a ‘real illness’ is repeatedly highlighted as a critical 
element of the physician-patient relationship. In addition to validation, the authors emphasize 
the importance of being honest, addressing patients’ concerns without engaging in unhelpful 
debates and demonstrating a commitment to patients’ treatment process. The physicians’ 
adoption of a supportive approach is identified as a key component of a treatment regime for 
patients.  
Within the section advocating for a supportive approach to treatment, the ways in 
which CFS can challenge the relationship between patient and physician are also 
interspersed. For example, the authors acknowledge that these patients are often time-
consuming: “It is often tempting to avoid such patients, since they can take up a great deal of 
time” (CFS). Further, they point out that CFS patients have complex needs and encourage 
the physicians to: “Accept the fact that you will not be able to satisfy all patients with this 
disease” (CFS). They also acknowledge that patients’ desire to understand the cause of CFS 
can strain the relationship and they advise physicians to “Avoid debate over the psychogenic 
versus organic origin of symptoms” (CFS) because there is no benefit to the patient. While 
the importance of demonstrating support for patients is emphasized, the authors also concede 
that providing care for CFS patients can be challenging for physicians.  
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Patient Information. The transition from healthy individual to patient with CFS 
is described in both patient information entries, The Basics and Beyond the Basics. For 
instance:  
Chronic fatigue syndrome is hard to deal with, because people who get it were 
usually active before. They did not tend to worry about being sick. Then, all 
of sudden, they feel tired and can’t figure out what is wrong with them. Even 
the doctor often can’t find a cause for the symptoms. And to make matters 
worse, other people sometimes think their symptoms are “all in their head.” 
This can make people with chronic fatigue syndrome feel angry, helpless, and 
sad. (CFS Basics)  
 
Both patient information sources also repeatedly validate the existence of the illness.  
If you have chronic fatigue syndrome, try to remember that you have a real 
medical condition. You are not imagining your symptoms, and your problem 
is not “made up.” Scientists have not yet figured out how to explain or cure 
chronic fatigue syndrome, but they do know that it is real. (CFS Basics) 
 
Here, the intention is to reassure patients that CFS is a ‘real medical condition’ and that, 
while scientists do not yet know the cause or cure of CFS, they too believe it to be real. In the 
Beyond the Basics entry, there is recognition that the condition may not be a physical 
abnormality but rather may originate in the mind.  
There is no point to debating whether symptoms of CFS/SEID originate in 
your mind or are the result of a not-yet identified abnormality. If the cause is 
in your mind, the symptoms are no less real (a difficult concept for some 
patients and/or their families). If the cause is an abnormality in your body, it is 
not yet known how to find it or treat it. (CFS Beyond) 
 
The importance of validation by the patient’s own health care professional is asserted 
repeatedly in The Basics and Beyond the Basics.  
The most important thing you can do to deal with your condition is to find a 
doctor or nurse whom you trust and like and who believes that your condition 
is real. Only that way can the 2 of you work together to figure out how best to 
deal with your symptoms. (CFS Basics) 
 
In both entries the need for physicians to accept CFS as a real condition is emphasized as ‘the 
most important’ element of their treatment. The Beyond the Basics information also 
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emphasizes the importance of building a relationship that “include[s] trust on both sides and 
a willingness to believe that CFS/SEID is both real and disabling” (CFS Beyond). Both 
patient information sources emphasize the necessity for finding a health care provider who is 
‘willing’ to believe that CFS is real; however, there is also recognition that many healthcare 
providers are not knowledgeable abut the condition. 
Living with CFS/SEID can be frustrating because most people, including 
healthcare providers, have a limited understanding of why or 
how CFS/SEID develops. In addition, there are limited treatment options. 
(CFS Beyond) 
 
In light of the lack of cure, the goal of treatment for CFS is reduction of fatigue.  
There is no cure for chronic fatigue syndrome (CFS), also called systemic 
exertion intolerance disease (SEID); the goal of treatment is to reduce 
symptoms of fatigue and help you to cope. Many therapies have been tried in 
CFS/SEID but none has been consistently successful. Cognitive behavioral 
therapy and graded exercise appear to be the most effective treatments. (CFS 
Beyond) 
 
The content presented in this excerpt from Beyond the Basics (i.e., lack of cure, the goal to 
reduce fatigue, the many trialed therapies, and identification of cognitive behavioural therapy 
and graded exercise therapy as CFS treatments) aligns with the content presented in The 
Basics as well as the main entry. Short descriptions of cognitive behaviour therapy and 
graded exercise therapy are provided in both patient information sources.  
Following the identification of the two proven therapies, both patient information 
sources highlight that other therapies have been trialed but with little success.  
Researchers have also checked whether different medicines, supplements, and 
special diets help with chronic fatigue syndrome. So far, none of these 
approaches has proven helpful (CFS Basics).  
 
Indeed, Beyond the Basics provides a list of five treatments that have been trialed and 
“not proven to improve symptoms of CFS/SEID include the following” (CFS Beyond, 
emphasis in original). The trials and unproven efficacy of multiple treatments are also 
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highlighted in the main CFS entry. 
Particular attention is brought to the lack of a role for antibiotics in treating CFS. This 
matter is highlighted with considerable detail in both The Basics and the Beyond the Basics 
patient entry.  
There is no role for antibiotics in the treatment of CFS/SEID, and there is the 
potential for serious side effects from prolonged use of antibiotics. Your 
doctor might offer you antibiotics, especially if you test positive for Lyme 
disease. But antibiotics do not work on chronic fatigue syndrome. And testing 
positive for Lyme does not mean that your symptoms are caused by Lyme 
disease. Plus, taking antibiotics for a long time when you do not need them 
can cause health problems. (CFS Beyond) 
 
In this case, the content of the two patient information sources and the main entry written for 
professional are well-aligned.  
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Case Analysis: Grief and Bereavement 
The question of whether grief arising from the death of a loved one is a natural human 
process or a serious condition that may require medical attention is longstanding (Breen & 
O’Connor, 2007; Engel, 1961; Glass, 2005). In 1917, Freud explored this very tension in his 
classic essay “Mourning and Melancholia” and distinguished between two different 
responses to loss. Mourning while painful and difficult, was recognized to be also time-
limiting, natural, and normal. In contrast, melancholia affects one’s sense of self-worth, and 
is long-lasting and pathological. This distinction between ‘normal’ and ‘abnormal’ grief has 
been discussed for a century, and in turn, the ways in which physicians and health care 
professionals treat grief have also been debated.  
A change to the foundational psychiatric text, the Diagnostic Statistical Manual of 
Mental Disorders (DSM), in 2013, may start to define treatment of grief more clearly and 
affect the way grief is understood and, in turn, how the medical profession handles grief. In 
the fifth edition, a feature termed the “grief exemption” or “bereavement exclusion” was 
removed (American Psychiatric Association, 2013). Prior to 2013, bereavement was the only 
life event or stressor specifically excluded from a diagnosis of major depression in DSM-IV. 
In removing the so-called bereavement exclusion, clinicians can diagnose major depression 
in persons who have experienced the death of a loved one after only two weeks of depressive 
symptoms. The goal of the change is to identify individuals who require treatment for major 
depression, which has been triggered or precipitated by the death of a loved one. However, 
the unintentional effect of this proposed change could be the medicalization of grief and an 
increase in the labelling of healthy, but grieving people with a psychiatric diagnosis.  
Further complicating the treatment and handling of grief and bereavement is the 
proposed disorder of ‘complicated grief’. Complicated grief disorder, officially named 
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‘persistent complex bereavement disorder’ by a DSM working group, is a proposed disorder 
assigned to individuals experiencing grief that is prolonged, intense and debilitating. Grief is 
considered prolonged if patients have not demonstrated adaptation to the loss and integration 
of bereavement into their lives by six months (Bonanno et al., 2002). Complicated grief is 
differentiated from other mental disorders including major depression and post-traumatic 
stress disorder.  
In consideration of this context, the case study on grief and bereavement includes two 
UpToDate entries written by the same authors:  Grief and Bereavement in Adults: 
Management (NGB) which addresses the treatment of what is often coined normal grief and 
bereavement, and Complicated Grief in Adults: Treatment  (CGB), which addresses the 
treatment of complicated grief in adults. The two entries were chosen to represent the single 
case because the degree of medicalization was a key factor in the selection of cases; as such, 
the overlap across and the distinction between the two entries is very important. 
Descriptive Analysis: Normal Grief and Bereavement (2015) 
The normal grief and bereavement (NGB) entry includes 20 cited references, the 
fewest number of references across the eight entries analysed. The 20 references were all 
published between 2000 and 2014 with more than half (n=11, 55%) published between 2010 
and 2015. Only seven of the 20 references were published in UpToDate’s core journals.  
Half of the references (n=10) cited in the NGB entry are not recognized as types of 
evidence within the 6S hierarchy classification (see Figure 17). All six studies cited in the 
main entry for the NGB were quantitative, of which four were randomized controlled trials. 
The locations of study for the six studies were the United Kingdom (n=2), United States 
(n=2), the Netherlands (n=1), and one multinational spanning the United Kingdom and the 
United States.  Two systematic reviews were cited, as well as two summary level resources. 
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The two summary resources included in the NGB main entry were clinical practice 
guidelines. 
 
Figure 17: Types of Evidence in NGB Main Entry 
The 20 references included in the main entry for NGB were written by a total of 88 
authors. Across the 20 papers, the highest known proportional representation (.41) of the 
authors had a Basic Scientist (PhD) background. The relative proportion of authors with a 
Medical Doctor (MD) background was .24. The proportion of authors where the background 
authorship was unknown was .29 (see Figure 18).  
 
 
 
Figure 18: Relative Contributions by Author Background for NGB main entry 
 
Descriptive: Complicated Grief (CGB, 2015) 
The main professional entry addressing complicated grief (CGB) cited 30 references. 
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There is minimal overlap of references across the NGB and CGB entries (only two sources 
were cited in both entries). The 30 references were published between 1998 and 2015. 
Seventy per cent (n=21) were published between 2010 and 2015. Only nine of the 30 
references (30%) were published in UpToDate’s core journals. The most commonly cited 
journal was Death Studies, which is not identified as a core journal by UpToDate. 
Seventy-seven per cent of references (n=23) cited in the CGB entry were studies; all 
but one was quantitative. Eleven of the 22 quantitative studies were randomized controlled 
trials.  Three systematic reviews were cited. Only four references cited (13%) in the CGB 
entry were not sources of evidence recognized as evidence by the 6S hierarchy classification. 
 
Figure 19: Complicated Grief and Bereavement in Adults: Treatment (CGB) 
 
The 30 references included in the main entry for CGB were written by a total of 127 
authors. Across the 30 papers, the highest known proportional representation (.35) of the 
authors had a Basic Scientist (PhD) background. The relative proportion of authors with a 
Medical Doctor (MD) background was .24. The proportion of authors whose background was 
unknown was .36.  
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Figure 20: Relative Contributions by Author Background for NGB main entry 
 
Textual Analysis 
Situating the Author- Normal Grief and Bereavement (NGB, 2015).  In the main 
entry for NGB the authors do not readily provide their recommendations, nor do they readily 
position their expertise within the content. The authors provide explicit recommendations 
only three times in the entry. For example, the authors offer their recommendation for 
treatment for bereaved patients who do not have mental disorders: “For bereaved individuals 
who do not have mental disorders, we suggest not routinely administering grief counseling or 
other psychotherapies” (NGB). In one additional instance, the authors provide their 
endorsement for treatments implicitly by describing their own approach to care: “For 
bereaved individuals who do not have mental disorders, we generally do not use 
benzodiazepines” (NGB). Their strategy to avoid prescription of these psychotropic drugs is 
reinforced more explicitly later in the entry by using the phrase ‘we suggest.’ Explicit 
recommendations are infrequent in the main entry for NGB. 
There are sections of the NGB entry where the source of the knowledge is unclear. 
The authors do not always attribute the information to themselves or to published materials. 
For example, the authors describe patients’ experience before and following death: 
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If possible, clinicians should summon families prior to an expected death. If 
this is not possible and the patient dies, the clinician should promptly call 
immediate family members who are not present at the bedside in order to 
inform them, express condolences, answer questions, and offer them the 
option of viewing the body. (NGB) 
 
For patients who are worried about their reaction to the death, education may 
be helpful. As an example, patients without mental disorders may be alarmed 
by hallucinations of the deceased, and can be reassured that this is not a 
manifestation of psychotic illness. Some people worry about the intensity or 
uncontrollability of emotions; this too is a typical feature of acute grief. 
(NGB) 
 
In the first excerpt the authors provide guidance about what the clinician should do prior to 
the death of a patient. In the second the authors advise physicians about how patients might 
react when faced with the death of a loved one, and how best to respond to such reactions. 
The sections without any attribution to a source, neither evidence nor expertise, often relate 
to the role of the physician, as demonstrated in the first excerpt, or the experience of the 
patient, as demonstrated in the second exerpt. The ambiguity of the source of knowledge and 
the nature of the information provided suggests that the authors are providing implied 
guidance and recommendations based on tacit knowledge gained through their own 
experience. 
Situating the Author- Complicated Grief and Bereavement (CGB). In the 
Complicated Grief entry, the (same) authors are more forthcoming with their own 
recommendations and refer predominantly to their own expertise through their explicit 
recommendations. Seven recommendations made by the authors in the CGB explicitly use 
the phrase ‘we recommend’ or ‘we suggest,’ as encouraged by the Editorial Policy of 
UpToDate. The recommendations endorse specific therapies and are often followed up by 
published evidence.  
For patients with complicated grief, we recommend CBT adapted for 
complicated grief as first-line treatment. CBT has been widely studied and 
multiple randomized trials indicate that CBT targeted for complicated grief is 
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efficacious; the evidence supporting CBT includes head-to-head trials 
comparing CBT with other active treatments (rather than waiting list controls 
or usual care). As an example, a 12-week trial compared CBT with grief 
counseling in 54 patients, and found that improvement of complicated grief 
was greater with CBT and that its clinical effect was large. (CGB) 
 
Not all recommendations were followed by evidence. For example, the authors provide 
guidance for physicians caring for patients who have not responded to cognitive behaviour 
therapy:  
If patients are not responding to first-line treatment with complicated grief 
therapy or other forms of CBT targeted for complicated grief, we suggest re-
evaluating patients with respect to psychosocial problems that can derail 
treatment, and addressing any such problems. As an example, patients may 
have serious financial, occupational, or interpersonal problems such as 
lawsuits related to the death, disability due to incapacitating symptoms, or 
conflicts with family members in settling the estate. (CGB) 
 
The lack of clarity about the origin of information included in the CGB entry is 
common. In one instance, the authors infer their endorsement of treatment through accounts 
of their typical practice. In the Summary and Recommendations, the authors reinforce their 
endorsement of complicated grief therapy by describing their choice of this therapy in their 
own practice stating “We typically use a form of CBT called “complicated grief therapy” 
(CGB). While the authors do no overtly share their recommendation using ‘we recommend,’ 
their account of their typical practice endorses the practice implicitly.  
Situating the Evidence, Normal Grief and Bereavement (NGB, 2015).  Almost 
half of the references cited (9 of 20) in the entry for NGB are not types of evidence 
recognized within the 6S hierarchy of evidence. Six quantitative studies were cited in the 
NGB entry. The authors provided short description of two of the six studies cited in the NGB 
entry, both were randomized controlled trials: 
A six-week randomized trial compared diazepam (2 mg, up to three times per 
day) with placebo in 30 individuals who were bereaved within the past two 
weeks; patients were allotted 20 tablets for the entire study. Outcomes were 
comparable at the end of the treatment and at the six-month follow-up. (NGB) 
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A subsequent randomized trial compared psychoeducation (four sessions, 
each lasting two hours, administered during home visits) with no intervention 
in 83 individuals bereaved through suicide; improvement of depressive 
symptoms (including suicidal ideation) and complicated grief symptoms in the 
two groups was comparable. (NGB) 
 
As shown in the excerpts, the category of high quality trial (i.e., randomized controlled trial) 
was highlighted in both descriptions. The information about the intervention, comparison, 
and outcomes was provided; however, information about the patients was scant. Both 
descriptions describe studies in which the intervention did not result in a meaningful benefit. 
The NGB main entry cited three synthesis level evidence sources, the meta-analysis 
comparing the efficacy of various grief interventions including counseling, psychotherapies, 
and support groups with control groups. Short descriptions were provided about all meta-
analysis. A meta-analysis evaluating grief interventions with usual care was described briefly 
as:  
A meta-analysis of nine trials compared interventions (eg, support groups) 
intended to prevent complicated grief with control conditions (eg, usual care 
or minimal treatment) in 1545 bereaved individuals, and found that the 
incidence of complicated grief was comparable. (NGB) 
 
Once again, the authors are transparent that these interventions are not beneficial to the 
patient. Despite the outcomes of this meta-analysis and other research showing no benefit to 
grief interventions for normal grief and bereavement, the authors go on to explain when grief 
counselling can be helpful:  
However, grief counseling can be helpful specifically for bereaved individuals 
who request it, and may also be helpful when it is coupled with other efforts 
that are focused upon new activities as well as experiences intended to restore 
one’s life. (NGB) 
 
The authors assert that grief counselling can be helpful for those who request it, citing a 2007 
systematic review.  
Finally, two World Health Organization (WHO) clinical practice guidelines were 
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cited. The guidelines cited addressed the use of benzodiazepines. The authors’ aversion to 
using benzodiazepines was compared to the WHO guidelines: “Our approach is consistent 
with treatment guidelines from the World Health Organization” (NGB). The citation of 
clinical practice guidelines was used as a means to further validate their recommended 
approach.  
Situating the Evidence, Complicated Grief (CGB).  In contrast with the NGB main 
entry, the authors rely heavily on studies as evidence for the content presented in the 
complicated grief main entry. Specifically, 23 of the 30 cited references (77%) were studies - 
the highest proportion across the eight main entries analysed for this multiple case study.   
The authors present their recommendation for first-line therapy for complicated grief 
as cognitive behaviour therapy (CBT) adapted for complicated grief. The strength of their 
recommendation is directly connected with the evidence.  
CBT has been widely studied and multiple randomized trials indicate that 
CBT targeted for complicated grief is efficacious; the evidence supporting 
CBT includes head-to-head trials comparing CBT with other active treatments 
(rather than waiting list controls or usual care) For example, a 12-week trial 
compared CBT with grief counseling in 54 patients, and found that 
improvement of complicated grief was greater with CBT and that its clinical 
effect was large” (CGB) 
 
This approach of acknowledging a larger body of evidence and then selecting examples from 
the body was also used when describing a specific therapy called “complicated grief 
therapy”: 
Evidence for the efficacy of complicated grief therapy includes randomized 
trials that studied the treatment in different age groups: 
One trial compared complicated grief therapy with interpersonal 
psychotherapy in 95 patients (mean age approximately 48 years). Both 
treatments were administered in 16 weekly sessions, and patients were 
allowed to continue antidepressants initiated prior to study intake. Response 
occurred in more patients who received complicated grief therapy than 
interpersonal psychotherapy (51 versus 28 percent). 
A second trial by the same principal investigator, using similar methods, 
compared complicated grief therapy with interpersonal psychotherapy in 151 
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patients (mean age approximately 66 years). More patients responded to 
complicated grief therapy than interpersonal psychotherapy (70 versus 32 
percent), and response was sustained six months post-treatment. (CGB) 
 
The authors select two studies from the body of randomized trials for which to provide 
descriptions that included details about the patients, intervention, comparators and outcomes 
of the study as well as the study design (i.e., randomized controlled trials). Study design is a 
common element highlighted in the CGB entry.  The authors’ preference for randomized 
trials is implicit in the entry.  
No randomized trials have demonstrated that antidepressants are efficacious 
for complicated grief, and these drugs are often not used. However, several 
small observational studies suggest that these drugs may be helpful. (CGB) 
 
The authors highlight that while observational studies suggest efficacy, randomized trials 
have not demonstrated efficacy. When describing three observational studies, the authors 
present outcomes with tempered certainty using words such as suggest and may (be helpful).  
The authors provided a short description of one of the three synthesis level evidence 
sources.  
Randomized trials indicate that the best treatment for complicated grief is 
psychotherapy that is specific for complicated grief. As an example, a meta-
analysis of five trials compared psychotherapies (eg, cognitive-behavioral 
therapy [CBT]) adapted for complicated grief with control conditions (eg, 
nonspecific supportive psychotherapy) in 368 patients. Improvement was 
greater with psychotherapies adapted for complicated grief and the clinical 
benefit was moderately large. In addition, one study followed patients beyond 
the end of treatment and found that improvement remained greater in patients 
who received active treatment. However, the heterogeneity across the five 
trials was large. (CGB) 
 
In this excerpt, the authors highlight that the meaningful clinical benefit of delivering 
psychotherapies specific for complicated grief. They also emphasize one of the five studies 
that demonstrated that improvements extended beyond the duration of the treatment. The two 
other systematic reviews cited in the entry appeared only as parenthetical references in a list 
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of possible treatments for non-responsive patients. In addition to proof of efficacy, 
descriptions of the way in which cognitive behaviour therapy is designed and delivered are 
provided in the CGB entry.  
The second-line treatment, behavioural activation, is presented more briefly in the 
CGB main entry. Much less explanation about what behavioural activation is or how it is 
delivered is included. Only one randomized controlled trial was described in order to 
demonstrate the efficacy of behavioural activation in complicated grief:  
Evidence for the efficacy of behavioral activation includes a 12-week 
randomized trial that compared behavioral activation with a waiting list 
control in 25 patients; after 12 weeks, patients in the control group received 
behavioral activation. Behavioral activation was administered in 12 to 14 
individual sessions, and included education about complicated grief, self-
monitoring of activities, identifying patterns and reinforcers of avoidant 
behavior, and scheduling alternative rewarding activities. Improvement was 
greater with active treatment; among the 25 patients, response at posttreatment 
occurred in 45 percent. At the follow-up assessment 12 weeks after treatment 
ended, response was observed in 60 percent of patients. In addition, symptoms 
of depression and PTSD also improved. (CGB) 
 
Interestingly, the account of the behavioural activation therapy included in this study 
description is the only explanation of the intervention in the main CGB entry.  
Cognitive behaviour therapy and behavioural activation are considered the first- and 
second-line therapies and, as such, the authors provide evidence of their efficacy. When these 
first- and second-line therapies fail, the presentation of evidence and the strength of evidence 
provided in the entry are markedly reduced. When these therapies fail, the authors suggest an 
amalgamation of approaches including: education about complicated grief, counseling and 
support, encouragement, correcting dysfunctional thoughts, anticipating anniversary dates, 
antidepressant medications. With the exception of the use of antidepressants, for which the 
authors state a lack strong evidence, these approaches are not situated within a body of 
evidence but rather are only presented as a list in the CGB main entry. Following failure of 
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these interventions, another list of possible therapies is presented.  
For patients with complicated grief who do not respond to this combination of 
interventions, we suggest interpersonal psychotherapy, narrative therapy, 
meaning making therapy, psychodynamic psychotherapy, family therapy, eye 
movement desensitization and reprocessing, or art therapy. (CGB) 
 
While no descriptions of these therapies or descriptions of the evidence supporting these 
therapies are provided, each of these therapies does include at least one parenthetical citation, 
either a systematic review or a study.  
Situating the Patient-Physician Relationship, NGB 
The authors of the normal grief and bereavement entry address the normalcy of the 
grief process by declaring that many people do not require treatment when they are going 
through the processes of grief and bereavement. 
Acute grief does not typically require treatment. Most bereaved individuals 
are resilient and grief is transformed and integrated during a natural adaptive 
process that typically unfolds with the support and encouragement of close 
family and friends, as well as clergy. (NGB) 
 
The resiliency of bereaved individuals is highlighted alongside the need for the support and 
encouragement of others. Grief, as a natural process that does not require treatment but rather 
support, is reinforced throughout the case and informs the way in which the patient-physician 
relationship is described in the main entry for NGB. 
While it is often not necessary for physicians to provide treatment for the bereaved, 
the authors do emphasize that patients often welcome the physician’s acknowledgement of 
and support for their loss. Throughout the entry, the authors provide strategies and tactics for 
physicians to support the bereaved.   
Support from clinicians for acute grief typically includes empathic listening, 
information about the wide range of typical grief symptoms, reassurance, and 
monitoring. Condolence letters, telephone calls, attending the funeral or memorial 
service, and home visits may be helpful as well. (NGB) 
 
              148 
 
Clinicians are advised also to be aware of social and environmental issues that may 
hamper the bereavement process:  
Clinicians can guide bereaved patients in managing social or environmental 
problems that supervene in the aftermath of a loss and become the focus of 
thoughts and behaviors. As an example, if a widow is left with insufficient 
funds to support herself, her partner’s affairs are in disarray, or she is 
ostracized or blamed after the death of a loved one, these situations demand 
attention because they may interfere with adaptation, trigger a depressive or 
anxiety disorder, or lead to complicated grief. (NGB) 
 
To further assist physicians, the authors provide suggestions for what to say to grieving 
patients and identify times and ways that physicians can support their patients through the 
grieving process.  
The physician is not positioned as the main source of bereavement support, but rather 
a natural one.  
Primary care clinicians are a natural source of support for bereaved 
individuals and typically view bereavement care as important and satisfying; 
however, many clinicians feel inadequately trained. (NGB) 
 
 The limitations of physicians’ comfort in treating patients is also underscored when the entry 
addresses the need to rule out other conditions including “Suicidal ideation and behaviour; 
Complicated grief; and Other mental disorders, such as major depression, posttraumatic 
stress disorder (PTSD), insomnia disorder, and anxiety disorders” (NGB). The authors advise 
that: “Primary care clinicians who are not comfortable diagnosing and treating mental 
disorders should refer patients to mental health clinicians” (NGB). The entry acknowledges 
that while physicians can be a helpful source of support, clinicians often feel underprepared 
to treat the bereaved, especially when complications and comorbidities develop. 
Through the identification of opportunities for support throughout the bereavement 
support, the authors also provide insight into the experiences of the patient. Patient 
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experiences are exposed through the description of ways in which patient education and 
patient encouragement can assist patients and:  
For patients who are worried about their reaction to the death, education may 
be helpful. As an example, patients without mental disorders may be alarmed 
by hallucinations of the deceased, and can be reassured that this is not a 
manifestation of psychotic illness. Some people worry about the intensity or 
uncontrollability of emotions; this too is a typical feature of acute grief. 
(NGB) 
 
Encouraging patients to maintain regular patterns of activity, sleep, exercise, 
and nutrition may help adaptation to the loss. Bereaved individuals may forget 
to care for themselves and may withdraw socially. If the deceased person 
lived in the same house, meals can trigger intense feelings of missing the 
person. Patients may eat food that a loved one especially enjoyed in order to 
feel close to the person, or avoid foods that serve as reminders of the loss. 
Sleep can be disrupted as well. (NGB) 
 
The intensity and uncontrollability of the patient emotions and reactions are described, as 
well as the resulting effect on daily life. More extensive descriptions of the patient 
experience are covered in the related UpToDate entry Grief and Bereavement: Clinical 
Features, however by exploring the opportunities for the physician to provide support, 
physician observation of the patient experience is also underscored. 
Situating the Patient-Physician Relationship, CGB 
Complicated grief is acute grief that becomes “unrelenting, intense, and functionally 
debilitating” (CGB). Unlike normal grief and bereavement, the authors claim that 
complicated grief requires treatment. The patient-physician relationship in complicated grief 
is dictated by the goal of treatment, which is outlined in the CGB entry as “resolving grief 
complications and fostering adaptation to the loss” (CGB). The authors reinforce that the 
goal of the treatment is not the elimination of all symptoms. They provide indicators of when 
the treatment is successful including improved emotion regulation, an ability to envision a 
positive life, and engagement in activities and relationships.  
One of the keys to providing treatment is educating the patient about complicated 
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grief as a disorder. The education is intended to assist patients by validating their experience 
and providing a diagnosis:  
Many patients with complicated grief are discouraged by the prolonged acute 
grief and feel hopeless, and are relieved to receive the diagnosis as well as 
education about the disorder. In addition, family and friends who initially 
were supportive may be critical and tired of trying to help because they do not 
realize the patient has a treatable condition. (CGB) 
 
The authors reinforce the validity of complicated grief as ‘real’ by describing it as a 
“treatable condition” (CGB). Patient education and validation of complicated grief as a 
disorder is presented as a key attribute of the patient-physician relationship. 
First- and second-line therapies for complicated grief are identified in the CGB 
treatment entry. Physicians are encouraged to treat patients first with cognitive behaviour 
therapy adapted for grief. If patients fail to respond, behavioural activation is suggested as 
the second line treatment. Prior to moving onto second line treatment clinicians are 
encouraged to assess for “psychosocial problems that can derail treatment” (CGB). Issues 
that may arise may relate to legal, occupational or financial problems as a result of the death. 
Physicians are encouraged to “address any such problems” (CGB). The complexity of the 
grieving patient is acknowledged by the authors stating: 
In addition, many patients with complicated grief have comorbid major 
depression, anxiety disorders, PTSD, or substance use disorders. If a disorder 
other than complicated grief is more salient, treatment should refocus upon the 
primary problem. (CGB) 
 
Repeatedly, complicated grief is framed as “a unique and recognizable condition that can be 
differentiated from other mental disorders” (CGB), however, the presence of complex 
psychosocial issues and comorbidities do raise questions about the simple description of 
complicated grief as a treatable condition. 
The responsibility for delivery of the first- and second- line treatments is ambiguous 
in the CGB entry. No clear indication is provided about what type of professional delivers 
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these treatments and what relationship exists between the patient, the primary care providers, 
and the treatment provider.  
UpToDate does not provide patient information for either normal or complicated 
grief.  
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Case Analysis: Intimate Partner Violence 
Intimate Partner Violence (IPV) describes physical, sexual, and emotional abuse by a 
current or former partner or spouse; it is differentiated from bi-directional conflict in 
relationships. Most victims of IPV are female; most perpetrators are male. Alongside the risk 
of death, very significant non-fatal outcomes and consequences include injuries and 
disabilities; mental health and behavioural consequences; and poor reproductive health 
(WHO, 2010). Because of the serious and pervasive health impacts, intimate partner violence 
is increasingly recognized as a public health concern requiring physician awareness and 
involvement.  
Physician support for a patient experiencing abuse is often initiated when IPV is 
detected, disclosed, and “diagnosed.” Physicians and health care workers are increasingly 
encouraged to talk about, assess risk, and provide options for support when intimate partner 
violence is disclosed (American College of Obstetricians and Gynecologists, 2012; 
Cronholm, Fogarty, Ambuel & Harrison, 2011; Society for Obstetricians and Gynecologists 
of Canada, 2009). Preventing IPV and ensuring supports and resources are available to those 
experiencing abuse is recognized as a priority, and the potential issues and consequences that 
emerge from these actions are numerous and complex. As such, the role of health care 
workers in identifying and providing intervention options for IPV has been debated 
extensively (Cole, 2000; Wathen & MacMillan, 2012).  
Descriptive Analysis  
The authors of the IPV case cite 28 references ranging in date of publication from 
1984-2015. Almost half (n=13, 46%) are published between 2010 and 2015. Forty-six (n=13) 
are published in UpToDate’s core journals. The most commonly cited journal in the IPV case 
was The Lancet, cited four times. 
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The UpToDate entry for IPV contains three types of evidence from the 6S hierarchy:  
Summary, Synthesis, and Study (see Figure 21). Half of the references (n=14) cited in the 
IPV case are not sources recognized as evidence within the 6S hierarchy; five non-
systematic/narrative reviews; four public websites, three published reports, a textbook and a 
resource manual. Five systematic reviews (Synthesis level), are cited, along with seven 
studies, including one qualitative, two RCTs and four non-RCT quantitative studies. Six of 
the seven studies took place in the United States and one in Australia.  
 
Figure 21: Types of Evidence in IPV Main Entry 
  
The 28 references cited in the IPV case were written by a total of 108 authors. Across 
the 46 papers, the highest known proportional representation (.22) of the authors was from 
professional organizations. Proportionally, medical doctors comprise .17 of the authors and 
other health professionals made up .21 of the authorship.  The relative proportion of authors 
who are Basic Scientists is .20 (see Figure 22). Proportionally across all 46 papers, .21 of the 
authors’ backgrounds are unknown.  
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Figure 22: Contributions by Authors’ Backgrounds for IPV main entry 
 
Textual Analysis 
Situating the Authors. The authors of the IPV case do not overtly locate themselves 
within its content. Unlike other cases, the authors never refer to themselves as “we” to 
designate content emerging from their own recommendations, practices, or expertise. 
Nevertheless, there are indications that selected guidance provided to the reader is based on 
authors’ expertise.  
Significant sections of the case are not anchored to a cited reference. For example, the 
authors provide the reader with sample phrases that may be used within the clinical 
encounter, e.g., “I want to help you through this in any way I can” (IPV). This type of advice 
commonly permeates the general literature on responding to IPV. Similarly, there are 
multiple instances of guidance and advice to the reader that align with general knowledge 
about supporting victims of IPV, without overt attribution as to where the advice originated:   
The clinician should ask the patient how afraid they are and what they think 
are their immediate and future safety needs. Unfortunately, many people 
minimize or deny their danger. Clinicians may be surprised or frustrated with 
the severity of abuse patients are willing to tolerate and should understand that 
love and other family concerns, such as children in the home and economic 
factors, often confound the picture. (IPV) 
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Providers should assure the abused patient that they are available for support. 
In addition the patient should be offered referral for counseling about options 
and safety, often to an onsite or local domestic violence agency where 
available. Patients may be reluctant or resistant to talking with anyone else 
because of fears about safety. On subsequent visits, you may emphasize 
ongoing support and concern and ask the patient again to consider referral to 
someone who can help think about options. (IPV) 
 
The authors provide the reader with guidance about how to communicate with and advocate 
for the IPV victim by explaining what the physician should do. They guide the physician 
through a patient encounter and offer insights into what the physician might expect when 
caring for victims of IPV. While the authors do not explicitly refer to themselves in this case, 
in the presence of advice and in the absence of published evidence, they do appear to be 
sharing their own experiences, knowledge, and expertise. 
Situating the Evidence. As noted above, significant sections of the IPV case are not 
attributed to published evidence. The case contains only seven studies: two RCTs, four non-
RCT quantitative studies (two U.S. National surveys, a tool validation, and a 
cohort/longitudinal study) and one qualitative study. (One RCT was misidentified as a meta-
analysis in the UpToDate entry). The descriptions of the evidence used within the case vary 
in the amount of detail provided. 
The case unusually contained one qualitative study (of two such studies in all the 
cases reviewed). No details about the study were provided other than its conclusion:  
“Attempting to or leaving a relationship with a perpetrator often increases the risk of injury. 
Providers should not encourage their patients to leave a relationship” (IPV).   
Importantly, one of the key messages communicated in the IPV main entry is that 
there is little evidence that demonstrates meaningful benefits of IPV interventions: “The 
effectiveness of interventions for domestic violence has been studied and have shown limited 
benefits for most women” (IPV). The authors call upon a systematic review and clinical 
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practice guidelines to support this claim:  
Studies have not shown conclusive benefits for advocacy or counseling 
interventions. A 2009 systematic review found insufficient evidence to 
determine if advocacy (providing information, support, and resource access) 
in healthcare settings is effective for women who live with their abusing 
partners. Intensive advocacy for women in shelters decreased physical abuse, 
but its effect on depression, quality of life, and psychological distress was 
uncertain. A subsequent multicenter trial randomized women who screened 
positive for IPV to an intervention of one to six counseling sessions or to no 
intervention. The response to a mailed survey at one year found no differences 
in the primary outcomes of quality of life, psychological health, or planning 
for safety, although the risk of depression was reduced in the intervention 
group. (IPV) 
 
The 2013 World Health Organization guidelines concluded that, except for 
women who have spent at least one night in a shelter or for pregnant women 
experiencing IPV, there is insufficient evidence that interventions for IPV 
improve health outcomes. 
 
While the conclusions of the systematic review and the clinical practice guidelines indicate 
that IPV interventions are not effective, the authors resist the notion that no intervention is 
necessary. Specifically, they state: “Counseling may strengthen the victim’s self-worth and 
provide ongoing support, although objective evidence to support these benefits is limited” 
(IPV). While there is not sufficient evidence to support the benefits of counselling, the 
authors suggest counselling as a means to provide support to the victim. 
The authors do bring attention to areas of IPV research in which there have been 
conflicting results across studies, particularly regarding the efficacy of treatments for 
pregnant women: 
In a 2012 meta-analysis of four trials, counseling interventions reduced IPV, 
improved birth outcomes for pregnant women, reduced IPV in the post-
partum period, and reduced unsafe relationships and pregnancy coercion for 
women seen in family planning clinics. However, a subsequent 2014 
systematic review looking at 9 studies concluded that there was insufficient 
evidence to assess the effectiveness of interventions for domestic violence on 
pregnancy outcomes due to the heterogeneity and poor quality of studies 
overall. (IPV) 
 
Throughout the case the authors are transparent in describing research that addresses the care 
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of IPV as inconsistent and inconclusive. 
The clinical practice guidelines from the World Health Organization, which occupy 
the summary level of evidence, are mentioned twice in the entry.  
The World Health Organization issued guidance in 2013 for responding to 
intimate partner violence and sexual violence against women. The guidelines 
stress the importance of woman-centered care as first-line support, to include 
confidentiality when possible, privacy, nonjudgmental support, validation, and 
not pressuring the woman to leave the relationship. The guidelines incorporate 
recommendations for initial support, care for survivors, clinician training, 
healthcare policy, and mandatory reporting. (IPV) 
 
The focus on a supportive, patient-centred approach to caring for the IPV victim is clearly 
conveyed in both the clinical practice guidelines and the UpToDate entry. The second 
reference to the guidelines addresses the lack of efficacy of IPV treatments. While not 
explicitly stated, the approach put forth by the authors does align with WHO guidelines. 
Situating the Physician-Patient Relationship. The authors explicitly and repeatedly 
state throughout the case that providing care for the patient requires supports beyond the 
physician: “Care of the patient experiencing IPV requires a team approach involving 
medical, institutional, and community resources” (IPV). Potentially helpful supports include 
social workers, women’s shelters, legal aid, hospital or community advocates, and 
community hotlines. The willingness of physicians to connect IPV victims with support is 
dictated by patient needs and experience. In particular, the authors highlight the importance 
of readiness:  
For patients who are not ready or are too fearful to proceed with referral, 
support and concern should be discussed on subsequent visits, and the patient 
should again be asked to consider referral to someone to help him or her think 
about their options. (IPV) 
 
The authors emphasize that patients’ needs and experiences guide care as well as referrals.  
The IPV main entry highlights that the focus of care in IPV is support: “Providers 
should assure the abused patient that they are available for support” (IPV).  Throughout the 
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case, the authors provide clarification about what ‘support’ entails.  
When IPV has been identified, the most important first consideration is to 
offer support to the patient. It is crucial that providers affirm their 
understanding of how difficult it must be for the patient to share this 
information, recognize the patient's strength in doing so, and provide 
assurance that they will be available to the patient for the future. This should 
be immediately followed by an assessment of the victim's safety. (IPV) 
 
The authors describe the importance of physicians being able to demonstrate their 
understanding, compassion, and respect.   
The immediate expression of empathy, acknowledgement, and continued 
ability to support and assist the patient are the most important components of 
care after a patient has disclosed abuse. (IPV) 
 
The authors provide further guidance about how to deliver this type of support. Specifically, 
they list possible statements that will help the physician convey empathy, validation, and 
assistance.  
The need for the clinician to recognize the uniqueness of patient experiences and 
situations is emphasized. Some differences across patients that are underscored in the entry 
include the level of danger victims are experiencing, as well as their readiness to change their 
situation, and the supports they have available. The authors are explicit that it can be 
challenging to provide care for victims of IPV. One of the key challenges is the clinicians’ 
disbelief that victims are willing to tolerate the abuse. While it may be difficult for physicians 
to understand the situations and choices of victims, the authors are very clear throughout the 
IPV case that decision-making is the right and responsibility of the patients: “Patients should 
be allowed to make autonomous decisions regarding health advice” (IPV).   The authors 
reinforce the importance of this by calling on the WHO clinical practice guidelines outlining 
the need to provide the environment that will allow victims to make their own decisions.  
The guidelines stress the importance of woman-centered care as first-line 
support, to include confidentiality when possible, privacy, nonjudgmental 
support, validation, and not pressuring the woman to leave the relationship. 
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(IPV) 
 
The clinical practice guidelines reinforce the responsibilities of physicians to ensure patient 
autonomy. Within this context, the legal aspects of providing care for IPV are acknowledged 
as one caution and limitation to patient autonomy. The compounding safety and legal issues 
that arise when children are exposed to IPV are emphasized: “Health providers and law 
enforcement officers, as well as teachers and child care providers, are mandated reporters in 
most states” (IPV).  
It is noteworthy that throughout the IPV entry, patients experiencing IPV are not 
limited to female victims. Although women are most at risk for experiencing IPV, the authors 
position the content as gender neutral, referring most often to their, and sometimes including 
both binary genders by referring to he/she or him/her.  
UpToDate provides no patient information for intimate partner violence. 
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Cross-Case Analysis 
Descriptive Analysis: 
 
In this cross-case descriptive analysis, the 427 references cited across the eight 
professional entries that make up the multiple case study are examined. Comparisons across 
the seven cases and eight entries are highlighted.  
Currency. One of the highly regarded benefits of online medical information is the 
capacity to update information with the most recent developments in a timely and efficient 
manner.  In this way, new medical knowledge can be integrated into online point of care 
resources such as UpToDate, into clinical practice, and into a patient’s care more quickly 
than ever before. According to its Editorial Policy, the content of UpToDate is “revised 
whenever important new information is published” (UpToDate, “Editorial Policy,” 2016). 
Table 22 provides an overview of the publication dates of the references cited across the 
professional entries across the cases analysed in this investigation.  All but the Grief and 
Bereavement (NGB) entry cited at least one publication published in the year of download, 
2015. The two entries with the highest percentage of references published between 2010 and 
2015 were the Grief and Bereavement (NGB) and Complicated Grief and Bereavement 
(CGB), both citing more than 50% of references published in a 5-year period prior to the 
review current date. It is noteworthy that these two entries were new entries in 2015 and are 
labelled version 1.0. In 2015, these two entries (NGB and CGB) replaced a single entry 
addressing all issues relating to bereavement. Because these two entries originated in 2015, 
older publications may not have been included in the entry with the result that the proportion 
of articles published in the last five years increased. In contrast, the two entries that have the 
lowest percentage of references published between 2010 and 2015, Acute Otitis Media and 
Chronic Fatigue Syndrome, are on versions 29.0 and 31.0 respectively. The high percentage 
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of articles published prior to 2010 in entries with a higher version number suggests that older 
articles may not be removed or updated when new versions are created.  
Table 5: Overview of publication dates of references cited across the eight professional 
entries 
UpToDate  
Main Entry 
Review 
Current 
Sate 
Earliest 
Publication 
Year 
Most Recent  
Publication 
Year  
Most 
Common 
Year(s) 
(Mode) 
2010-2015 
Acute Otitis 
Media 
08/2015 1980 2015 1999 22% 
(18/81) 
Androgenetic 
Alopecia 
10/2015 1987 2015 2002 29% 
12/41 
Irritable Bowel 
Syndrome 
10/2015 1984 2015 2012 39% 
(35/89) 
Fibromyalgia 11/2015 1986 2015 2008 41%  
(37/91) 
Chronic Fatigue 
Syndrome 
12/2015 1986 2015 2001 22% 
(10/46) 
Grief and 
Bereavement 
11/2015 2000 2014 
 
2005; 2010; 
2011; 2013 
55% 
(11/20) 
Complicated 
Grief 
11/2015 1998 2015 2013 70% 
(21/30) 
Intimate Partner 
Violence 
10/2015 1984 2015 2015 46% 
(13/28) 
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Journal Titles. UpToDate provides a list of 466 key journals that are identified as 
highly relevant and of high quality, which warrant hand-searching by the community of 
physician-authors that is responsible for selecting the evidence to be included in UpToDate. 
Hand-searching is a method that involves the examination of the entire contents of 
preselected journals to identify articles of interest. In this study, these journals are referred to 
as UpToDate’s core journals. Across the eight entries, of the total 427 cited references, 402 
were published articles from a total of 143 journal titles. Of the 143 journals cited, 43% 
(n=62) were part of UpToDate’s core journal list and represented 72% (n=285) of the 402 
cited journal articles. The percentage of references from core journals in each of the eight 
entries is presented in Table 6. Eighty-nine per cent of references cited in the Chronic 
Fatigue Syndrome main entry were published in the core journals. For three topics, Grief and 
Bereavement (normal), Complicated Grief and Bereavement, and Intimate Partner Violence, 
fewer than half of the references cited were published in the core journals.  
 AOM 
n=82 
AGA 
n=41 
IBS 
n=89 
FIB 
n=91 
CFS 
n=46 
NGB 
n=20 
CGB 
n=30 
IPV 
n=28 
Total 
n=427 
% from 
Core 
Journals 
74% 
(61) 
63% 
(26) 
70% 
(62) 
73% 
(66) 
89% 
(41) 
35% 
(7) 
30% 
(9) 
46% 
(13) 
67% 
(285) 
Table 6: Percentage of references cited from a core journal 
The five most cited journals are listed in Table 7. Across the eight professional 
entries, the most commonly cited journal was the Cochrane Database of Systematic Reviews. 
This title is not always considered a journal; however, because of its inclusion in the list of 
journals hand-searched, it is considered a journal for this analysis. The second most 
commonly cited journal was JAMA. Across all the topics the most commonly cited journal is 
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included on the core journal list with the exception of the entries for Normal Grief and 
Bereavement (NGB) and Complicated Grief (CGB) where Death Studies, the most frequently 
cited journal is not included among UpToDate’s core journals. 
Entry Most Commonly Cited Journal  Core 
AOM Pediatric Infectious Disease Journal (n=16) Yes 
AGA Journal of the American Academy of Dermatology (n=13)  Yes 
IBS American Journal of Gastroenterology (n=14) Yes 
FIB Arthritis and Rheumatology (n=18) Yes 
CFS Lancet (n=7) 
American Journal of Medicine (n=7) 
Yes 
Yes 
NGB JAMA (n=2) 
Journal of Palliative Medicine (n=2)  
Death Studies (n=2) 
Yes 
Yes 
No 
CGB Death Studies (n=4) No 
IPV Lancet (n=4) Yes 
Table 7: Most Commonly Cited Journals by UpToDate Main Entry 
 
Types of Evidence Resources. The corpus of cited references (n=427) that make up 
the evidence base of the eight entries is dominated by studies. Sixty-three per cent of the 
cited references are sources located at the study level of the 6S hierarchy of evidence 
whereas only 15% are meta-analyses or systematic reviews from the synthesis level of 
research. Eighteen per cent of the references cited across the eight entries are not types of 
resources identified as evidence in the 6S hierarchy.  
Table 8 describes the distribution of the references across the 6S hierarchy across the 
cases. 
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 AO
M 
n=82  
AGA 
n=41 
IBS 
n=89  
FIB 
n=91  
CFS 
n=46 
NGB 
n=20  
CBG 
n=30  
IPV 
n=28  
Tota
l 
n=42
7  
Not in 6S 
Hierarchy 
3% 
(15)  
22% 
(9) 
12% 
(11) 
8% 
(7) 
15% 
(7) 
45% 
(9) 
13% 
(4) 
50% 
(14) 
18% 
(76) 
System 
 
- - - - - - - - - 
Summary 
 
6% 
(5) 
2.4% 
(1) 
3% 
(3)  
3% 
(3) 
- - - 7%  
(2) 
3% 
(14) 
Synopsis/ Synthesis 
- - - 
2% 
(2) 
2% 
(1) 
10% 
(2) 
- - 
1% 
(5) 
Synthesis 
 
32% 
(14) 
2.4% 
(1) 
17% 
(15) 
21% 
(19) 
11% 
(5) 
15% 
(3) 
10% 
(3) 
18% 
(5) 
15% 
(65) 
Synopsis/ Study - - - - - - - - - 
Study 
 
59% 
(48)*  
73.2
% 
(30) 
67% 
(60)* 
66% 
(60)* 
72% 
(33)* 
30% 
(6)* 
77% 
(23)† 
25% 
(7)† 
63% 
(267) 
RCT 26% 
(21)  
59% 
(24) 
56% 
(50) 
35% 
(32) 
52% 
(24) 
20% 
(4) 
37% 
(11) 
7% 
(2) 
40% 
(168) 
* All studies for AOM; IBS; AGA; FIB; CFS were quantitative studies 
† One study in both CGB and IPV were qualitative studies 
Table 8: Distribution of Resources across the 6S Hierarchy 
 
The entries with the largest percentage of resources not considered to be evidence by 
the 6S hierarchy are in the Normal Grief and Bereavement (45%) and Intimate Partner 
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Violence (50%) cases. The Androgenetic Alopecia entry contained the highest percentage of 
RCTs and the lowest percentage of synthesis articles among its cited references.  
While UpToDate does not explicitly provide formal inclusion and exclusion criteria 
for evidence in the entries, the UpToDate Editorial Policy does suggest that evidence higher 
on the evidence hierarchies is favoured for inclusion:   
UpToDate follows a hierarchy of evidence consistent with most evidence-
based resources. At the top of the hierarchy are meta-analyses of randomized 
trials of high methodological quality, followed by randomized trials with 
methodological limitations, observational studies and unsystematic clinical 
observations. (UpToDate, “Editorial Policy”, 2017) 
 
Evidence hierarchies suggest that finding evidence higher in the hierarchy negates the need 
to evaluate lower level evidence. Across the eight entries analysed, 18.5% of the 351 
references considered in the 6S evidence hierarchy were from the synthesis level. In contrast, 
over three quarters of the evidence cited was from the lowest level on the hierarchy, the 
Studies level. 
In order to understand the availability of systematic reviews evaluating the clinical 
questions addressed within the UpToDate entries, systematic reviews that address the same 
or similar PICO elements (i.e. Patient, Intervention, Comparison, Outcomes) as cited clinical 
trials in UpToDate were identified through a portlet provided by PubMed (see Table 9). In 
the PubMed record for each trial, the portlet provides links to systematic reviews which cite 
that trial. Each individual clinical trial cited in each of the eight entries was evaluated for 
inclusion in a systematic review. The bibliographic information for the citing systematic 
reviews for each was recorded and compared to the reference list of the corresponding entry. 
Systematic reviews identified through the PubMed portlet that were deemed irrelevant to the 
topic were not counted (such as a clinical trial cited in the entry for Chronic Fatigue 
Syndrome that was cited by an article on post-stroke fatigue).  
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*date restrictions applied to limit “Review Current” date 
Table 9: Identification of Systematic Reviews (SRs) cited and not cited in UpToDate 
The level of convergence between the SRs cited in UpToDate and the potentially 
relevant SRs identified by PubMed is quite interesting.  In the entries for Acute Otitis Media, 
Androgenetic Alopecia, Fibromyalgia, Chronic Fatigue Syndrome, and Intimate Partner 
Violence there was at least one potentially relevant systematic review identified through the 
portlet that was not cited in UpToDate. For fibromyalgia, there were 12 systematic reviews 
identified by the PubMed portlet that were not cited in UpToDate. In contrast, only one 
systematic review for Androgenetic Alopecia was identified and it was cited by the authors. 
Generally, it appears that that systematic reviews addressing questions that were similar to 
those addressed in the entries were not always selected for inclusion. While there are many 
reasons that a systematic review may or may not be cited (e.g. perceived quality), UpToDate 
 AO
M AGA IBS FIB CFS CGB NGB IPV 
A.   SRs cited in UpToDate 14 1 15 19 5 3 2 5 
B.   SRs identified in PubMed 
Portlet* 
20 2 28 23 12 3 2 1 
C.   Highly relevant SRs from 
Portlet 
8 0 12 14 3 0 0 1 
D.   Overlap between A and C 5 0 5 2 1 0 0 0 
E.   Potentially relevant SRs 
identified          in Portlet not 
cited in UpToDate 
 
3 
 
0 
 
7 
 
12 
 
2 
 
0 
 
0 
 
1 
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does not provide an explicit statement of how evidence is selected for inclusion.  
Across the eight entries, only two qualitative studies were cited, one each in the IPV 
and CGB cases. In order to gain an understanding of the availability of qualitative research 
that address the case topics, PubMed was searched using search strings targeted at identifying 
qualitative research studies and meta-analysis. (Table 3, Chapter 3 outlines the search 
strategies used.) All searches except AGA retrieved highly relevant and focused qualitative 
research on the treatment of the conditions. The qualitative research retrieved on male 
alopecia were related to hair loss as a symptom of another condition (e.g., cancer). Grief and 
bereavement (subject headings did not differentiate between complicated and normal grief) 
and IPV had the highest number of available qualitative studies. Meta-analyses of qualitative 
research were available for the topics of fibromyalgia, chronic fatigue syndrome, grief and 
bereavement and intimate partner violence, but not cited in the entries. 
Case MeSH Term Qualitative 
Studies 
Qual. Meta-
Syntheses 
AOM "Otitis Media"[Majr] 3 0 
AGA "Alopecia"[Majr] AND "male"[MeSH Terms] 3* 0 
IBS "Irritable Bowel Syndrome"[Majr] 14 0 
FIB "Fibromyalgia"[Majr] 19 3 
CFS "fatigue syndrome, chronic"[Majr] 25 3 
N/CGB ("Grief"[Majr]) OR "Bereavement"[Majr]) 77 4 
IPV "Domestic Violence"[Majr] 167 6 
Table 10: Qualitative Research Assigned with Topic Subject Headings as Major 
Subject 
Location of Study. There were 237 articles describing research studies cited across 
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the eight entries. The majority of studies (58%) were located in the United States. The 
breakdown of what continent each study was conducted in is presented in Table 11. Studies 
located in North American and Europe made up 96% of all studies cited across cases. The 
content of all eight entries in UpToDate was written by authors situated in the United States. 
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 Author
s’ 
Countr
y 
North 
Americ
a 
United 
States 
Europe Austral
ia 
Asia Multi-
nationa
l 
Unkno
wn 
AOM 
n=48 
United 
States 
60%  
(29)  
56%  
(27)  
29%  
(14) 
2%  
(1)  
4% 
(1)  
6% 
(3)  
0% 
(0) 
AGA 
n=30 
United 
States 
70%  
(21) 
67%  
(20) 
10%  
(3) 
0% 
(0) 
10% 
(3) 
7% 
(2) 
3% 
(1) 
IBS 
n=60 
United 
States 
45%  
(27) 
43%  
(26) 
28% 
(17) 
8%  
(5) 
15% 
(9) 
3% 
(2) 
0% 
(0) 
FIB 
n=60 
United 
States 
72%  
(43) 
53%  
(32) 
20%  
(12) 
0% 
(0) 
2% 
(1) 
7% 
(4) 
0% 
(0) 
CFS 
n=33 
United 
States 
36% 
(12) 
36%  
(12) 
53%  
(19) 
0% 
(0) 
0% 
(0) 
3% 
(1) 
0% 
(0) 
NGB 
n=6 
United 
States 
33%  
(2) 
33%  
(2) 
67%  
(4) 
0% 
(0) 
0% 
(0) 
0% 
(0) 
0% 
(0) 
CGB 
n=23 
United 
States 
60% 
(14) 
57%  
(13) 
22% 
(5) 
4% 
(1) 
4% 
(1) 
8% 
(2) 
0% 
(0) 
IPV 
n=7 
United 
States 
86%  
(6) 
86% 
(6) 
0% 
(0) 
14% 
(1) 
0% 
(0) 
0% 
(0) 
0% 
(0) 
Total 
n=237 
 
 
65% 
(154) 
58%  
(138) 
31% 
(74) 
3% 
(8) 
5%  
(12) 
0% 
(0) 
0% 
(0) 
Table 11: Location of Study of Clinical Trials 
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Authorship. The 427 references cited across the eight entries were written by a total 
of 2230 authors. Among these, the highest known proportional representation (.39) of the 
authors were Medical Doctors (MDs) followed by Basic Scientists (.17) (see Table 12). The 
relative proportions of physicians across the eight entries are represented in Figure 23. The 
Acute Otitis Media entry had the highest relative proportion (0.56) of physician authors, 
while the Normal Grief and Bereavement had the lowest relative proportion (0.16).  
 
# of 
Authors 
Not 
Known 
MD Nurse 
Basic 
Scientis
t 
Pharm-
acist 
Public 
Health 
Other 
Prof 
Org 
AOM 
(82) 
376 0.25 0.56 0.01 0.08 0.01 0.00 0.02 0.06 
AGA 
(41) 
203 0.28 0.51 0.01 0.13 0.01 0.01 0.02 0.02 
IBS 
(89) 
534 0.54 0.33 0.00 0.08 0.00 0.00 0.03 0.02 
FIB 
(91) 
531 0.38 0.41 0.00 0.17 0.00 0.01 0.03 0.00 
CFS 
(46) 
259 0.38 0.32 0.01 0.25 0.01 0.01 0.02 0.00 
NGB 
(20) 
88 0.52 0.16 0.00 0.25 0.00 0.00 0.01 0.05 
CGB 
(30) 
127 0.60 0.18 0.00 0.22 0.00 0.00 0.00 0.00 
IPV 
(28) 
108 0.21 0.17 0.06 0.20 0.00 0.01 0.03 0.22 
ALL 
(427) 
2226 0.35 0.39 0.01 0.17 0.01 0.01 0.03 0.04 
Table 12: Background of Authors Across the Eight Cases 
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Figure 23: Relative Proportion of Authors with Physician Background 
 
Because the publication in core journals and the presence of physician authors 
followed a similar pattern across the cases, a two-sample t-test was conducted to determine 
whether there is a relationship between the proportion of physician authors and the 
publication in a journal identified as a core by UpToDate. The t-test indicates that the mean 
relative proportion of authors with a physician background was higher in cited articles 
published in core journals (M=.447, SD=.4) than in non-core journals (M=.2864, SD=.4, 
t(283)=3.87, p < .001, d = .16). (Note that Levene’s test indicated unequal variances (F = 
6.16, p = .433), so degrees of freedom were adjusted from 425 to 283).   
0
0.1
0.2
0.3
0.4
0.5
0.6
Relative Proportion of Authors 
with a Physician (MD) Background
AOM AGA IBS FIB CFS G&B CGB IPV
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Cross-Case Textual Analysis 
Situating the Authors. The degree to which the authors position themselves within 
the content varies greatly across the eight cases. As an indicator of this variance, the terms 
‘we’ and ‘our’ were used 34 times in the Fibromyalgia entry, but never used in the 
UpToDate entry for Intimate Partner Violence.  
The UpToDate authors position themselves in the content and share their expertise 
via the recommendations sections of the entries, although the frequency of explicit 
recommendations varied across the eight entries. Only the authors of the IPV entry chose not 
to make explicit recommendations using the phrases “we recommend” or “we suggest.” In 
the entries for Androgenetic Alopecia and Chronic Fatigue Syndrome, the authors only 
offered an explicit recommendation once. In contrast, recommendations were denoted with 
either the phrase “we recommend” or “we suggest” by the authors of the Acute Otitis Media, 
Fibromyalgia, and Irritable Bowel Syndrome cases 22, 16, and 15 times, respectively. The 
remaining three cases used the explicit phrases between three and 10 times.  
When authors provided explicit recommendations they did so most often by 
addressing the tailoring of treatments to meet patient needs or by providing details as to how 
to best operationalize treatment regimens:  
We suggest initiating therapy with a low dose of a tricyclic 
medication (eg, amitriptyline 10 mg) at night time, especially since 
these drugs are effective, widely available, and far less costly for 
most patients than some of the newer agents. (FIB) 
 
This focus on details about how and to whom to deliver treatment regimens was common 
across the recommendations provided by authors. In the case of IBS, however, the details 
included in the recommendations focused overwhelmingly on the authors’ approach to the 
order of and execution of treatments following up from ineffective or incompatible 
treatments:  
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In patients with IBS with constipation (IBS-C) who have failed a trial of 
soluble fiber (eg, psyllium/ispaghula), we suggest polyethylene glycol 
(PEG). We treat patients with persistent constipation despite treatment 
with PEG with lubiprostone or linaclotide. (IBS) 
 
Because of the differences among IBS patients, particularly in terms of their symptoms and 
their responses to treatments, these patients often undergo multiple attempts to find treatment 
success. The recommendations provided by the authors are intended to assist physicians to 
navigate treatment options over the course of multiple failed treatment attempts. Likewise, 
the entries for Chronic Fatigue Syndrome and Fibromyalgia refer to the need to try multiple 
treatment strategies, although the ordering of attempts was not explicit in these entries. 
In addition to the explicit recommendations indicated by the phrases “we 
recommend” or “we suggest,” the authors also endorse treatment approaches implicitly by 
sharing their approaches to care used within their own practices. For example, the authors of 
the Normal Grief and Bereavement entry implicitly advise against using benzodiazepines for 
patients without mental disorders: “For bereaved individuals who do not have mental 
disorders, we generally do not use benzodiazepines” (NGB). Similar to explicit author 
recommendations, the accounts of the authors’ practices also include specific details about 
how the authors implement treatment. For example, in the Fibromyalgia entry, the authors 
provide details about the ways in which they introduce and increase the drug Milnacipran for 
the treatment of fibromyalgia: 
Milnacipran is an alternative to duloxetine in patients with severe fatigue in 
addition to pain. We initiate therapy with 12.5 mg each morning, gradually 
titrating as tolerated to 50 mg twice daily. Some patients will require a higher 
dose; up to 100 mg twice daily may be needed … In those patients with more 
severe problems with sleep, we use pregabalin taken at bedtime. (FIB) 
 
The authors’ personal accounts of how they provide care for their patients convey an implied 
endorsement of those practices. This sharing of expertise was common in six of the eight 
entries: Acute Otitis Media, Irritable Bowel Syndrome, Fibromyalgia, Chronic Fatigue 
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Syndrome, Normal Grief and Bereavement, and Complicated Grief. 
Though some recommendations were followed up with supporting evidence 
(discussed in detail below in the Situating the Evidence section), explicit recommendations 
were also provided in lieu of or in the absence of strong evidence in the entries for Acute 
Otitis Media, Irritable Bowel Syndrome, and Fibromyalgia. The Acute Otitis Media entry 
provides a good example of authors providing a recommendation in the absence of strong 
evidence: 
There are no randomized trials to guide treatment of recurrent AOM in 
children. […] 
When recurrence occurs within 30 days of completion of antimicrobial 
treatment for the previous episode, we suggest [list of antibiotics]. (AOM) 
 
Similarly, the authors of the entry for fibromyalgia concede that there is limited evidence for 
the drug gabapentin; however, they do acknowledge their own use of the drug as an 
alternative to pregabalin: 
We use gabapentin, for which evidence is more limited, as an alternative to 
pregabalin in patients for whom cost of the medication or regulatory 
requirements limit the use of pregabalin. (FIB) 
 
The entries for Acute Otitis Media, Irritable Bowel Syndrome and Fibromyalgia all contained 
authors’ recommendations in spite of a lack of clear evidence. These recommendations are in 
line with the UpToDate editorial policy, which states: “When there is no published 
systematic evidence available (e.g., prednisone dosing regimen in pulmonary sarcoidosis), 
recommendations are based on the unsystematic clinical observations of our experts and 
reviewers, and on pathophysiologic rationale” (UpToDate, “Editorial Policy”, 2017).  
In the Fibromyalgia entry, the sharing of expertise extended beyond implicit and 
explicit recommendations. Here, the authors provided insight about what they have learned 
from their experiences and ultimately made comparisons between their own experiences and 
the outcomes of clinical trials. When the authors shared knowledge acquired from their 
              176 
 
experiences, they framed that knowledge using the phrase “in our experience.” For example, 
the authors share elements of patient education that they have found to be helpful: “In our 
experience, a discussion of the role of muscle ‘spasm’ and deficient muscle blood flow is 
useful when prescribing exercise and physical therapy” (FIB). The use of the phrase “in our 
experience” makes it clear that this knowledge is coming from their patient encounters. 
The authors of the Fibromyalgia entry are also forthcoming about disconnects 
between their own experiences with patient care and the results and conclusions garnered 
from clinical research. For example, they point out that: “In practice, it has been difficult to 
start and maintain fibromyalgia patients in a structured cardiovascular exercise program, 
because patients generally perceive that their pain and fatigue worsen as they begin to 
exercise” (FIB). Nevertheless, exercise remained a key recommendation for treatment based 
on clinical studies. The authors also refer to their own tacit knowledge:  “Despite the clinical 
trial efficacy, in ‘real-world experience’ the majority of fibromyalgia patients do not achieve 
great benefit from any single medication” (FIB). Here it is not the clinical trial but the real-
world experience of the authors that is used as evidence for ineffectiveness.  
In the entries addressing Intimate Partner Violence and Normal Grief and 
Bereavement, explicit recommendations or sharing of expertise by the authors are largely 
absent. However, within these entries there is also substantial content for which the origin of 
knowledge is unclear and not attributed to a source—neither published evidence nor the 
authors’ tacit knowledge. For example, the authors provide accounts of how people 
experience may react. Similarly, the authors of Intimate Partner Violence describe the 
complexities of providing care for the victim experiencing IPV. The authors here provide 
insight into what clinicians may witness from patients experiencing these challenges, in turn, 
tell the reader what the physician should do.  
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The entry for Intimate Partner Violence was different from all other entries in that the 
authors did not once refer to themselves as “we”. In all other entries, ’we’ references were 
connected to an explicit or implicit recommendation. In the entry for Chronic Fatigue 
Syndrome, the authors apply the term “we” in a unique way not seen in any other entries. 
They twice describe the collective community of clinicians and researchers, in which they 
themselves and the reader belong, in this way. Specifically, the authors encourage clinicians 
to “… emphasize [to the patient] that we have considerable knowledge and experience with 
SEID/CFS” (CFS).   
Situating the Evidence. The descriptive analysis of the eight entries demonstrates the 
dominance of sources of evidence from the Study level of the 6S hierarchy in the UpToDate 
content. While synthesized resources are encouraged, systematic reviews and meta-analyses 
are much less common in the entries than are individual studies, even when these are 
available. There was considerable variability in the extent to which authors provided details 
about and descriptions of the studies and systematic reviews cited in the entries. For some 
evidence, no description was provided, but rather only a parenthetical reference following a 
statement arising from the source conclusions; for others the authors provided extensive 
details about all four elements of the clinical question: the patient, the intervention, the 
comparators and the outcomes (PICO). The outcomes of the study sometimes appeared to 
affect the level of detail provided about it. For instance, in the entry for acute otitis media, a 
single meta-analysis that demonstrated benefit of antibiotic care was described in 
considerable detail while the description of five systematic reviews that do not support the 
use of antibiotics was captured in a single sentence. 
A common attribute often included is the descriptions of a study’s design, particularly 
those using randomized controlled trials, the ‘gold standard’ in EBM hierarchies. The quality 
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and certainty of the results presented in the entries appear to rely heavily on this type of 
study, e.g.: 
No randomized trials have demonstrated that antidepressants are efficacious 
for complicated grief, and these drugs are often not used. However, several 
small observational studies suggest that these drugs may be helpful. (CGB) 
 
In this instance, randomized trials are presented to demonstrate effectiveness, while 
observational studies suggest effectiveness. The inclusion of study design emphasizes the 
importance placed on RCTs as a source of certainty. The authors also emphasized 
information that was based on conclusions from systematic reviews.  
The authors’ choice to highlight study attributes when citing RCTs contrasts sharply 
with their treatment of qualitative studies. Only two qualitative studies were cited across the 
cases, one in the Intimate Partner Violence entry and the other in the Complicated Grief & 
Bereavement entry. In neither instance was the qualitative nature of the study design 
acknowledged by the authors, nor was any information about the study provided other than a 
parenthetical reference.  The authors also rarely acknowledged the type of resource used if 
they cited sources not included as evidence within 6S hierarchy. For example, the authors of 
the Irritable Bowel Syndrome entry note that “Patients with IBS should be advised to exclude 
foods that increase flatulence (e. g., beans, onions, celery, carrots, raisins, bananas, apricots, 
prunes, Brussels sprouts, wheat germ, pretzels, and bagels), alcohol, and caffeine” without 
acknowledging that the source of this information is the Textbook of Gastroenterology. 
While the UpToDate Editorial Policy acknowledges that in some instances “the type of study 
or the data are not stated explicitly,” there does appear to be a pattern in what authors chose 
to highlight (or not).    
In addition to underlining the PICO elements and study design of evidence, the 
authors’ descriptions of the evidence often extended to include depictions of shortcomings 
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within individual research studies and deficiencies within the evidence base as a whole. The 
authors of the entries provided caveats on individual studies based on shortcomings or 
limitations of the research design: 
However, the results of this study should be interpreted with caution due 
to methodological limitations and small sample size. (IBS) 
 
However, many of the studies included in the meta-analyses had increased 
risk of bias (related to nonstringent diagnostic criteria, inclusion of children 
with mild disease, exclusion of patients <2 years of age, use of an 
inappropriate antibiotic or inappropriate dose, etc), making the results difficult 
to interpret. (AOM) 
 
 Across the seven cases authors also point out where more studies and attention are needed to 
create a stronger evidence base and   advocate prudence when they consider evidence to be 
uncertain or inconclusive. 
The authors’ choice to use particular evidence is evident throughout the cases. At 
times, they are transparent about their selection of what they consider to be the best example 
from the evidence available to them. For example,   
The efficacy of these agents was best described in a meta-analysis of five 
placebo-controlled randomized trials (four with pregabalin and one with 
gabapentin) consisting of 2918 patients with fibromyalgia. Compared with 
placebo, active therapy significantly reduced pain and improved sleep and 
quality of life. Evidence in support of the efficacy of each agent is described 
separately below. (FIB) 
  
Likewise, when making recommendations, the authors follow a similar pattern, first 
providing their recommendation for treatment then following up with evidence that supports 
that recommendation. For example, the authors of the Acute Otitis Media entry recommend 
against the use of decongestants and antihistamines and then provide support for the 
recommendation with evidence: 
We recommend not using decongestants and/or antihistamines in the 
symptomatic management of AOM in children. 
Studies of the efficacy of antihistamines and decongestants in treating 
AOM suggest a lack of benefit and a potential for delayed resolution of 
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middle ear fluid. A 2007 systematic review found that decongestants and 
antihistamines alone or in combination were associated with increased 
medication side effects and did not improve healing or prevent surgery or 
other complications in AOM [cited reference, systematic review]. In 
addition, treatment with antihistamines may prolong the duration of middle 
ear effusion [cited reference, study]. (AOM) 
 
Here, the authors supported their recommendation against these two classes of drugs with 
descriptions of studies and systematic reviews that demonstrate a lack of benefit and the risk 
of side effects. The sequence of providing a recommendation and then supporting evidence is 
common in the entries for Acute Otitis Media, Fibromyalgia, and Irritable Bowel Syndrome, 
where recommendations lead the content.  The authors of all eight entries acknowledge that 
multiple treatments have been evaluated unsuccessfully for effectiveness (particularly so in 
the entry for Chronic Fatigue Syndrome) and compare their approaches with clinical practice 
guidelines provided by key associations. 
Situating the Physician-Patient Relationship. 
The authors make overt reference to the physician-patient relationship in the entries 
for Irritable Bowel Syndrome and Chronic Fatigue Syndrome. The authors in the Irritable 
Bowel Syndrome entry advocate that physicians establish a “therapeutic clinician-patient 
relationship” as a key component of treatment. Details about the relationship include 
validation, patient education, and shared decision-making.  Similarly, a supportive approach 
is identified as a treatment strategy in the Chronic Fatigue Syndrome entry, where the 
authors emphasize the importance of providing validation, being honest, addressing patients’ 
concerns without engaging in unhelpful debates and demonstrating a commitment to 
patients’ treatment process. The overt naming of the physician-patient relationship as a 
component of treatment and care occurs only in these two entries.  
While not overtly named, the relationship between physician and patient is also a core 
component of the entries for Intimate Partner Violence and Normal Grief and Bereavement. 
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Intervention in both conditions focuses on interactions between patient and clinician. For 
normal grief, physicians are described not as a main source of bereavement support, but a 
rather natural and important one. Support “for acute grief typically includes empathic 
listening, information about the wide range of typical grief symptoms, reassurance, and 
monitoring.” (NGB). Similarly, the IPV entry emphasize key components of the physician- 
patient interaction:  
The immediate expression of empathy, acknowledgement, and continued 
ability to support and assist the patient are the most important components of 
care after a patient has disclosed abuse. (IPV) 
 
A feature unique to both of the Intimate Partner Violence and Normal Grief and 
Bereavement entries is the provision of authors’ guidance to the reader about how to deliver 
messages of support.  
Validation of the condition as a real illness was a key theme in the entries for Irritable 
Bowel Syndrome, Fibromyalgia, Chronic Fatigue Syndrome, and Complicated Grief and 
Bereavement. In each of these entries, the physicians’ role in reassuring the patient that they 
have a real illness was underlined and emphasized. The authors suggest that patients 
experience a sense of relief when they have a diagnosis of a “treatable condition” (CGB).  
While not an illness, the importance of validation is also recognized in the entry for Intimate 
Partner Violence. Validation is a key element of care across five of the eight entries. 
With respect to decision-making, two of the entries place responsibility with the 
patient. In the IBS entry, the authors call explicitly for the involvement of the patient in 
decision-making: “The clinician should establish realistic expectations with consistent limits 
and involve the patient in treatment decisions” (IBS). In the IPV entry, decision-making is 
situated overtly and solely as the responsibility and right of the victim. Here, the authors 
underline repeatedly that the patient’s autonomy and choice is paramount. They advocate 
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that: “Patients should be allowed to make autonomous decisions regarding health advice” 
(IPV). In contrast, in six of the eight entries, the primary responsibility for decision-making 
is implicitly or explicitly situated with the physician. Presenting decision-making as the sole 
responsibility of physicians conflicts with key clinical practice guidelines including those of 
the American Academy of Pediatrics and the American Academy of Family Physicians. 
Throughout all eight entries, the authors develop content for physicians rather than a 
wide variety of health care providers. The majority of the care, including pharmaceutical 
treatments, described in the eight entries is treatment delivered by physicians, although the 
authors of the entries for Irritable Bowel Syndrome, Fibromyalgia, Chronic Fatigue 
Syndrome, and Intimate Partner Violence do acknowledge the need for care beyond that 
provided by physicians. For example, the authors of the Irritable Bowel Syndrome entry 
mention the need for professional dieticians to provide dietary education if patients are 
placed on a low FODMAP diet. Similarly, the authors of the Chronic Fatigue Syndrome 
entry call for an exercise therapist to supervise a graded exercise therapy program. The 
entries for FIB and IPV advocate for interdisciplinary care more broadly. For example: 
“Ideally, treatment should include an integrated, multidisciplinary 
nonpharmacologic and pharmacologic approach, but there have been 
relatively few trials that have formally evaluated such a combined approach to 
therapy.”  (FIB) 
 
The authors of the IPV entry also advocate for care by multiple professionals asserting, “Care 
of the patient experiencing IPV requires a team approach involving medical, institutional, 
and community resources” (IPV). While the content does not address the delivery of 
treatment and care delivered by professionals across the health professions, there is 
recognition of need for interprofessional care.  
The analysis of the patient information provided in the entries for Acute Otitis Media, 
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Fibromyalgia7, Chronic Fatigue Syndrome, and Irritable Bowel Syndrome further provides 
insight into the positioning of the patient within UpToDate. The patient information for these 
four conditions both diverges from and converges with the clinician information 
(interestingly, no patient information is provided for the entries for Normal Grief and 
Bereavement, Complicated Grief, or Intimate Partner Violence).  
Like the clinician information, the patient information for Fibromyalgia, Chronic 
Fatigue Syndrome and Irritable Bowel Syndrome acknowledge that there are treatments to 
alleviate symptoms, but physicians are not currently able to cure these conditions. Similarly, 
the lack of understanding and knowledge about these conditions is highlighted. For example, 
the Beyond the Basics patient information for FIB states that “despite ongoing research, the 
cause, diagnosis, and optimal treatment of fibromyalgia are not clear” (Beyond FIB). CFS 
advice repeatedly highlights the authenticity of the condition and validates the patient 
experience. The long-term trial and error nature of treatment for IBS is acknowledged in the 
patient information. Patients with IBS are encouraged to be open to treatment options, but 
recognize the need for long-term management. 
Compared to the clinician entries, decision-making is presented as a more 
collaborative process in the patient information for FIB, CFS, and the Basics patient 
information for AOM. Patients are encouraged explicitly to communicate with their health 
professionals and to work together as a team. In contrast, the responsibility for decision 
making in the clinician entry and the AOM Beyond the Basics is assigned primarily to 
physicians.   
The central role of patients in non-pharmacological approaches to treatment is 
                                                 
7 Because the content of the Beyond the Basics was directed towards clinicians and written at a very 
high level of sophistication, the cross-case analysis focuses on The Basics patient information for 
Fibromyalgia included in UpToDate 
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emphasized in the patient information for AOM (i.e., monitoring, follow-up), IBS (i.e., 
exercise, symptom monitoring, dietary modifications), FIB (i.e., maintaining a positive 
attitude, exercising), and CFS (i.e., exercise). For example, patients are encouraged to 
understand, monitor, and alter their fibre intake: “By reading the product information panel 
on the side of the package, you can determine the number of grams of fiber per serving” 
(IBS, Beyond). While patients are rarely recognized as decision-makers, the patients are 
encouraged to take an active role in their care through non-pharmacological treatments. 
These patient activities and roles are similarly emphasized in the main clinical entries. 
Although largely absent in the clinician entries, psychological elements and factors 
are overtly acknowledged in the patient information for AGA, IBS, FIB and CFS. There were 
also other examples of divergences between the clinicians’ entry and patient information 
provided by UpToDate.  For instance, in the AOM Beyond the Basics patient information, 
the authors included the side effects and risks of antibiotic use, although this was absent in 
the information for clinician.  Similarly, only in the Beyond the Basics entry is the preference 
to try non-pharmacological approaches for treating IBS prior to medications recommended.  
It is possible that such discrepancies between the information directed toward clinicians and 
patients may contribute to misunderstandings during the clinical encounter.  
Circuit of Culture 
In order to bring insight to the position and meaning of UpToDate in medical and 
information fields, Hall’s Circuit of Culture was applied to the cross case analysis. 
Specifically, an increased understanding of UpToDate emerges using the five elements of the 
Circuit of Culture: representation; production; consumption; identity; and regulation (du Gay 
et al., 1997).  
UpToDate is a commercial product that evolved from an identified need and 
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opportunity within medical practice (production). Specifically, the producers and publishers 
of UpToDate responded to the observation that medical doctors were confronted with 
countless clinical questions that require nuanced approaches. Concurrently, physicians were 
faced with an overabundance of research-based evidence, and the emerging imperatives of 
evidence-based practice, that required intense translation to be deemed applicable for clinical 
practice. In response, UpToDate was developed to sell evidence packaged by physicians, for 
physicians. UpToDate recognized the value that physicians place on consultations with other 
physicians as a source of information and expertise; as such, the product is closely associated 
with physician-experts as content producers. UpToDate represents clinicians’ desire for 
certainty in clinical decision-making (representation). Physicians’ certainty is increased by 
invoking the available evidence as part of recommendations made by fellow physicians, 
themselves recognized as topic experts.  
While the creators do not publish a systematic and explicit framework or policies for 
the development of content in UpToDate, the content is organized and regulated by the 
norms and conventions of EBM, including evidence hierarchies (regulation). For example, as 
noted above, the principles of EBM most value systematic reviews and randomized 
controlled trials, and therefore privilege such sources for inclusion in the point-of-care tool. 
UpToDate is used by students and clinicians faced with clinical uncertainty (consumption), 
and, laterally, by patients (directly or via their physicians). Physicians and medical students 
(largely unquestioningly) accept and use UpToDate as its creators intended it, as an 
evidence-based clinical tool. This use aligns with Hall’s concept of the ‘preferred reading,’ 
meaning that the audience (i.e. the users of UpToDate) use the product the way the producers 
intended (Hall, 1980). UpToDate closely identifies itself with the author-experts. UpToDate 
is thus marketed as “an evidence-based, physician-authored clinical decision support 
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resource which clinicians trust to make the right point-of-care decisions” (UpToDate, “About 
Us,” 2017). While UpToDate is marketed and consumed as an evidence-based tool, the 
notion that it is produced and consumed by trustworthy and responsible physician-experts is 
central to the identity of UpToDate (identification). The experience and status of the authors 
is underlined by UpToDate: “Although these physicians serve on the faculty of prestigious 
medical schools, practice medicine, and in some cases conduct groundbreaking research, they 
repeatedly carve time from their demanding schedules to contribute to UpToDate” 
(UpToDate, “Physician Authors and Editors,” 2017).  For UpToDate, the authors’ identity as 
trusted and prestigious experts is key to bringing together evidence and practice for 
practicing physicians. 
Summary of Results 
Evidence Selection 
In the absence of transparent, clear, and systematic guidelines for the production of 
content for UpToDate, the selection of evidence is loosely aligned with the commonly 
accepted guidelines of evidence-based medicine. For example, systematic reviews and 
clinical trials highly valued within evidence hierarchies were commonly privileged for 
selection by UpToDate authors. In contrast, evidence sources often overlooked in evidence 
hierarchies (such as qualitative research) were very rarely included.  
Authors selected evidence for their entries from a large corpus of research. In order to 
better understand what is overlooked or omitted as evidence for UpToDate, searches aimed at 
understanding the body of literature from which evidence was selected were completed. For 
each topic two targeted searches were performed: one to identify systematic reviews 
addressing clinical questions similar or the same as those addressed in the entry, and one to 
identify qualitative research on the topics of the cases. The availability of systematic reviews 
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and qualitative research varied across the topics. For example, the UpToDate entry for 
fibromyalgia cited the most systematic reviews, yet the targeted search still identified the 
highest number of potentially relevant systematic reviews that had not been cited. In contrast, 
while the fewest systematic reviews and the greatest number of clinical trials were cited in 
the entry for androgenetic alopecia, no additional systematic reviews were identified in the 
targeted search.  Despite a robust body of clinical trials there appeared to be a dearth of 
systematic reviews available on the topic. For androgenetic alopecia, this lack of systematic 
reviews may reflect the commercial investment in trials of treatment, but not the synthesis of 
the trials. This analysis demonstrated that additional systematic reviews addressing clinical 
questions similar to those addressed in the entry were available. However, in the absence of 
clear guidelines by UpToDate, the reasons reviews were or were not cited are not known. 
The targeted searches indicated that availability of qualitative research varied for each 
topic. Not surprisingly, searches identified the largest bodies of qualitative research for the 
topics of grief and bereavement and intimate partner violence, both of which have prominent 
social, emotional, and psychological features. Qualitative meta-analyses, which aims to 
synthesize a large body of qualitative studies, were also identified for the topics of 
fibromyalgia, chronic fatigue syndrome, grief and bereavement, and intimate partner 
violence. Although qualitative research was often available, across the eight topics, only two 
qualitative studies were cited (neither of which were syntheses). Qualitative research helps to 
provide increased understanding of the patient experience of illness from the patient 
perspective, and this knowledge is largely absent from the content of UpToDate. 
In addition to methodological approaches to research, other commonalities also 
existed across the evidence selected for inclusion. For example, although the authorship of 
the evidence cited was made of up many professional backgrounds, the voice of the 
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physician was dominant. . Only in the cases of Grief and Bereavement and Intimate Partner 
Violence did non-physician authors equal or slightly exceed the numbers of physician-
authors. The journals that UpToDate identified as key journals for evidence selection (core 
journals) were heavily called upon and also further favoured the physician voice. Not 
surprisingly, the physician-authors favoured the expert voice of fellow physicians. The 
favouring of like-voices also transferred to the location of the studies cited. The content of all 
eight entries was written by physicians situated within the United States. Similarly, research 
that was located with the context of the United States was more commonly cited than 
research undertaken in other countries. While research is often transferrable across sites, it is 
reasonable to expect that the availability of drug and treatment options and coverage may 
vary across nations. This is noteworthy because UpToDate is widely marketed for use around 
the world. UpToDate is used by physicians in more than 187 countries across the globe 
(UpToDate, “Around the Globe”, 2017). While the content of UpToDate is only available in 
English, the search is available in nine languages. The emphasis on American authorship and 
research seems a divergence from the international marketing focus.  
Situating the author, the evidence, and the patient-physician relationship 
Authors situated themselves as experts sharing their knowledge and guidance within 
the entries. Suggestions and professional guidance, made explicitly or implicitly, by the 
authors often focused on operationalizing treatment regimes in practice to meet the needs of 
individual patients. Author recommendations for treatment were also provided when the 
literature base lacked strong evidence to address a clinical question. How the authors position 
themselves in the content varied across the eight cases. For example, much of the content of 
the entry for Acute Otitis Media was situated as emerging from the authors’ expertise. In 
contrast, the authors of the entry for Intimate Partner Violence referred explicitly to 
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themselves as a source of expertise only once. While some authors appear to be cautious 
about positioning themselves explicitly, their experiences, expertise, and tacit knowledge are 
present within all eight entries. 
The evidence selected by the authors for inclusion in the entries was generally 
situated within the entry as support for the authors’ implicit and explicit recommendations. 
For selected evidence, the authors’ provided detailed descriptions of the study design, patient 
population, and outcomes of the research. Robust descriptions often were included for 
clinical trials and systematic reviews which clearly supported authors’ recommendations. 
Authors sometimes provided commentary on the quality and quantity of evidence available 
on the topics. In the absence of a clear and consistent framework for the topics, the authors 
selected, presented, and used the evidence in ways that supported their approach and their 
recommendations. 
The patient-physician relationship was not situated prominently across the entries. 
The patient’s role in decision-making was nearly absent across the entries, with the exception 
of the entries for Intimate Partner Violence and Irritable Bowel Syndrome. The importance 
of the physicians’ role in validating the condition as ‘real’ was a key element for entries for 
the more contested conditions: Irritable Bowel Syndrome, Fibromyalgia, Chronic Fatigue 
Syndrome, and Complicated Grief. Where included, the patient information provided 
additional insight as to how the patient is situated in UpToDate, but key elements of the 
patient-physician relationship, such as decision-making responsibilities, sometimes appeared 
to contradict content in the expert entry.  
The Circuit of Culture and the Emergence of Expertise 
Applying the Circuit of Culture provides additional understanding of the position and 
meaning of UpToDate within the health and information environments. UpToDate is 
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represented and consumed as an evidence-based clinical tool; however, concurrently, 
expertise emerges prominently across the five elements of the Circuit of Culture: 
representation, production, consumption, identity, and regulation. UpToDate is produced for 
physicians, by physicians and the analysis using Circuit of Culture suggests that expertise is 
an important facet in securing the meaning and position of UpToDate in the health 
information environment. The content producers of UpToDate do not follow a rigid 
framework as often associated with evidence based medicine resources. Instead, they 
interpose their experience and expertise with the evidence in order to increase the 
applicability of evidence to clinical practice. The emergence of expertise across the five 
elements of the Circuit of Culture points to ways in which UpToDate may bridge evidence 
with the realities of clinical practice.  
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Chapter 4: Discussion and Conclusion 
Discussion 
Findings from this study illustrate what evidence and whose voices are privileged in 
the process of creating clinical guidance for the widely used information tool, UpToDate. 
The analysis of the seven cases reveals that physician-authors are situated not only as writers 
and creators, but also as sources of expertise. While the ways in which the authors enact or 
position their expertise varies, the authors incorporated their own recommendations, 
suggestions, and clinical experiences, as well as their tacit knowledge into each of the entries 
studied. In the absence of explicit guidelines, the authors chose evidence to support their 
recommendation, loosely adhering to the principles of evidence-based medicine. The 
permeation of expertise across the five components of Hall’s Circuit of Culture reinforces the 
importance of expertise in UpToDate. From the overall analysis, UpToDate emerges as a 
potential surrogate for consultation and knowledge-sharing between physicians, traditionally 
performed through face-to-face interactions. Specifically, those engaged in the production of 
UpToDate are not simply intermediaries who replicate information, but rather are mediaries 
who transform, translate, and modify information for consumption (Latour, 2005). Through 
the mediary functions of the producers, UpToDate becomes a technological surrogate and 
performs the roles of ‘Curbside Consultant’ and ‘Mentor’.  
UpToDate within the EBM Landscape 
Although evidence-based medicine was conceived by David Sackett as an approach 
to practice that promoted the application of evidence within the context of clinical judgement 
and patient needs and preferences, it quickly evolved into a structured set of rules and 
guidelines that privileged and excluded certain types of information and knowledge. While 
the focus on evidence was intended to move clinical practices away from anecdotes, habits, 
              192 
 
and traditions, the first decade of the evidence based medicine movement created an 
overabundance of evidence that had limited application to clinical settings. Clinical trials, 
synthesized bodies of trials, algorithms, and rules have not been able to adequately address 
the complex realities facing individual patients. As such, in recent years, the value of 
applying a broader range of knowledge to clinical questions, beyond the data provided by 
studies, is increasingly being integrated into the practices of evidence-based medicine. 
Likewise, there is an increased recognition of the uncertainty inherent in evidence, as well as 
appreciation of the importance of psychosocial elements of care, patient experiences, and the 
physicians’ expertise. In the last decade, new models are evolving in order to integrate 
expertise and uncertainty into evidence tools in a systematic way. One such example is 
GRADE, the Grading of Recommendations Assessment, Development and Evaluation 
approach, which produces a rating of the quality of a recommendation based on transparent 
criteria of the evidence including study design, risk of bias, imprecision, inconsistency, 
inconsistency, indirectness, and magnitude of effort (Guyatt, Oxman, Vist, Kunz, Falck-
Ytter, Alonso-Coello, et al., 2008), while also considering issues such as acceptability (to 
providers and patients), feasibility and equity. The systematic and transparent process leads 
to the classification of recommendations along a continuum, from conditional to strong, 
which also leaves room for the emergence of new, potentially different, evidence and 
knowledge. 
In seven of the eight entries analysed in this study, the UpToDate authors applied a 
final assessment of the evidence with a GRADE ranking, but the structured process was not 
applied or shared. Similar to the ways that evidence is selected following overarching EBM 
principles in the absence of an explicit and systematic process, the comprehensive and 
transparent steps of the GRADE process were not followed. Instead, the authors loosely 
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applied these principles, choosing to address and expand the evidence through their own 
narratives, tacit knowledge and expertise. This expertise appears to emerge as a critical 
component of UpToDate’s capacity to bridge evidence and practice. 
The Emergence of Mediary Roles  
Examining how physician expertise permeates the five components of the Circuit of 
Culture is useful for understanding the techno-social aspects of clinical practice tools, such as 
UpToDate, which can act as surrogates for traditional physician interactions and knowledge 
sharing in face-to-face contexts. As Champ and Brooks (2010) explain:  
those promoting the circuit of culture argue that, even more than recognizing 
these separate locations of meaning-making activity, we must attempt to 
account for the interrelation of the five processes of representation, identity, 
production, consumption, and regulation… It is the researcher’s task to 
identify and describe how particular meanings result from the overlap of these 
processes. (pp. 576-577) 
 
A key role of UpToDate authors, the content producers, is to provide expertise to the 
consumers of the UpToDate product. Expertise, in turn, becomes an important element of the 
representation, identity, and regulation of the tool. Through the provision of expertise, the 
authors of UpToDate are not simply intermediaries who reproduce information without 
modification, but rather, are mediators who transform, distort, translate and modify the 
meaning of the information they convey (Latour, 2005). Content producers are mediators 
positioned “between the information sources [the evidence] and the information seekers 
[physicians]” (Wyatt, Harris & Wathen, 2008). In 2008, Wyatt, Harris, and Wathen used this 
framework to construct the concept of info(r)mediation wherein health information (or in this 
case, evidence) is translated and transformed to effect changes in thinking, behaviour, or 
attitude. In this case, the physician-authors of UpToDate attempt to effect change in, or at 
least guide, others’ clinical practice.  
The overt recognition of the mediator function of the content producers is critical 
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because the hierarchies, rules, and guidelines of EBM can “become a form of collective 
forgetting, or naturalization, of the contingent, messy work that they replace” (Bowker & 
Star, p. 299). Providing evidence to guide physicians in answering multifaceted clinical 
question is “messy work” and can often be concealed by the presentation of EBM’s 
somewhat facile rules and frameworks (Wieringa, Engebretsen, Heggen & Greenhalgh, 
2017). To recognize content producers and the subsequent technologies/tools that collect and 
share medical evidence not as intermediaries, but as mediators, ensures that the social 
elements and the complexity of the process of creating ‘practice-ready’ advice are 
acknowledged.  
Through their sharing of clinical experiences, expertise, and judgement, UpToDate’s 
authors are key mediators who exist between the evidence and the information users and are 
integral to creating a technological surrogate for key physician interactions, specifically, as a 
Curbside Consultant (Findling, Shaker, Brickner, Riordan & Aron, 1996; Kuo, Gifford & 
Stein, 1998) and as a Mentor (Balmer, D’Alessandro, Risko, Gusic, 2011; Taylor, Taylor & 
Stoller, 2009).  
UpToDate as Curbside Consultant  
In much of the content analyzed in the cases included in this study, authors are 
prominent not only as the selectors and interpreters of evidence and content, but as sources of 
clinical expertise. The UpToDate Editorial Policy highlights that evidence is not enough to 
make decisions, but rather clinical expertise “is required to move from evidence to 
recommendations” (UpToDate, “Editorial Policy,” 2017). Further, the Editorial Policy 
defines expertise as the ability to address what evidence cannot. Specifically, the Policy 
points to Guyatt and colleagues’ observation that evidence cannot address “the benefits and 
risks, inconvenience, and costs associated with alternative management strategies, and … the 
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patient's values” (Guyatt, Rennie, Meade & Cook, 2002). This type of knowledge is often 
attained through experience, a key contributor to the attainment of expertise (Haynes, 2002).  
The sharing of clinical expertise is reflected in the authors’ provision of recommendations, 
suggestions, and experiences, and is a key component of building a resource “which 
clinicians trust to make the right point-of-care decisions” (UpToDate, “About Us,” 2017). As 
reflected in this statement, UpToDate is situated as a trusted colleague upon whom 
physicians would call for advice. Positioning UpToDate as a trusted colleague aligns with 
longstanding research recognizing the value of colleagues in physician information seeking 
and decision-making (Dawes & Sampson, 2003; Leckie, 1996; Verhoeven et al., 1995). 
Toward this end, the content producers provide recommendations for treatment, made 
explicitly or implicitly, across all cases examined. While, “[i]t is the policy of UpToDate to 
make specific recommendations for patient care whenever possible” (UpToDate, “Editorial 
Policy,” 2017), explicit recommendations were most prevalent in the entries for Acute Otitis 
Media, Fibromyalgia, and Irritable Bowel Syndrome. Further, in alignment with the 
UpToDate Editorial Policy, recommendations were often denoted with the phrase ‘we 
recommend’ or ‘we suggest’. The use of the collective first person pronoun implicitly 
denotes that the recommendation is emerging from the individual (albeit collective) 
experience and expertise, rather than directly from the evidence. Explicit recommendations 
most often provided details about how to implement or tailor treatments to best meet the 
needs of specific patients.  
Because there are recognized challenges in effectively applying the results of 
structured research studies to the complexities of practice (Greenhalgh, 2002; Greenhalgh & 
Weiringa, 2011; May et al., 2006; Tonelli, 1998), recommendations are rarely a reiteration or 
intermediation of research conclusions. EBM requires clinicians to translate the results of 
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RCTs or systematic reviews into a treatment plan for an individual (May et al., 2006). For 
example, unavoidably, the patients who comprise the subject base of a given study, often 
those most likely to be responsive, do not necessarily or precisely reflect the population seen 
by physicians in their clinics (Daly, 2005). The authors of UpToDate attempt to address this 
limitation of evidence by sharing their expertise and experience as a means to provide 
recommendations for tailoring treatment for an array of patients. Such recommendations, 
shared by the expert authors in UpToDate, reflect the “experiential know-how” of tacit 
knowledge (Abidi, Cheah & Curran, 2005, p. 193). Abidi et al. provide a simple 
differentiation between explicit and tacit knowledge in health care: Explicit knowledge is 
documented and articulated knowledge presented in the published medical literature and 
presents “how things should work”; while tacit knowledge focuses on “what really works and 
how to make it work” and embodies experiential know-how, personal skills, and intuitive 
judgment (p. 194). At times, the tacit knowledge shared by the authors in the analysed entries 
seems to be in conflict with the explicit knowledge presented in the published literature. For 
example, the authors of the entry for Fibromyalgia are very direct about their perception of 
the lack of effectiveness of a single medication in the “real-world”, despite promising study 
outcomes: 
Despite the clinical trial efficacy, in “real-world experience” the majority 
of fibromyalgia patients do not achieve great benefit from any single 
medication. (FIB) 
 
Because tacit knowledge relies heavily on personal experiences (anecdotes), individuals with 
familiarity and expertise often share their tacit knowledge through personal exchanges 
(Panahi, Watson & Partridge, 2015). In health care, informal interactions during which 
physicians share their expertise and guidance as it relates to patient care are referred to as 
curbside (or hallway) consultations. Curbside consultations are informal physician-to-
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physician information exchanges regarding the management of a particular patient, without 
the consultant seeing the patient or keeping any written record (Findling, Shaker, Brickner, 
Riordan & Aron, 1996; Kuo, Gifford & Stein, 1998). Information studies scholars have long 
recognized interpersonal resources as a key information source of physicians (Dawes & 
Sampson, 2003; Elayyan, 1988; Haug, 1997; Leckie, 1996; Verhoeven et al., 1995), and such 
interpersonal sources continue to be central avenues—primarily due to ease of accessibility 
and time efficiency—through which physicians seek answers to clinical questions (Andrews, 
Pearce, Ireson & Love, 2005; Clarke et al., 2013; Gonzalez-Gonzalez et al., 2007). Increasing 
workloads and pressure to see more patients may “squeeze out the time that previously 
allowed them to provide curbside consultations” (Cook, Sorensen, & Wilkinson, 2014, p. 
606).  Clinicians may feel uncomfortable imposing on the busy schedules of their colleagues 
to ask for guidance and advice. Additional challenges in curbside consultations identified by 
Cook et al. include incomplete or misinformation, trouble accessing an expert, and 
communication barriers. It may be challenging in the context of a fragmented and busy 
health care system to conduct meaningful curbside consultations and so the popularity of 
UpToDate may indicate a shift from interpersonal to new digital resources as a source of tacit 
knowledge.  
UpToDate as Mentor  
In addition to providing tacit knowledge about how to implement treatment regimes 
in ‘the real world’, UpToDate authors also share their tacit knowledge in relation to what to 
expect from the patient encounter. Specifically, most of the entries analyzed for this study 
include authors’ perceptions of the patient experience, advice on how to navigate the patient-
physician relationship, and descriptions of the challenges in providing care, especially to 
those with contested and uncertain diagnoses, treatment and outcomes. The sharing of this 
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type of tacit knowledge aligns with the mentorship that occurs in the clinical setting. The role 
of senior physicians in providing socialization, guidance, and modeling for younger 
colleagues is a long-standing and important tradition in medicine (Boudreau, Macdonald & 
Steinert, 2014; Cruess, Cruess, Boudreau, Snell & Steinert, 2015; Kenny, Mann & McLeod, 
2002). The information shared about the patient-physician encounter is akin to the tacit 
knowledge shared from mentor to mentee. 
The authors provide detailed guidance to the reader about how to navigate the patient-
physician encounter. For example, they suggest that those experiencing normal grief and 
bereavement will appreciate “condolence letters, telephone calls, attending the funeral or 
memorial service, and home visits” (NGB).  In the entries for Intimate Partner Violence and 
Grief & Bereavement, the authors provide talking points and scripts to help physicians speak 
with patients. The authors also detail what information physicians should provide to patients 
to ensure proper follow-up and self-care.  
In addition to providing guidance about navigating the patient-physician relationship, 
UpToDate also brings readers’ attention to features of certain conditions that physicians may 
find challenging. For example, authors warn readers that doctors “will not be able to satisfy 
all patients with [chronic fatigue syndrome]” (CFS), patients will “take up a great deal of 
time” (CFS), and doctors “may be surprised or frustrated” (IPV). The authors emphasize that 
these conditions are not simple or easy to treat.  While the evidence establishes that no 
treatment can cure these conditions, the authors’ sharing of professional challenges helps 
prepare the reader for interactions with patients. The authors’ experiences and tacit 
knowledge of the difficulties faced in practice is also validating to the reader—and is a form 
of emotional and psychological support—one of the key components of the mentorship 
relationship (Balmer, D’Alessandro, Risko, Gusic, 2011; Taylor, Taylor & Stoller, 2009).  
              199 
 
While UpToDate entries may help to prepare physicians for patient encounters, 
especially potentially difficult ones, the authors in these cases place little emphasis on the 
role and experience of the patient. For example, the patient’s role in decision-making was 
largely ignored in most of the entries directed at clinicians.  In the majority of cases 
examined, authors position the physician as the primary decision-maker, either by explicitly 
stating so or by not mentioning the patient when discussing treatment options in the 
professional entries. The physician is, explicitly or implicitly, the individual given primary 
responsibility for decision-making in all professional entries except Intimate Partner 
Violence. The focus on the physician in decision-making can be contrasted against the patient 
information entries which were more likely to suggest a greater decision-making role for the 
patient. By placing the responsibility for decisions solely with the physician in the 
professional entries, UpToDate may in fact reinforce the patriarchal doctor-centred model of 
medicine and, simultaneously, through the patient education material that appears to 
contradict this message, set up potential conflicts as a result of  competing expectations in the 
physician-patient encounter.  
The emphasis on physicians’ roles in decision-making found in these case entries 
aligns with the literature addressing the socialization of medical students. Specifically, the 
teachings of patient-centred care and the role of patients in their own care, which are often 
provided early in the medical curriculum and often delivered in the preclinical classroom 
sessions with medical students, may be overshadowed by the informal “hidden curriculum” 
represented in the experiences and socialization to which students are exposed during their 
clinical education (Hafferty, 1998; Haidet et al., 2002). Medical students have demonstrated 
an increase in doctor-centred attitudes and a decrease in patient-centredness as they moved 
from their pre-clerkship (classroom) training to clinical training (Haidet et al., 2002; Hur, 
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Kim, Park, Cho & Choi, 2014). This may be a result of the students’ observations of the 
“dissonance between didactic concepts from the curriculum and observed medical practices” 
(Gallentine, Salinas-Miranda, Bradley-Klug, Shaffer-Hudkins, Hinojosa & Monroe, 2014, p. 
95).  Because UpToDate is used heavily by medical students, medical residents and new 
medical professionals, the mentorship role of UpToDate has the potential to reinforce the 
hidden curriculum of medicine by de-emphasizing the patient in clinical decision-making. 
Additionally, the authors’ description of the patient experience via imparting their personal 
perceptions, rather than calling upon research, may further reinforce the potential for doctor-
centred approaches over patient-centred approaches, as well as re-affirm the position of 
UpToDate as mentor.  
As noted above, qualitative research was almost entirely absent in the content 
analysed. Despite the availability of qualitative research for all but one topic, only two 
qualitative studies were cited across all eight entries. As such, patient experience was 
presented through the eyes and experiences of the physician, not of the patient. For example, 
the authors of the Chronic Fatigue Syndrome entry explain that “[b]ecause of the lack of 
laboratory abnormalities, most patients struggle with the validity of their disease (as do many 
of their clinicians) and may experience feelings of guilt” (CFS). While the authors describe 
what they commonly see in their practice, this information is not situated in the documented 
lived experiences that would evolve from a qualitative study. For example, participants in 
Winger et al.’s (2014) phenomenological study describe adolescents with CFS observing 
their teachers’ doubt and skepticism of their condition through body language and 
disbelieving glances. The study emphasized the participants’ feelings of disrespect and 
isolation (Winger, Elstedt, Wyller & Helseth, 2014). Qualitative research attempts to capture 
patients’ complex and multifaceted lived reality. The lack of inclusion of qualitative evidence 
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that captures the illness experience through the lens of the patient may re-enforce the 
dominance of the physician perspective. 
The authors of UpToDate entries attempt to assist physicians through the patient 
encounter, providing guidance and advice, disclosing their practices, and sharing 
experiences. This type of information sharing is an essential element of the apprenticeship 
model of medical education. In the cases examined in this study, the authors seem 
(consciously or unconsciously) to replicate these practices and roles that they have 
experienced as trainees and enacted as mentors. 
Summary 
This analysis, which situates authors, evidence and the patient-physician relationship 
within UpToDate, reveals how the function of UpToDate extends beyond that of merely 
providing a quick summary of evidence. Through the lens of the Circuit of Culture, expertise 
emerges as an important element in the role and meaning of UpToDate in the information 
landscape. UpToDate represents an attempt to address documented gaps between evidence 
and practice. In particular, the evidence contained within hierarchies such as 6S that are 
called upon to inform summary resources appear to be a poor fit when it comes to addressing 
the complex needs of individual patients, the need for tailored care, and the challenges of the 
patient-physician interaction. Within this research, UpToDate is revealed to be a mediator, 
rather than an intermediary, between evidence and clinicians. Specifically, the function of 
UpToDate extends to include the roles of mentor and curbside consultant. In these roles, 
UpToDate emerges as not only a supplement to, but a technological surrogate for human 
interaction and expert consultation. The challenges embedded within these surrogate roles 
also mirror those of the human interaction. This dominance of the author in describing the 
patient experience, alongside the tendency to place decision-making responsibility with the 
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physician, may lead UpToDate to reinforce doctor-centered care, as well as perpetuate the 
much criticized ‘art of medicine.’  
Limitations and Future Research 
Two potential limitations of the current study that may limit the applications of the 
findings are: 1) the selection of entries to represent specific phenomena, rather than, for 
example, a random selection; and 2) the selection of a single summary resource. While the 
selection of eight entries, representing seven topic cases, aligned with the principles of 
qualitative research and case study methodology (Cresswell, 2007; Stake, 2006; Yin, 2009), 
the extent to which these findings are generalizable across all entries is unknown. These eight 
entries were chosen from more than 9,500 topics across 24 specialties. Case study research 
allows the researcher to purposefully select cases that represent different contexts for 
phenomenon of interest to exist (Stake, 2006). The criteria used to select the eight entries 
were to represent varying levels of medicalization, certainty, and contestation within the 
cases. These eight entries are not, and are not intended to be, representative of all 9,500 
topics. Many of the topics addressed in UpToDate are conditions with recognized organic 
causes and have a widely accepted level of certainty in their aetiology, treatment and 
outcomes. Additional research is required to evaluate the generalizability of the themes and 
analyses from in this study across the numerous topics of UpToDate. For example, future 
research may explore how the authors, evidence, and patient-physician relationship is 
situated in acute conditions, rare diseases, or conditions that are not considered to be 
contested or medicalized. 
UpToDate is one example of point of care resources occupying the Summary level 
from the 6S Model. Across the literature, UpToDate is consistently reported to be the most 
useful product for answering clinical questions (Ahmadi et al., 2011; Campbell & Ash, 2006; 
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Thiele, 2010) and is cited to change the way physicians manage patients (Isaac, Xheng & 
Jha, 2012). Other resources situated on the Summary level of evidence include DynaMed, 
FirstConsult, BMJ’s Best Practice and, generally, clinical practice guidelines from a wide 
range of authors (Ahmadi et al., 2011; Campbell & Ash, 2006). Each point of care resource 
will apply a different set of editorial policies and make use of different authors. As evident in 
this study, editorial policies and author approaches are likely to influence greatly the final 
product, especially if standardized criteria are lacking. In order to gain an understanding of 
how the findings from this analysis of UpToDate compares to other Summary resources, 
repeating such analysis in comparable products would be beneficial. Using the same methods 
to analyze the same cases would not only advance understanding of how the author, 
evidence, and patient-physician relationship are situated, but should also reveal the overlap 
and divergences of what evidence is included and excluded and, in turn, inform a greater 
understanding of resource creation and utility. Comparing the same topics in another 
summary evidence resource (e.g. DynaMed) would not only expose differences in processes 
between two summary resources but would also reveal whether it is possible that two sets of 
authors, using the same evidence, arrive at similar or different recommendations and 
guidance. Further, exploring differences in the knowledge contained across the resources 
(e.g., presence or absence of tacit knowledge) may be useful in understanding the reported 
application, utility, and influence of UpToDate (Ahmadi et al., 2011; Campbell & Ash, 2006; 
Thiele, 2011; Isaac, Xheng & Jha, 2012). 
This study points to additional opportunities for future research for library and 
information studies scholars. For example, while research-derived evidence is one part of 
evidence-based practice, this analysis accentuates the key roles of expertise and tacit 
knowledge in the information practices of physicians (Dawes & Sampson, 2003; Elayyan, 
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1988; Haug, 1997; Leckie, 1996; Nasir, Nicholson, Vandermeer, Kumar& Robinson, 2014; 
Verhoeven et al., 1995). Building on the results of the current study, future research should 
address the consequences of documented shortcomings of evidence-based practice through 
the sharing of observations, experiences and acquired expertise. In a resource like UpToDate, 
such tacit information guides readers through the clinical encounter, possibly at the cost of 
returning to a model of care that is more doctor-centered and that relies on the ‘art of 
medicine.’ Further investigation into this dynamic would be valuable.  
Future research should also focus on the information seeking behaviours within 
UpToDate. This research has identified potential new functions for UpToDate as a 
technological surrogate for mentors and curbside consultants. The importance and influence 
of the tacit knowledge that contributes to these functions is not known. Are these surrogate 
roles a driver for UpToDate’s popularity? If so, what conditions lead to the need for 
physicians to seek out this information through technology? Further, what information is 
most memorable and most used in UpToDate? How does the importance and application of 
the tacit knowledge presented in UpToDate compare to the application of evidence from 
clinical studies? Further investigation is needed to understand how the need for UpToDate to 
fulfill the role of mentor and consultant developed and to understand the importance and 
influence of sharing tacit information alongside clinical evidence. 
Conclusion 
Prior to the evidence-based medicine movement, clinicians relied heavily on a 
knowledge base made up their own experience and the collective experiences of the 
profession learned through apprenticeship and modeling (the so-called ‘art’ of medicine) to 
navigate decision-making. While evidence based medicine is a widely accepted feature of 
contemporary medical practice, the applicability of clinical trials to clinical practice is often 
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questioned. Within this context, UpToDate emerges as one of the most popular and heavily 
used Summary level, point-of-care evidence resources. While studies have been done 
previously to evaluate the utility and features of UpToDate, no critical analysis of the content 
has yet been undertaken. This study is an attempt to understand the context, process, and 
underlying meaning of how lower order evidence (i.e., studies and synthesis) evolves into 
highly applicable evidence in Summary resources.  
While it was expected that patterns would emerge based on the level of certainty and 
medicalization of the topic, the results of the study indicate that the variability across the 
cases did not appear to follow a systematic pattern based on attributes of the cases. In 
contrast to the loose adherence to principles of EBM found in UpToDate, structure and 
hierarchy are a fundamental features of evidence-based medicine. UpToDate’s lack of 
explicit structure calls into question the truth of its primary claim that it is “an evidence-
based, physician-authored clinical decision support resource which clinicians trust to make 
the right point-of-care decisions” (UpToDate, “About Us,” 2017). 
By applying the lens of Science and Technology Studies in this research, the value of 
investigating the development of evidence (and evidence tools) as ‘social’ rather than merely 
‘technological’ acts has been underlined. Library and information practitioners and scholars 
often view the production as an act of intermediation, whereby information is transported 
without transformation (Latour, 2005). The present results support Latour’s observation that 
individuals who create, develop and package evidence for clinical care “translate, transform, 
and modify” research in order to create meaning and initiate change in practitioners (Latour, 
p. 39). Authors who contribute to UpToDate not only provide and translate evidence, but also 
interpose their own expertise and tacit knowledge. Analysing the results through the lens of 
Hall’s Circuit of Culture suggests that expertise is an integral element of the role and 
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meaning of UpToDate within the health information environment.  
This research broadens what is known about the content and functions of UpToDate 
and offers insights that may help to explain the immense popularity of this clinical tool. 
UpToDate attempts to address a very real gap between evidence and practice, but this 
research sheds light on a ‘hidden curriculum’ that is embedded in the tool. UpToDate 
attempts to bridge evidence with practice by incorporating clinical judgment, clinical 
expertise, and the incorporation of ways to tailor care for patients with selected evidence; 
however, the results of this study raise important questions about the nature of this content 
and the potential risk in entrenching physician-centred care and the ‘art of medicine’ —the 
very things that evidence-based medicine was intended to attenuate - within a tool marketed 
as ‘evidence-based’.   
 
 
 
 
 
  
              207 
 
References 
Abidi, S. S. R., Cheah, Y. N., & Curran, J. (2005). A knowledge creation info-structure to 
acquire and crystallize the tacit knowledge of health-care experts. IEEE Transactions 
on Information Technology in Biomedicine, 9(2), 193-204.  
Addison, J., Whitcombe, J., & Glover, S. W. (2013). How doctors make use of online, point-
of-care clinical decision support systems: A case study of UpToDate©. Health 
Information & Libraries Journal, 30(1), 13–22. 
Agee, J. (2009). Developing qualitative research questions: A reflective process. International 
Journal of Qualitative Studies in Education, 22(4), 431-447. 
Ahmadi, S. F., Faghankhani, M., Javanbakht, A., Akbarshahi, M., Mirghorbani, M., 
Safarnejad, B., & Baradaran, H. (2011). A comparison of answer retrieval through four 
evidence-based textbooks (ACP PIER, Essential Evidence Plus, First Consult, and 
UpToDate): A randomized controlled trial. Medical Teacher, 33(9), 724–730. 
Alper, B. S., White, D. S., & Ge, B. (2005). Physicians answer more clinical questions and 
change clinical decisions more often with synthesized evidence: A randomized trial in 
primary care. Annals of Family Medicine, 3(6), 507–513.  
Amber, K. T., Dhiman, G., & Goodman, K. W. (2014). Conflict of interest in online point-of-
care clinical support websites. Journal of Medical Ethics, 40(8), 578-80.  
American College of Obstetricians and Gynecologists. (2012). Committee opinion: Intimate 
partner violence. Retrieved from: http://www.acog.org/Resources-And-
Publications/Committee-Opinions/Committee-on-Health-Care-for-Underserved-
Women/Intimate-Partner-Violence 
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental 
disorders (5th ed.) Washington, DC, American Psychiatric Publishing.  
              208 
 
Andrews, J. E., Pearce, K. A., Ireson, C., & Love, M. M. (2005). Information-seeking 
behaviors of practitioners in a primary care practice-based research network (PBRN). 
Journal of the Medical Library Association, 93(2), 206-212. 
Armstrong, D. (2002). Clinical autonomy, individual and collective: The problem of 
changing doctors’ behaviour. Social Science & Medicine, 55(10), 1771–1777.  
Banzi, R., Liberati, A., Moschetti, I., Tagliabue, L., & Moja, L. (2010). A review of online 
evidence-based practice point-of-care information summary providers. Journal of 
Medical Internet Research, 12(3).  
Balmer, D., D'Alessandro, D., Risko, W., & Gusic, M. E. (2011). How mentoring 
relationships evolve: A longitudinal study of academic pediatricians in a physician 
educator faculty development program. Journal of Continuing Education in the 
Health Professions, 31(2), 81-86. 
Banzi, R., Liberati, A., Moschetti, I., Tagliabue, L., & Moja, L. (2010). A review of online 
evidence-based practice point-of-care information summary providers. Journal of 
Medical Internet Research, 12(3).  
Barker, K. K. (2008). Electronic support groups, patient-consumers, and medicalization: The 
case of contested illness. Journal of Health and Social Behavior, 49(1), 20–36.  
Bates, D. W., et al. (2003). Ten commandments for effective clinical decision support: 
making the practice of evidence-based medicine a reality. Journal of the American 
Medical Informatics Association, 10(6), 523-530. 
Bawden, D. (2012). On the gaining of understanding: Syntheses, themes and information 
analysis. Library and Information Research, 36(112), 147–162. 
Beach, R., et al. (2009). Defining the critical in critical content analysis. In L. Leander, D. 
Rowe, D. K. Dickinson, M. K. Hundley, R. T. Jimenez, & V. J. Risko (Eds.), Yearbook 
              209 
 
of the National Reading Council (58th ed., pp. 120–143). Oak Creek, WI: National 
Reading Conference, Inc. 
Bennett, N. L., Casebeer, L. L., Kristofco, R., & Collins, B. C. (2005). Family physicians’ 
information seeking behaviors: A survey comparison with other specialties. BMC 
Medical Informatics and Decision Making, 5(1), 9.  
Berg, B. L. (1995). Qualitative research methods for the social sciences (2nd ed). Needham 
Heights, Mass.: Allyn and Bacon.  
Berg, B. L. (2007). Qualitative research methods for the social sciences (6th ed). Needham 
Heights, Mass.: Allyn and Bacon.  
Black, N. (1994). Why we need qualitative research. Journal of Epidemiology and 
Community Health, 48, 425-426. 
Bonanno, G. A., Wortman, C. B., Lehman, D. R., Tweed, R. G., Haring, M., Sonnega, J., ... 
& Nesse, R. M. (2002). Resilience to loss and chronic grief: A prospective study from 
preloss to 18-months postloss. Journal of personality and social psychology, 83(5), 
1150. 
Bonis, P. A., Pickens, G. T., Rind, D. M., & Foster, D. A. (2008). Association of a clinical 
knowledge support system with improved patient safety, reduced complications and 
shorter length of stay among Medicare beneficiaries in acute care hospitals in the 
United States. International Journal of Medical Informatics, 77(11), 745–753.  
Borry, P., Schotsmans, P., & Dierickx, K. (2006). Evidence-based medicine and its role in 
ethical decision-making. Journal of Evaluation in Clinical Practice, 12(3), 306–311.  
Boudreau, J. D., Macdonald, M. E., & Steinert, Y. (2014). Affirming professional identities 
through an apprenticeship: Insights from a four-year longitudinal case study. 
Academic Medicine, 89(7), 1038-45. 
              210 
 
Bowker, G. C., & Star, S. L. (2000). Sorting things out: Classification and its consequences. 
Cambridge, Mass.: MIT Press. 
Brown-Epstein, H. A. (2012). Let’s climb an evidence pyramid. Journal of Hospital 
Librarianship, 12(3), 218–228. 
Bryant, S. L. (2004). The information needs and information seeking behaviour of family 
doctors: Information needs of GP. Health Information & Libraries Journal, 21(2), 84–
93.  
Campbell, R., & Ash, J. (2006). An evaluation of five bedside information products using a 
user-centered, task-oriented approach. Journal of the Medical Library Association, 
94(4), 435–e207. 
Cash, T. F. (2001). The psychology of hair loss and its implications for patient care. Clinics 
in Dermatology, 19(2), 161-166. 
Cavanagh, S. (1997). Content analysis: Concepts, methods and applications. Nurse 
Researcher, 4(3), 5–13.  
Centre for Evidence Based Medicine. (2017). Asking Focused Questions. University of 
Oxford. Retrieved from http://www.cebm.net/asking-focused-questions/ 
Chambliss, M. L., & Conley, J. (1996). Answering clinical questions. Journal of Family 
Practice, 43(2), 140–144. 
Chan, R., & Stieda, V. (2011). Evaluation of three point-of-care healthcare databases: BMJ 
Point-of-Care, Clin-eguide and Nursing Reference Centre. Health Information & 
Libraries Journal, 28(1), 50–58. 
Charlton B. G., & Miles, A. (1998). The rise and fall of EBM. QJM, 91(5), 371-374. 
Chisholm, R., & Finnell, J. T. (2012). Emergency department physician internet use during 
clinical encounters. AMIA Annual Symposium Proceedings, 2012, 1176–1183. 
              211 
 
Clarke, M. A., Belden, J. L., Koopman, R. J., Steege, L. M., Moore, J. L., Canfield, S. M., & 
Kim, M. S. (2013). Information needs and information-seeking behaviour analysis of 
primary care physicians and nurses: A literature review. Health Information & 
Libraries Journal, 30(3), 178–190.  
Cochrane, A. (1989). Foreword. In I. Chalmers, M. Enkin, & M. Keirse (Eds.), Effective care 
in pregnancy and childbirth. Oxford: Oxford University Press. 
Cochrane, A. L. (1979). 1931–1971: A critical review, with particular reference to the 
medical profession. In G. Teeling-Smith (Ed.), Medicines for the year 2000. London: 
Office of Health Economics. 
Cochrane, A. L. (1999). Effectiveness and efficiency: Random reflections on health services. 
London: The Royal Society of Medicine Press Ltd. 
Cockburn J., & Pit S. (1997). Prescribing behaviour in clinical practice: patients' expectations 
and doctors' perceptions of patients' expectations–a questionnaire study. BMJ, 315, 
520–3.  
Cohen, A. M., Stavri, P. Z., & Hersh, W. R. (2004). A categorization and analysis of the 
criticisms of evidence-based medicine. International Journal of Medical Informatics, 
73(1), 35–43. 
Cole, T.B. (2000). Is domestic violence screening helpful?  JAMA, 284(5), 551-553  
Conrad, P. (2005). The shifting engines of medicalization. Journal of Health and Social 
Behavior, 46(1), 3–14.  
Conrad, P. (2007). The Medicalization of Society: On the Transformation of Human 
Conditions into Treatable Disorders. Baltimore: John Hopkins University Press.  
Conrad, P., & Leiter, V. (2004). Medicalization, markets and consumers. Journal of Health 
and Social Behavior, 45, 158–176. 
              212 
 
Cook, D. A., Enders, F., Linderbaum, J. A., Zwart, D., & Lloyd, F. J. (2014). Speed and 
accuracy of a point of care web-based knowledge resource for clinicians: A controlled 
crossover trial. Interactive journal of medical research,3(1). 
Cook, D. A., Sorensen, K. J., & Wilkinson, J. M. (2014, May). Value and process of curbside 
consultations in clinical practice: a grounded theory study. Mayo Clinic Proceedings, 
89(5), 602-614. 
Cook, D. A., Sorensen, K. J., Wilkinson, J. M., & Berger, R. A. (2013). Barriers and 
decisions when answering clinical questions at the point of care: A grounded theory 
study. JAMA Internal Medicine, 173(21), 1962–1969.  
Cook, D. J., & Greengold, N. L. (1997). The relation between systematic reviews and 
practice guidelines. Annals of Internal Medicine, 127(3), 21-216. 
Coomarasamy, A., & Khan, K. S. (2004). What is the evidence that postgraduate teaching in 
evidence based medicine changes anything? A systematic review. BMJj, 329(7473), 
1017-1021. 
Cooper, A. L., & Elnicki, D. M. (2011). Resource utilisation patterns of third-year medical 
students. The Clinical Teacher, 8(1), 43–47.  
Creswell, J. W. (2007). Qualitative inquiry & research design: Choosing among five 
approaches (2nd ed.). Thousand Oaks: Sage Publications. 
Cronholm, P. F., Fogarty, C. T., Ambuel, B., & Harrison, S. L. (2011). Intimate partner 
violence. American Family Fhysician, 83(10), 1165-1172. 
Crowley, S. H., Owens, T. A., Schardt, C. M., Wardell, S. I., Peterson, J., Garrison, S., & 
Keitz, S. A. (2003). A web-based compendium of clinical questions and medical 
evidence to educate internal medicine residents. Academic Medicine, 78(3), 270–74. 
Cruess, R. L., Cruess, S. R., Boudreau, J. D., Snell, L., & Steinert, Y. (2015). A schematic 
              213 
 
representation of the professional identity formation and socialization of medical 
students and residents: A guide for medical educators. Academic Medicine, 90(6), 
718-725. 
Daly, J. (2005). Evidence-based medicine and the search for a science of clinical care. 
Berkeley: Milbank Memorial Fund. 
Dancet, E. A. F., Van Empel, I. W. H., Rober, P., Nelen, W. L. D. M., Kremer, J. A. M., & 
d'Hooghe, T. M. (2011). Patient-centred infertility care: A qualitative study to listen to 
the patient's voice. Human Reproduction, 26(4), 827-833. 
Davidoff, F., Haynes, B., Sackett, D., & Smith, R. (1995). Evidence-based medicine. BMJ 
(Clinical Research Ed.), 310(6987), 1085–1086.  
Davis, J. E. (2010). Medicalization, social control, and the relief of suffering. In W. 
Cockerham (Ed.), The new Blackwell companion to medical sociology (pp. 211–241). 
Malden, MA: Wiley-Blackwell.  
Dawes, M., & Sampson, U. (2003). Knowledge management in clinical practice: A 
systematic review of information seeking behavior in physicians. International Journal 
of Medical Informatics, 71(1), 9–15. 
Del Mar, C., Venekamp, R. P., & Sanders, S. (2015). Antibiotics for children with acute 
otitis media. JAMA, 313(15), 1574-1575. 
DiCenso, A., Bayley, L., & Haynes, R. B. (2009). Accessing pre-appraised evidence: Fine-
tuning the 5S model into a 6S model. Annals of Internal Medicine, 151(6), JC3–2, 
JC3–3. 
Djulbegovic, B. (2001a). Acknowledgment of uncertainty: A fundamental means to ensure 
scientific and ethical validity in clinical research. Current Oncology Reports, 3(5), 
389–395.  
              214 
 
Djulbegovic, B. (2001b). Acknowledgment of uncertainty: A fundamental means to ensure 
scientific and ethical validity in clinical research. Current Oncology Reports, 3(5), 
389–395.  
Dorsch, J. L., Aiyer, M. K., & Meyer, L. E. (2004). Impact of an evidence-based medicine 
curriculum on medical students’ attitudes and skills. Journal of the Medical Library 
Association, 92(4), 397–406. 
du Gay, P., Hall, S., Janes, L., Mackay, H., & Negus, K. (1997) Doing cultural studies: The 
story of the Sony Walkman. Sage Publications. 
Duran-Nelson, A., Gladding, S., Beattie, J., & Nixon, L. J. (2013). Should we Google it? 
Resource use by internal medicine residents for point-of-care clinical decision making. 
Academic Medicine, 88(6), 788–794.  
Edson, R. S., Beckman, T. J., West, C. P., Aronowitz, P. B., Badgett, R. G., Feldstein, D. A., 
... & McDonald, F. S. (2010). A multi-institutional survey of internal medicine 
residents’ learning habits. Medical Teacher, 32(9), 773-775.  
Egle, J. P., Smeenge, D. M., Kassem, K. M., & Mittal, V. K. (2015). The Internet School of 
Medicine: use of electronic resources by medical trainees and the reliability of those 
resources. Journal of Surgical Education, 72(2), 316-320. 
Elayyan, R. M. (1988). The use of information by physicians. International Library Review, 
20(2), 247–265. 
Ellis, J. A., Sinclair, R., & Harrap, S. B. (2002). Androgenetic alopecia: Pathogenesis and 
potential for therapy. Expert Reviews in Molecular Medicine, 4(22), 1-11. 
Ensan, L. S., Faghankhani, M., Javanbakht, A., Ahmadi, S.F., & Baradaran, H. R. (2011). To 
Compare PubMed Clinical Queries and UpToDate in teaching information mastery to 
clinical residents: A crossover randomized controlled trial. PLoS ONE, 6(8).  
              215 
 
Farrell, A. (2008). An evaluation of the five most used evidence-based bedside information 
tools in Canadian health libraries. Evidence-based Library and Information Practice, 
3(2), 3–17. 
Feinstein, A. R., & Horwitz, R. I. (1997). Problems in the ‘evidence’ of ‘evidence-based 
medicine’. The American Journal of Medicine, 103(6), 529–535.  
Fenton, S. H., & Badgett, R. G. (2007). A comparison of primary care information content in 
UpToDate and the National Guideline Clearinghouse. Journal of the Medical Library 
Association, 95(3), 255–259. 
Findling, J. W., Shaker, J. L., Brickner, R. C., Riordan, P. R., & Aron, D. C. (1996). 
Curbside consultation in endocrine practice: a prospective observational study. The 
Endocrinologist, 6(4), 328-331. 
Fox, R. C. (1957). Training for uncertainty. In R. K. Merton, G. Reader, & P. Kendall (Eds.), 
The student physician (pp. 207–241). Cambridge: Harvard University Press. 
Fox, R. C. (2012). Medical uncertainty revisited. In G. Bendelow, M. Carpenter, C. Vautier, 
& S. Williams (Eds.), Gender, health and healing: The public/private divide. London: 
Routledge. 
French, P. (2002). What is the evidence on evidence-based nursing? An epistemological 
concern. Journal of Advanced Nursing, 37(3), 250–257.  
Freshwater, D., & Rolfe, G. (2004). Deconstructing evidence-based practice. London: 
Routledge. 
Gallentine, A., Salinas-Miranda, A. A., Bradley-Klug, K., Shaffer-Hudkins, E., Hinojosa, S., 
& Monroe, A. (2014). Student perceptions of a patient-centered medical training 
curriculum. International Journal of Medical Education, 5, 95-102. 
Ghali, W. A., Saitz, R., Eskew, A. H., Gupta, M., Quan, H., & Hershman, W. Y. (2000). 
              216 
 
Successful teaching in evidence-based medicine. Medical Education, 34(1), 18–22.  
Given, L. M. (Ed.) (2008). The SAGE encyclopedia of qualitative research methods. 
Thousand Oaks, CA: SAGE. 
Gluud, C., & Nikolova, D. (2007). Likely country of origin in publications on randomised 
controlled trials and controlled clinical trials during the last 60 years. Trials, 8(7). 
Goldenberg, M. J. (2006). On evidence and evidence-based medicine: Lessons from the 
philosophy of science. Social Science & Medicine, 62(11), 2621-2632. 
Goldenberg, M. J. (2010). Clinical evidence and the absent body in medical phenomenology: 
On the need for a new phenomenology of medicine. International Journal of Feminist 
Approaches to Bioethics, 3(1), 43–71. 
González-González, A. I., Dawes, M., Sánchez-Mateos, J., Riesgo-Fuertes, R., Escortell-
Mayor, E., Sanz-Cuesta, T., & Hernández-Fernández, T. (2007). Information needs and 
information-seeking behavior of primary care physicians. Annals of Family Medicine, 
5(4), 345–352.  
Good, M.-J. D. (1998). American medicine: The quest for competence. Berkeley: University 
of California Press. 
Gorman, P. N., Ash, J., & Wykoff, L. (1994). Can primary care physicians’ questions be 
answered using the medical journal literature? Bulletin of the Medical Library 
Association, 82(2), 140–146. 
Gorman, P. N., & Helfand, M. (1995). Information seeking in primary care: How physicians 
choose which clinical questions to pursue and which to leave unanswered. Medical 
Decision Making: An International Journal of the Society for Medical Decision 
Making, 15(2), 113–119. 
Grandage, K. K., Slawson, D. C., & Shaughnessy, A. F. (2002). When less is more: A 
              217 
 
practical approach to searching for evidence-based answers. Journal of the Medical 
Library Association, 90(3), 298–304. 
Green, M. L. (2000). Evidence-based medicine training in graduate medical education: Past, 
present and future. Journal of Evaluation in Clinical Practice, 6(2), 121–138.  
Greenhalgh, T. (2002). Intuition and evidence—Uneasy bedfellows? British Journal of 
General Practice, 52(478), 395–400. 
Greenhalgh, T. (2012). Outside the Box: Why are Cochrane reviews so boring? The British 
Journal of General Practice, 62(600), 371.  
Greenhalgh, T., Howick, J., & Maskrey, N. (2014). Evidence based medicine: A movement 
in crisis?. BMJ, 348, g3725. 
Greenhalgh, T., & Wieringa, S. (2011). Is it time to drop the ‘knowledge translation’ 
metaphor? A critical literature review. Journal of the Royal Society of Medicine, 
104(12), 501–509.  
Grijalva, C. G., Nuorti, J. P., & Griffin, M. R. (2009). Antibiotic prescription rates for acute 
respiratory tract infections in US ambulatory settings. JAMA, 302(7), 758-766. 
Guyatt, G., Cook, D., & Haynes, B. (2004). Evidence-based medicine has come a long way. 
BMJ, 329(7473), 990–991. 
Guyatt, G. H., Rennie, D., Cook, D. J., & Meade, M. O. (Eds.). (2008). Users’ guides to the 
medical literature: A manual for evidence-based clinical practice (2nd ed.). New York: 
McGraw Hill Medical. 
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & 
Schunemann, H. J. (2008). GRADE: an emerging consensus on rating quality of 
evidence and strength of recommendations. BMJ, 336(7650), 924-926. 
Hadler, N. M. (2003). " Fibromyalgia" and the Medicalization of Misery. Journal of 
              218 
 
Rheumatology, 30(8), 1668-1670. 
Hafferty, F. W.  (1998). Beyond curriculum reform: Confronting medicine’s hidden 
curriculum. Academic Medicine, 73, 403–7.  
Haidet, P., Dains, J. E., Paterniti, D. A., Hechtel, L., Chang, T., Tseng, E., & Rogers, J. C. 
(2002). Medical student attitudes toward the doctor–patient relationship. Medical 
education, 36(6), 568-574. 
Hall, S. (1986).  Encoding / Decoding. In, S. Hall, A. Lowe & P. Willis (eds.): Culture, 
media, language. working papers in cultural studies, 1972-79 (pp, 128–138). London: 
Hutchingson. 
Hatala R, & Guyatt G. (2002). Evaluating the teaching of evidence-based medicine. JAMA, 
288(9), 1110–1112.  
Hansen, M. P., Howlett, J., Del Mar, C., & Hoffmann, T. C. (2015). Parents’ beliefs and 
knowledge about the management of acute otitis media: A qualitative study. BMC 
family practice, 16(1), 82. 
Harris, M., Bhatti, Y. & Darzi, A. (2016). Does the country of origin matter in health care 
innovation diffusion. JAMA, 315(11), 1103-4. 
Harris, M., Macinko, J., Jimenez, G., Mahfoud, M., & Anderson, C. (2015). Does a research 
article's country of origin affect perception of its quality and relevance? A national 
trial of US public health researchers. BMJ Open, 5(12). 
Hasty, R. T., Garbalosa, R. C., Barbato, V. A., Valdes Jr, P. J., Powers, D. W., Hernandez, 
E., ... & Jose, S. S. (2014). Wikipedia vs peer-reviewed medical literature for 
information about the 10 most costly medical conditions. Journal of the American 
Osteopathic Association, 114(5), 368-373. 
Haug, J. D. (1997). Physicians’ preferences for information sources: A meta-analytic study. 
              219 
 
Bulletin of the Medical Library Association, 85(3), 223–232. 
Hayes, S. (2012). North East Consortium for Health Information (NECHI) explores 
DynaMed and Up-To-Date as viable research tools and point-of-care resources for the 
purpose of facilitating informed purchasing by library and hospital administrators. 
Journal of Hospital Librarianship, 12(4), 336–341.  
Haynes, R. B. (2001). Of studies, summaries, synopses, and systems: The “4S” evolution of 
services for finding current best evidence. Evidence Based Mental Health, 4(2), 37-38. 
Haynes, R. B. (2002). What kind of evidence is it that evidence-based medicine advocates 
want health care providers and consumers to pay attention to? BMC Health Services 
Research, 2(1). 
Haynes, R. B. (2006). Of studies, syntheses, synopses, summaries, and systems: The ‘5S’ 
evolution of information services for evidence-based health care decisions. ACP 
Journal Club, 145(3), A8. 
Hitt, J. (2001, December 9). The year in ideas: A to Z; Evidence-based medicine. The New 
York Times. Retrieved from http://www.nytimes.com/2001/12/09/magazine/the-year-
in-ideas-a-to-z-evidence-based-medicine.html 
Holmes, D., Murray, S. J., Perron, A., & Rail, G. (2006). Deconstructing the evidence-based 
discourse in health sciences: Truth, power and fascism. International Journal of 
Evidence-Based Healthcare, 4(3), 180–186.  
Hoogendam, A., Stalenhoef, A. F., de Vries Robbe, P. F., & Overbeke, A. J. P. (2008). 
Answers to questions posed during daily patient care are more likely to be answered by 
UpToDate than PubMed. Journal of Medical Internet Research, 10(4).  
Horwitz, R. I. (1996). The dark side of evidence-based medicine. Cleveland Clinic Journal of 
Medicine, 63(6), 320–323.  
              220 
 
Hsieh, H. F., & Shannon, S. E. (2005). Three approaches to qualitative content analysis. 
Qualitative Health Research, 15(9), 1277–1288.  
Huibers, M. & Wessely, S. (1996). The act of diagnosis: Pros and cons of labeling chronic 
fatigue syndrome. Psychological Medicine, 36(7), 897-900 
Huang, X., Lin, J., & Demner-Fushman, D. (2006). Evaluation of PICO as a knowledge 
representation for clinical questions. AMIA Annual Symposium Proceedings, 2006, 
359-363. 
Hur, Y., Kim, S., Park, J. H., Cho, A. R., & Choi, C. J. (2014). Changes in medical students' 
patient-centeredness attitudes by implementation of clinical performance 
examination. Korean Journal of Medical Education, 26(2), 99-106. 
Hyde, C., Stanworth, S., Brunskill, S., & Murphy, M. (2005). Putting clinical trials into 
context. The Lancet, 366(9490), 980–981.  
Institute of Medicine. (2011). Clinical Practice Guidelines We Can Trust. Washington (DC): 
National Academies Press.  
Institute of Medicine. (2015). Beyond mylagic encephalomyelitis/Chronic Fatigue Syndrome: 
Redefining an illness. Washington, DC” National Academies Press.  
Isaac, T., Zheng, J., & Jha, A. (2012). Use of UpToDate and outcomes in US hospitals. 
Journal of Hospital Medicine, 7(2), 85–90.  
Jason, L. A., Sunnquist, M., Brown, A., McManimen, S., & Furst, J. (2015). Reflections on 
the Institute of Medicine’s systemic exertion intolerance disease. Polskie Archiwun 
Medycyny Wewneterznej, 125(7-8), 576-581. 
Jeffery, R., Navarro, T., Lokker, C., Haynes, R. B., Wilczynski, N. L., & Farjou, G. (2012). 
How current are leading evidence-based medical textbooks? An analytic survey of four 
online textbooks. Journal of Medical Internet Research, 14(6).  
              221 
 
Julien, H. (2008). Content analysis. In L. M. Given (Ed.), The SAGE handbook of qualitative 
research (pp. 120–121). Thousand Oaks, Calif.: SAGE Publications. 
Juni, P., Altman, D. G., & Egger, M. (2001). Assessing the quality of controlled clinical 
trials. BMJ : British Medical Journal, 323(7303), 42–46. 
Kendall, E., Sunderland, N., Muenchberger, H., & Armstrong, K. (2009). When guidelines 
need guidance: considerations and strategies for improving the adoption of chronic 
disease evidence by general practitioners. Journal of Evaluation in Clinical 
Practice, 15(6), 1082-1090.  
Kenny, N. P., Mann, K. V., & MacLeod, H. (2003). Role modeling in physicians’ 
professional formation: Reconsidering an essential but untapped educational strategy. 
Academic Medicine, 78(12), 1203-1210.  
Ketchum, A. M., Saleh, A. A., & Jeong, K. (2011). Type of evidence behind point-of-care 
clinical information products: A bibliometric analysis. Journal of Medical Internet 
Research, 13(1), 25–25.  
Kim, S., Willett, L. R., Murphy, D. J., O’Rourke, K., Sharma, R., & Shea, J. A. (2008). 
Impact of an evidence-based medicine curriculum on resident use of electronic 
resources: A randomized controlled study. Journal of General Internal Medicine, 
23(11), 1804–1808.  
Krippendorff, K. (2013). Content analysis: An introduction to its methodology (3rd ed.). Los 
Angeles: SAGE Publications. 
Kronenfeld, M. R., Bay, R. C., & Coombs, W. (2013). Survey of user preferences from a 
comparative trial of UpToDate and ClinicalKey. Journal of the Medical Library 
Association, 101(2), 151-154. 
Kuo, D., Gifford, D. R., & Stein, M. D. (1998). Curbside consultation practices and attitudes 
              222 
 
among primary care physicians and medical subspecialists. JAMA, 280(10), 905-909. 
Lai, C. J., Aagaard, E., Brandenburg, S., Nadkarni, M., Wei, H. G., & Baron, R. (2006). 
Multiprogram evaluation of reading habits of primary care internal medicine residents 
on ambulatory rotations. Journal of General Internal Medicine, 21(5), 486–489.  
Latour, B. (2005). Reassembling the social: An introduction to actor-network-theory. Oxford 
University Press. 
Leckie, G. J., Pettigrew, K. E., & Sylvain, C. (1996). Modeling the information seeking of 
professionals: A general model derived from research on engineers, health care 
professionals, and lawyers. The Library Quarterly, 66(2), 161–193. 
Leff, B., & Harper, G. M. (2006). The reading habits of medicine clerks at one medical 
school: Frequency, usefulness, and difficulties. Academic Medicine, 81(5), 489-494. 
Lewis, S. J., & Orland, B. I. (2004). The importance and impact of evidence-based 
medicine. Journal of Managed Care Pharmacy, 10(5 Suppl A), S3-5. 
Lieberthal, A. S., Carroll, A. E., Chonmaitree, T., Ganiats, T. G., Hoberman, A., Jackson, M. 
A., ... & Schwartz, R. H. (2013). The diagnosis and management of acute otitis 
media. Pediatrics, 131(3), e964-e999. 
Marshall, J. G., et al. (2013). The value of library and information services in patient care: 
Results of a multisite study. Journal of the Medical Library Association , 101(1), 38–
46.  
May, C. (2007). The clinical encounter and the problem of context. Sociology, 41(1), 29–45.  
May, C., Rapley, T., Moreira, T., Finch, T., & Heaven, B. (2006). Technogovernance: 
Evidence, subjectivity, and the clinical encounter in primary care medicine. Social 
Science & Medicine, 62(4), 1022–1030.  
Maynard, A. (1997). Evidence-based medicine: An incomplete method for informing 
              223 
 
treatment choices. The Lancet, 349(9045), 126–128. 
McCracken, S. G., & Marsh, J. C. (2008). Practitioner expertise in evidence-based practice 
decision making. Research on Social Work Practice, 18(4), 301-310. 
McDonald, F. S., Zeger, S. L., & Kolars, J. (2007). Factors associated with medical 
knowledge acquisition during internal medicine residency. Journal of General Internal 
Medicine, 22(7), 962–968.  
McKibbon, K. A., Lokker, C., Keepanasseril, A., Wilczynski, N. L., & Haynes, R. B. (2013). 
Net Improvement of correct answers to therapy questions after PubMed Searches: 
Pre/post comparison. Journal of medical Internet research, 15(11). 
McNulty C. A., Nichols T., French D. P., Joshi P., & Butler C. C. (2013). Expectations for 
consultations and antibiotics for respiratory tract infection in primary care: the RTI 
clinical iceberg. British Journal of General Practice, 63, 429–36. 
Miles, A., Loughlin, M., & Polychronis, A. (2008). Evidence‐based healthcare, clinical 
knowledge and the rise of personalised medicine. Journal of Evaluation in Clinical 
Practice, 14(5), 621-649. 
Moja, L., & Banzi, R. (2011). Navigators for medicine: Evolution of online point-of-care 
evidence-based services. International Journal of Clinical Practice, 65(1), 6–11.  
Moynihan, R., Heath, I., & Henry, D. (2002). Selling sickness: The pharmaceutical industry 
and disease mongering. BMJ : British Medical Journal, 324(7342), 886–891. 
Murray, S. J., Holmes, D., & Rail, G. (2008). On the constitution and status of ‘evidence’ in 
the health sciences. Journal of Research in Nursing, 13(4), 272–280.  
National Collaborating Centre for Methods and Tools (NCCMT). (n.d.). Search: Evidence-
informed public health. Retrieved 25 July 2013, from 
http://www.nccmt.ca/eiph/search-eng.html 
              224 
 
Nasir, F., Nicholson, K., Vandermeer, B., Kumar, M., & Robinson, J. (2014). Utilization of 
clinical practice guidelines: a survey of Canadian pediatric physicians. International 
Journal of Medicine, 3(1), 1-7. 
Naylor, C. D. (1995). Grey zones of clinical practice: Some limits to evidence-based 
medicine. The Lancet, 345(8953), 840–842. 
Nikolopoulos, T. P. (2014). To give or not to give antibiotics in non-severe acute otitis 
media? The American Academy of Pediatrics guidelines that do not guide. 
International Journal Pediatric Otorhinolaryngology. 78(7), 983-4.  
Neuendorf, K. A. (2002). The content analysis guidebook. Thousand Oaks, Calif: SAGE 
Publications. 
Norman, G. R., & Shannon, S. I. (1998). Effectiveness of instruction in critical appraisal 
(evidence-based medicine) skills: A critical appraisal. Canadian Medical Association 
Journal, 158(2), 177-181. 
O'Carroll, A. M., Westby, E. P., Dooley, J., & Gordon, K. E. (2015). Information-Seeking 
Behaviors of Medical Students: A Cross-Sectional Web-Based Survey. Journal of 
Medical Internet Research, 17(6). 
Panahi, S., Watson, J., & Partridge, H. (2015). Information encountering on social media and 
tacit knowledge sharing. Journal of Information Science, 42(4), 539-550. 
Pandis, N. (2011). The evidence pyramid and introduction to randomized controlled trials. 
American Journal of Orthodontics and Dentofacial Orthopedics, 140(3), 446–447.  
Peterson, M. W., Rowat, J., Kreiter, C., & Mandel, J. (2004). Medical students’ use of 
information resources: Is the digital age dawning? Academic Medicine, 79(1), 89–95. 
Petticrew, M. & Roberts, H. (2006). How to appraise the studies: an introduction to assessing 
study quality. In Systematic Reviews in the Social Sciences: a Practical Guide (pp. 
              225 
 
125-163). Oxford: Blackwell.  
Phua, J., & Lim, T. K. (2008). How residents and interns utilise and perceive the personal 
digital assistant and UpToDate. BMC Medical Education, 8(1), 39.  
Phua, J., See, K. C., Khalizah, H. J., Low, S. P., & Lim, T. K. (2012). Utility of the electronic 
information resource UpToDate for clinical decision-making at bedside rounds. 
Singapore Medical Journal, 53(2), 116–120. 
Pottinger, B. C. (n.d.). How did Intimate Partner Violence (IPV) evolve into an orthopaedic 
medical issue? Historical perspective on IPV in orthopaedic surgery. Retrieved from 
https://www.hopkinshistoryofmedicine.org/sites/default/files/SC%20Brent%20Potteng
er.pdf 
Prorok, J. C., Iserman, E. C., Wilczynski, N. L., & Haynes, R. B. (2012). The quality, 
breadth, and timeliness of content updating vary substantially for 10 online medical 
texts: An analytic survey. Journal of Clinical Epidemiology, 65(12), 1289–1295.  
Rashidian, A., Eccles, M. P., & Russell, I. (2008). Falling on stony ground? A qualitative 
study of implementation of clinical guidelines’ prescribing recommendations in 
primary care. Health Policy, 85(2), 148–161.  
Reed, D. A., West, C. P., Holmboe, E. S., Halvorsen, A. J., Lipner, R. S., Jacobs, C., & 
McDonald, F. S. (2012). Relationship of electronic medical knowledge resource use 
and practice characteristics with internal medicine maintenance of certification 
examination scores. Journal of General Internal Medicine, 27(8), 917–923.  
Richardson, W., Wilson, M., Nishikawa, J., & Hayward, R. (1995). The well-built clinical 
question: A key to evidence-based decisions. ACP Journal Club, 123(3).  
Roberts, A. R., & Yeager, K. (2004). Desk reference on evidence-based practice in health 
care and human services. New York: Oxford University Press. 
              226 
 
Rosenberg, W., & Donald, A. (1995). Evidence-based medicine: An approach to clinical 
problem-solving. BMJ , 310(6987), 1122–1126. 
Rudolf, M., et al. (2002). What's the use of Archimedes?. Archives of disease in childhood, 
87(2), 168-169. 
Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. 
(1996). Evidence-based medicine: What it is and what it isn’t. BMJ, 312(7023), 71–72.  
Schilling, L. M., Steiner, J. F., Lundahl, K., & Anderson, R. J. (2005). Residents’ patient-
specific clinical questions: Opportunities for evidence-based learning. Academic 
Medicine, 80(1), 51–56. 
Schlosser, R. W., Raghavendra, P., & Sigafoos, J. (2013). Appraising systematic reviews: 
From navigating synopses of reviews to conducting one’s own appraisal. In Evidence-
based practices (pp. 45-64). Emerald Group Publishing Limited.  
Sepers, C., & ter Meulen, R. (2005). Regulating health care: The development of guidelines 
in medical practice and health policy. In R. ter Meulen, N. Biller-Andorno, & C. Lenk 
(Eds.), Evidence-based practice in medicine and health care: A discussion of the 
ethical issues (pp. 9–15). New York: Springer. 
Shariff, S. Z., et al. (2011). Searching for medical information online: A survey of Canadian 
nephrologists. Journal of Nephrology, 24(6), 723-732.  
Shurtz, S., & Foster, M. J. (2011). Developing and using a rubric for evaluating evidence-
based medicine point-of-care tools. Journal of the Medical Library Association, 99(3), 
247–254. doi:10.3163/1536-5050.99.3.012 
Sismondo, S. (2010). An introduction to science and technology studies (2nd ed.). Malden, 
MA: Wiley-Blackwell. 
Society of Obstetricians and Gynecologists of Canada. (2009). Intimate partner violence 
              227 
 
consensus statement. SOGC: Ottawa. Retrieved from: 
http://www.cfpc.ca/uploadedFiles/Resources/Resource_Items/Health_Professionals/Inti
mate_partner_violence_consensus.pdf 
Stake, R. E. (2005). Qualitative research studies. In N. K. Denzin & Y. S. Lincoln (Eds.), The 
SAGE handbook of qualitative research (3rd ed., pp. 443–466). Thousand Oaks: Sage 
Publications. 
Stake, R. E. (2006). Multiple case study analysis. New York: The Guilford Press. 
Staller, K. M. (2006). Railroads, runaways, & researchers returning evidence rhetoric to its 
practice base. Qualitative Inquiry, 12(3), 503–522. 
Strauss, A., & Corbin, J. M. (1990). Basics of qualitative research: Grounded theory 
procedures and techniques. Sage Publications: Newbury Park, CA. 
Szolovits, P. (1995). Uncertainty and decisions in medical informatics. Methods of 
Information in Medicine, 34(1), 111–121. 
Taket A., Wathen C. N., & MacMillan H. L. (2004). Should health professionals screen all 
women for domestic violence?  PLoS Med, 1(1), e4. 
Taylor, C. A., Taylor, J. C., & Stoller, J. K. (2009). The influence of mentorship and role 
modeling on developing physician–leaders: Views of aspiring and established 
physician–leaders. Journal of General Internal Medicine, 24(10), 1130-1134. 
Thiele, R. H., Poiro, N. C., Scalzo, D. C., & Nemergut, E. C. (2010). Speed, accuracy, and 
confidence in Google, Ovid, PubMed, and UpToDate: Results of a randomised trial. 
Postgraduate Medical Journal, 86(1018), 459–465.  
Timmermans, S., & Angell, A. (2001). Evidence-based medicine, clinical uncertainty, and 
learning to doctor. Journal of Health and Social Behavior, 42(4), 342–359.  
Tonelli, M. R. (1998). The philosophical limits of evidence-based medicine. Academic 
              228 
 
Medicines, 73(12), 1234–1240. 
Turpin, M., & Higgs, J. (2009). Clinical reasoning and evidence-based practice. In T. 
Hoffmann, S. Bennett, & C. Del Mar (Eds.), Evidence-based practice across the health 
professions. Chatswood, N.S.W.: Elsevier Australia. 
Turvey, S. L., Hussain, N., Banfield, L., & Bhandari, M. (2013). Orthopaedic surgical 
content associated with resources for clinical evidence. Journal of the Canadian Health 
Libraries Association, 34(1), 17–23. 
UpToDate. (2017). About us. Retrieved from http://www.uptodate.com/home/about-us 
UpToDate. (2017). Around the world. Retrieved from 
http://www.uptodate.com/home/uptodate-around-world 
UpToDate. (2017). Creating content. Retrieved from 
http://www.uptodate.com/home/creating-content 
UpToDate. (2017). Editorial policy. Retrieved from 
http://www.uptodate.com/home/editorial-policy  
UpToDate. (2017). Searching in nine languages. Retrieved from 
http://www.uptodate.com/home/uptodate-search-9-languages 
UpToDate. (2017). Physician authors and editors. Retrieved from 
http://www.uptodate.com/home/physician-authors-and-editors 
UpToDate. (2017). The UpToDate story. Retrieved from 
http://www.uptodate.com/home/uptodate-story 
Van Loon, E., Zuiderent-Jerak, T., & Bal, R. (2013). Diagnostic work through evidence-
based guidelines: Avoiding gaps between development and implementation of a 
guideline for problem behaviour in elderly care. Science as Culture, 1–24.  
Vergison, A., Dagan, R., & Arguedas A., et al. (2010). Otitis media and its consequences: 
              229 
 
Beyond the earache. Lancet Infectious Disease, 10, 195-203.  
Verhoeven, A. A., Boerma, E. J., & Meyboom-de Jong, B. (1995). Use of information 
sources by family physicians: A literature survey. Bulletin of the Medical Library 
Association, 83(1), 85–90. 
Vidyarthi, A. R., Kamei, R., Chan, K., Goh, S. H., & Ngee, L. (2015). Factors associated 
with medical student clinical reasoning and evidence based medicine practice. 
International Journal of Medical Education, 6, 142–148. 
Weare, C., & Lin, W.-Y. (2000). Content analysis of the World Wide Web opportunities and 
challenges. Social Science Computer Review, 18(3), 272–292.  
Wathen, C.N., MacMillan, H.L. (2012). Health care's response to women exposed to partner 
violenceMoving beyond universal screening [Editorial]. Journal of the American 
Medical Association, 308(7):712-713. 
Weber, R. P. (1990). Basic content analysis (2nd ed.). Newbury Park, Calif.: SAGE 
Publications. 
Wieringa, S., Engebretsen, E., Heggen, K., & Greenhalgh, T. (2017). Has evidence‐based 
medicine ever been modern? A Latour‐inspired understanding of a changing EBM. 
Journal of Evaluation in Clinical Practice. 
West, C. P., Jaeger, T. M., & McDonald, F. S. (2011). Extended evaluation of a longitudinal 
medical school evidence-based medicine curriculum. Journal of General Internal 
Medicine, 26(6), 611–615.  
White, M. D., & Marsh, E. E. (2006). Content analysis: A flexible methodology. Library 
Trends, 55(1), 22–45.  
Windish, D. (2013). Searching for the right evidence: How to answer your clinical questions 
using the 6S hierarchy. Evidence Based Medicine, 18(3), 93-97. 
              230 
 
Worster, A., & Haynes, R. B. (2012). How do I find a point-of-care answer to my clinical 
question? CJEM, 14(01), 31-35.  
Wyatt, S., Harris, R., & Wathen, N. (2008). The go-betweens: Health, technology and 
info(r)mediation. In Mediating Health Information (pp. 1-17). Palgrave Macmillan 
UK. 
Yin, R. K. (2009). Case study research: Design and methods (4th ed.). Los Angeles: SAGE 
Publications. 
Yin, R. K. (2012). Applications of case study research (3rd ed.). Thousand Oaks, Calif.: 
SAGE Publications.  
Yip, L., Rufaut, N., Sinclair. R. (2011). Role of genetics and sex steroid hormones in male 
androgenetic alopecia and female pattern hair loss: An update of what we now know. 
Australasia Journal of Dermatology, 52(2), 81–8. 
Young, T., Rohwer, A., Volmink, J., & Clarke, M. (2014). What are the effects of teaching 
evidence-based health care (EBHC)? Overview of systematic reviews. PloS one, 9(1), 
e86706. 
Zachar, P., First, M. B., & Kendler, K. S. (2017). The Bereavement Exclusion Debate in the 
DSM-5: A History. Clinical Psychological Science, 2167702617711284. 
Zillmer, D. A. (2000). Domestic violence: The role of the orthopaedic surgeon in 
identification and treatment. Journal of the American Academy of Orthopaedic 
Surgeons, 8(2), 91-96. 
Zola, I. K. (1972). Medicine as an institution of social control. The Sociological 
Review, 20(4), 487-504. 
Zuiderent-Jerak, T., & Bruun Jensen, C. (2007). Unpacking ‘intervention’ in science and 
technology studies. Science as Culture, 16(3), 227–235.  
              231 
 
  
  
              232 
 
Appendix A: Descriptive Data Extraction Form 
 
Resource and Review Information 
Completed 
  Yes 
  No 
Clinical Question 
Clinical Question in PICO Format that the resource addresses, if applicable. 
[Text] 
UpToDate Entry: 
Title of UpToDate Entry 
[Text] 
Study Reference ID # 
Study Code i.e: AOM-1 
[XXX-#] 
Reference ID # from UpToDate 
Reference number from ref list. 
[#] 
Bibliographic Information from UpToDate 
Bibliographic Information from UpToDate 
[Text] 
Published in 
Journal title, if applicable 
[Text] 
From UpToDate Core Title List 
[Text] 
Has this article been cited in a systematic review (identified through PubMed SR 
portlet? 
  Yes 
  No 
              233 
 
Bibliographic Information from citing SRs 
[Text] 
Professional Background of Authors 
Indicate number of authors from each of the professional backgrounds.  
 Response 
Unknown # 
Medical Doctor # 
Nurse # 
Basic Scientist (PhD) # 
Librarian # 
Pharmacist # 
Public Health # 
Other # 
Professional Organization # 
Location of Study 
  United States 
  Canada 
  Australia 
  United Kingdom 
  Other, specify: 
  Not applicable (ie: review) 
Publication Date 
Month and Year 
Reviewed by: 
SB 
Date of Review 
Full date  
Abstract 
[Text][ 
Other Notes on General Information 
[Text] 
              234 
 
Resource Type 
Level of Evidence (Haynes 6S Model) 
  System 
  Summary 
  Synopsis of Synonym 
  Synthesis 
  Synopsis of Synthesis 
  Study 
  Not in the 6D Hierarchy of Evidence 
Type of Resource 
  UpToDate Entry 
  Practice Guideline 
  Systematic Review 
  Research, quantitative 
  Research, qualitative 
  Research, mixed method 
  Other, specify 
Quantitative Research Design 
If quantitative research design 
Quantitative Research Design 
  Randomized Controlled Trial 
  Non-Randomized Controlled Trial 
  Cohort/Prospective/Longitudinal 
  Before-After/Time Series 
  Other quantitative design, specify 
  Not Applicable 
              235 
 
Qualitative Research Design 
If Qualitative Research Design 
Qualitative Research Design 
  Ethnography 
  Phenomenology 
  Case Study 
  Grounded Theory 
  Other qualitative design, specify: 
  Not Applicable 
Review Article Design 
If Review Article 
Type of Reviews 
  Systematic Review 
  Meta-Analysis 
  Meta-Synthesis 
  Scoping Review 
  Narrative Review 
  Other, specify: 
  Not applicable 
Type of review clearly identified in paper? 
  Yes 
  No 
Clear Criteria for inclusion of literature 
  Yes 
  No 
If yes, indicate criteria: 
[Text] 
              236 
 
References Used 
 Response 
Number of references that met inclusion criteria # 
Review Conclusions 
[Text] 
 (P) Population/Patient Details 
Applicable 
  Yes 
  No 
Who is the population of interest? 
[Text] 
What was sample size? 
Please indicate N/A if not appropriate 
# 
Information extracted from Abstract only 
  Yes 
  No 
 (I) Intervention Details 
Applicable 
  Yes 
  No 
What was the intervention that was delivered? 
[Text[ 
Information extracted from Abstract only 
  Yes 
  No 
              237 
 
(C) Comparison Details 
Applicable 
  Yes 
  No 
Was there a comparison included in the study? 
  Yes 
  No 
If yes, what type of comparison was included? 
  Patient 
  Intervention 
Describe the Comparison? 
[Text] 
Information extracted from Abstract only 
  Yes 
  No 
 (O) Outcome Details 
Applicable 
  Yes 
  No 
What are measured outcome(s) of the Intervention? 
[Text] 
[Text] 
[Text] 
Were any adverse outcomes reported? 
  Yes 
  No 
If so, what adverse outcomes were reported? 
[Text] 
              238 
 
Information extracted from Abstract only 
  Yes 
  No 
Conclusions 
What conclusions did the author come to? 
[Text] 
Information extracted from Abstract only 
  Yes 
  No 
UpToDate Summary 
How is the study represented in the UpToDate summary? 
Cut and paste text of UpToDate Statement that references this evidence. 
[Text] 
  
              239 
 Curriculum Vitae Selinda Adelle Berg   
Education  PhD. Candidate, Faculty of Information and Media Studies “Expertise, Mediation, and Technological Surrogacy: A Mixed Method Critical Analysis of a Point of Care Evidence Resource” Western University, London Ontario 2008- 2017  Masters of Library and Information Studies University of Alberta, Edmonton May 2004  Bachelor of Science Nutrition, with Distinction College of Pharmacy and Nutrition University of Saskatchewan, Saskatoon May 1998  
Professional Practice  2017- 2018 Associate University Librarian  University of Windsor Leddy Library   Interim     Library Administration  2016- 2017 Department Head   University of Windsor Leddy Library        Information Services  2015-2016 Researcher-in-Residence  University of Saskatchewan’s    (July-June sabbatical position)  Centre for EBLIP       2008-present  Medical Librarian    University of Windsor        Schulich School of Medicine- Windsor        Leddy Library.  2013-present Adjunct Appointment   Schulich School of Medicine & Dentistry        Dept. of Biostats and Epidemiology  2014-2015 Limited Duties Instructor  University of Western Ontario        Fac of Information and Media Studies   2004-2008  Research and Instruction Librarian   University of Western Ontario        Western Libraries  
              240 
 
Publications Hoffmann, K., Berg, S., & Koufogiannakis, D. (2017). Understanding factors that encourage research productivity for academic librarians. Evidence Based Library and Information 
Practice, 12(4), 102-128. Berg, S. A., & Jacobs, H. L. M. (Editors). (2016). Special Issue Valuing Librarianship: Core Values in Theory and Practice. Library Trends, 64(3). Berg, S. A. & Jacobs, H. L. M. (2016). Introduction: Valuing librarianship: Core values in theory and practice. Library Trends, 64(3), 459-467. Berg, S. A., & Banks, M. (2016). Beyond Competencies: Naming Librarians’ Capacity for Research. The Journal of Academic Librarianship, 42(4), 469-471.  Wilson, V, & Berg S. A. (2016). Reciprocal benefits of Researcher-in-Residence program. 
Evidence Based Library and Information Practice, 11(2).  Johnston, D. J., Berg, S. A., Pillon, K., & Williams, M. (2015). Ease of use and usefulness as measures of student experience in a multi-platform e-textbook pilot. Library Hi Tech, 
33(1), 65-82.  Hoffmann, K., Berg, S. A., & Koufogiannakis, D. (2014). Examining success: Identifying factors that contribute to research productivity across librarianship and other disciplines. 
Library and Information Research, 38(119), 13-28. Hoffmann, K., & Berg, S. A. (2014). "You can't learn it in school": Field experiences and their contributions to education and professional identity. Canadian Journal of Information 
and Library Science, 38(3), 220-238. Meadows, K. N., Berg, S. A., Hoffmann, K., Torabi, N., & Gardiner, M. M. (2013). A needs-driven and responsive approach to supporting the research endeavours of academic librarians. 
Partnership: the Canadian Journal of Library and Information Practice and Research, 8(2). Berg, S. A. & Jacobs, H. L. M. (2013). By librarians, for librarians: Building a strengths-based institute to develop librarians’ research culture in Canadian academic libraries. Journal 
of Academic Librarianship, 39(3), 227-231. Berg, S. A., Jacobs, H. L. M., & Cornwall, D. (2013). Academic librarians and research: A study of Canadian library administrator perspectives. College & Research Libraries, 74(6), 560-572. Jacobs, H. L. M., Berg, S. A. (2011). Reconnecting information literacy with the core values of librarianship. Library Trends, 60(2). Special Issue on Information Literacy Policy, 383-394. Berg, S. A. Harris, R. (2011). “Everyone’s dressed the same”: Pre-clerkship medical students learn who’s who on the health care team. Health and Education, 24(1). Jacobs, H. L. M., Berg, S. A., & Cornwall, D. (2010). Something to talk about: Rethinking conversations on research culture in Canadian academic libraries, Partnership: The 
Canadian Journal of Library and Information Practice and Research, 5(2). Berg, S. A., Hoffmann, K., Dawson, D. (2010). Not on the same page: Undergraduates information retrieval in electronic and print books, Journal of Academic Librarianship, 36(6), 518-525. Berg, S. A., Hoffmann, K., Dawson, D. (2009). Integrating research into LIS field experiences in academic libraries, Journal of Academic Librarianship, 25(6), 591-598. 
 
              241 
 
Selected Conference Presentations 2013-17   Berg, S. A., Hoffmann, K. M., & Koufogiannakis, D. A. (2017). Understanding Research Productivity: Fresh New Evidence for Librarians. Evidence-Based Library and Information Practice 9. Philadelphia, Pennsylvania.  Berg, S. A., Hoffmann, K. M., & Koufogiannakis, D. A. (2017). Understanding Ourselves as 
Researchers; Critical Reflections on National Survey. Canadian Association of 
Professional Academic Librarians. Toronto, Ontario. Berg, S. A., Hoffmann, K. M., & Koufogiannakis, D. A. (2017). Focus on what matters: Factors that improve the research productivity of academic librarians. Ontario Library Association, Toronto, Ontario.  “Success in research: Factors that contribute to research productivity in LIS” May 2014. Canadian Association of Information Science. St. Catharines, Ontario. (Peer reviewed)  
Invited Keynote:  Making it our own: Research culture in Canadian academic libraries. April 2014. Concordia Libraries’ 12th Annual Research Forum. Montreal, Quebec. (Closing Plenary) “‘I felt like a real librarian’: Field experiences as an opportunity for professional identity development” January 2013. Association of Library and Information Sciences Education. Seattle, Washington. with Kristin Hoffmann (Peer reviewed)  "Perceptions of current and ideal research environments:  Feedback from the inaugural Librarians' Research Institute in Canada" July 2013. Evidence Based Library and Information Practice. Saskatoon, Saskatchewan. With Cathy Maskell (Peer reviewed)  
Research Grants and Awards  
Canadian Association of Research Libraries Research Grant: Co-Principal-Investigator Co-op Placements in Academic Libraries: Their Role in the Formation of Professional Identity - Award Date: November 2009  
Research Grant for Women (University of Windsor): Principal Investigator Early Medical Students Perceptions of Information Application & Exchange in Clinical Settings -  Award Date: April 2009 
Courses Taught W2014 & W2015 LIS 9320: Consumer Health   Faculty of Information and Media Studies, Western University  2009- 2015   Patient Centered Context: Integration & Application Year 1     Schulich School of Medicine, Windsor Program  2010- 2015   Patient Centered Context: Integration & Application Year 2    Schulich School of Medicine, Windsor Program   
              242 
 
Related Teaching Experiences 
Research Workshops 
 May 2016 Delving Deeper: Building a Meaningful Program of Research CAPAL 2016 Pre-conference Workshop (workshop design only)  October 2015 Transforming Ideas into Well-Designed Research Questions C-EBLIP 2015 Pre-symposium Workshop  March 2015 Questions, Methods, and Habits: Preconference Workshop Association of College and Research Libraries Conference, Seattle Presented with Heidi LM Jacobs and Kristin Hoffmann  Nov  2014 Librarians as Researchers Grant McEwan Library, Edmonton Workshop presented with Heidi LM Jacobs and Denise Koufogiannakis  May 2014 Questions, Methods, & Habits: A Research Workshop University of Toronto Libraries Workshop presented with Heidi LM Jacobs and Kristin Hoffmann 
Selected Service to Library and Academic Community  2015- present Reviewer: Canadian Journal of Academic Librarianship  Canadian Association of Professional Academic Librarians  2014- present  Reviewer: Partnership Journal   Partnership: The Provincial and Territorial Library Assocs of Canada  2012- present  Reviewer: Journal of Academic Librarianship  Elsevier  2015- 2016 Researcher-in-Residence  Centre for Evidence-Based Library and Information Practice  University of Saskatchewan 2013 and 2014  Librarians’ Research Institute, Program Chair    Canadian Association of Research Libraries  2010 – 2012  2012 Librarians’ Research Institute, Creator, and Program Chair    Canadian Association of Research Libraries 
 
